<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.science.org/doi/10.1126/scitranslmed.abj6824');</script>

        <script> var body_html = '<body > <div > <div > <div > <div > <div > <div > <div > <div > <div > <div > <span >Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header > <div ><div ><div ><div ><div ><div ><div ><a ><div >science</div></a></div></div><div ><div ><a ><div >science advances</div></a></div></div><div ><div ><a ><div >science immunology</div></a></div></div><div ><div ><a ><div >science robotics</div></a></div></div><div ><div ><a ><div >science signaling</div></a></div></div><div ><div ><a ><div >science translational medicine</div></a></div></div><div ><div ><a ><div >science partner journals</div></a></div></div></div></div></div></div></div> <div > <div > <div > <div > <div ><div ><div ><label >Searching:</label><div ><div ><div >AnywhereScienceScience AdvancesScience ImmunologyScience RoboticsScience SignalingScience Translational Medicine</div></div></div></div><div > <a ><u>Advanced Search</u></a> </div></div></div> </div> </div> </div> <div > <div > <div > <h6 >Trending Terms:</h6> <ul > <li > covid-19 </li> <li > climate </li> <li > science policy </li> <li > genome editing </li> <li > batteries </li> </ul> </div> </div> </div> </div> </header><div ><div ><div > <div > <div > <ul > <li > Current Issue </li> <li > First release papers </li> <li > Archive </li> <li > <div > About <div > About Science Translational Medicine Mission Scope Editors and Advisory Boards Editorial Policies Information for Authors Information for Reviewers Journal Metrics Staff Contact Us Subscribe Free Sample Articles </div> </div> </li> </ul> </div> <div > <ul > <li > Submit manuscript </li> <li > <div > More </div> </li> </ul> </div> </div> GET OUR E-ALERTS </div></div></div> <main > <div ><div ><div ><div ><div > <div >HomeScience Translational MedicineFirst ReleaseEscape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity</div><div >Back To First Release</div> </div> <article ><section ><header><div ><div ><div ><div >OPEN ACCESS</div><div >Research Article</div><div >CORONAVIRUS</div></div><div ><div > <div >Share on</div> </div></div></div><h1 >Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity</h1><div ><span ><span >Catherine Riou https://orcid.org/0000-0001-9679-0745 [email protected], Roanne Keeton https://orcid.org/0000-0003-4808-9756, Thandeka Moyo-Gwete https://orcid.org/0000-0002-4269-9281, Tandile Hermanus https://orcid.org/0000-0003-4734-1980, Prudence Kgagudi, Richard Baguma https://orcid.org/0000-0002-5106-021X, Ziyaad Valley-Omar https://orcid.org/0000-0003-4804-3774, … Show All … , Mikhail Smith, Houriiyah Tegally https://orcid.org/0000-0002-7102-8540, Deelan Doolabh, Arash Iranzadeh, Lynn Tyers https://orcid.org/0000-0002-0535-9165, Hygon Mutavhatsindi https://orcid.org/0000-0001-6605-6275, Marius B. Tincho https://orcid.org/0000-0002-1293-5933, Ntombi Benede https://orcid.org/0000-0002-3319-8215, Gert Marais https://orcid.org/0000-0003-1477-6101, Lionel R. Chinhoyi https://orcid.org/0000-0002-5266-4613, Mathilda Mennen, Sango Skelem, Elsa du Bruyn https://orcid.org/0000-0002-5088-2158, Cari Stek<span >, <span >SA-CIN<a ><sup>†</sup></a></span></span>, Tulio de Oliveira https://orcid.org/0000-0002-3027-5254, Carolyn Williamson https://orcid.org/0000-0003-0125-1226, Penny L. Moore https://orcid.org/0000-0001-8719-4028, Robert J. Wilkinson, Ntobeko A. B. Ntusi https://orcid.org/0000-0003-2347-7883, and Wendy A. Burgers https://orcid.org/0000-0003-3396-9398 [email protected] Show Fewer</span></span></div><div >Science Translational Medicine • 21 Dec 2021 • First Release • DOI: 10.1126/scitranslmed.abj6824</div><div ><div > <div > <a ><div ><div ><h6>PREVIOUS ARTICLE</h6><div>A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus</div></div></div>Previous</a><a ><div ><div ><h6>NEXT ARTICLE</h6><div>A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates</div></div></div>Next</a> </div> </div></div></div></header><div ><div ><section ><h2 >Abstract</h2><div >SARS-CoV-2 variants have emerged that escape neutralization and potentially impact vaccine efficacy. T cell responses play a role in protection from reinfection and severe disease, but the potential for spike mutations to affect T cell immunity is incompletely understood. We assessed neutralizing antibody and T cell responses in 44 South African COVID-19 patients infected either with the Beta variant (dominant from November 2020 to May 2021) or infected prior to its emergence (first wave, Wuhan strain), to provide an overall measure of immune evasion. We show that robust spike-specific CD4 and CD8 T cell responses were detectable in Beta-infected patients, similar to first wave patients. Using peptides spanning the Beta-mutated regions, we identified CD4 T cell responses targeting the wild type peptides in 12/22 first wave patients, all of whom failed to recognize corresponding Beta-mutated peptides. However, responses to mutated regions formed only a small proportion (15.7%) of the overall CD4 response, and few patients (3/44) mounted CD8 responses that targeted the mutated regions. Among the spike epitopes tested, we identified three epitopes containing the D215, L18, or D80 residues that were specifically recognized by CD4 T cells, and their mutated versions were associated with a loss of response. This study shows that in spite of loss of recognition of immunogenic CD4 epitopes, CD4 and CD8 T cell responses to Beta are preserved overall. These observations may explain why several vaccines have retained the ability to protect against severe COVID-19 even with substantial loss of neutralizing antibody activity against Beta.</div></section></div></div></section><section ><div ><section ><h2>INTRODUCTION</h2><div >High levels of ongoing SARS-CoV-2 transmission have led to the emergence of successive new viral variants, which now dominate the pandemic. Variants of concern have been characterized as having increased transmissibility, potentially greater pathogenicity, and the ability to evade host immunity (<a ><i>1</i></a>). Five such variants of concern have circulated around the world, namely Alpha, Beta, Gamma, Delta, the latter widely replacing many other variants, and more recently Omicron (<a ><i>2</i></a>–<a ><i>7</i></a>). A primary concern is whether the immune response generated against ancestral SARS-CoV-2 strains, upon which all approved first generation vaccines are based, still confers protection against variants. The potential threat of reduced vaccine efficacy has prompted swift action from vaccine manufacturers, and adapted vaccines based on other variants have been developed and tested in preclinical and clinical trials (<a ><i>8</i></a>, <a ><i>9</i></a>).</div><div >Before the recent emergence of the SARS-CoV-2 Delta variant, the Beta variant, which was first described in South Africa in October 2020 (<a ><i>5</i></a>), was responsible for &gt;95% of infections in the country and has spread across much of southern Africa (<a ><i>6</i></a>). It was a concerning variant from an immunological perspective, demonstrating the greatest reduction in neutralization sensitivity to COVID-19 convalescent and vaccinee plasma (<a ><i>10</i></a>–<a ><i>15</i></a>), as well as reduced vaccine efficacy (<a ><i>16</i></a>–<a ><i>18</i></a>). However, some vaccines have still demonstrated high efficacy against severe COVID-19 after Beta infection (<a ><i>19</i></a>), suggesting that T cell immunity plays an important role in immune protection, and may mitigate the effect of reduced neutralizing antibody activity.</div><div >To date, efforts to characterize immune evasion by SARS-CoV-2 variants have focused mainly on their ability to escape neutralization (<a ><i>10</i></a>–<a ><i>15</i></a>). There is limited data addressing whether SARS-CoV-2 variants can evade T cell immunity (<a ><i>20</i></a>–<a ><i>24</i></a>) in natural infection or after vaccination. Furthermore, spike-specific T cell responses in COVID-19 patients infected with variant lineages have not been investigated. Here, we determined whether Beta spike mutations affect the recognition of T cell epitopes in patients infected with the ancestral or Beta SARS-CoV-2 lineages. We demonstrate that loss of CD4 T cell recognition does indeed occur in Beta-mutated spike regions, although the majority of the T cell response is maintained. Furthermore, Beta-infected patients mounted comparable spike responses as those infected with earlier strains. These results have important implications for reinfection and vaccine efficacy.</div></section><section ><h2>RESULTS</h2><section ><h3>T cell responses in patients infected with ancestral strains or Beta</h3><div >SARS-CoV-2 spike-specific neutralizing antibody and T cell responses were measured in hospitalized COVID-19 patients enrolled at Groote Schuur Hospital (Western Cape, South Africa) during the first wave of the COVID-19 pandemic (n = 22), prior to the emergence of the Beta variant, and during the second wave of the pandemic (n = 22), after the Beta variant became the dominant lineage (<a ><b>Fig. 1A</b></a>). During the first wave, all sequenced virus corresponded to ancestral SARS-CoV-2 lineages (Wuhan and D614G). Conversely, during the second wave, the Beta lineage accounted for &gt;95% of reported SARS-CoV-2 infections at the time of sample collection (<a ><b>Fig. 1B</b></a><b>)</b>. Beta is defined by nine amino acid changes in the spike protein, and all second wave participants that we sequenced (19/22) had confirmed infection with Beta and harbored 7 to 8 changes associated with the Beta lineage (<a ><i>5</i></a>) (<b>Fig. S1</b>). Although SARS-CoV-2 viral sequences were not available for patients recruited in June to August 2020 during the first wave, we assumed that all participants were infected with a virus closely related to the ancestral virus, since Beta was first detected in October 2020 in the Western Cape.</div><div >First, we compared the magnitude of CD4 and CD8 T cell responses directed at the spike protein of SARS-CoV-2 in first and second wave patients. Using flow cytometry, we measured the production of IFN-γ, TNF-α or IL-2 in response to a peptide pool covering the full ancestral spike protein (‘Full spike’) (<a ><b>Fig. 1C</b></a>). All participants tested exhibited a CD4 response, with a comparable frequency of spike specific-CD4 T cells in first and second wave patients (<i>P</i> = 0.072, <a ><b>Fig. 1D</b></a>). A detectable spike CD8 response was observed in 63.6% (14/22) of first wave patients and 81.8% (18/22) of second wave patients (<i>P</i> = 0.31, Fisher's exact test). Amongst CD8 responders, the frequency of SARS-CoV-2 spike-specific CD8 T cell response was not significantly different between first and second wave patients (<i>P</i> = 0.054). As previously reported (<a ><i>25</i></a>), the magnitude of the SARS-CoV-2 spike-specific CD8 T cell response was significantly lower compared to the CD4 response in both first and second wave patients (<i>P</i> = 0.0005 and <i>P</i> = 0.007, respectively). Moreover, there were no significant differences in the frequency of SARS-CoV-2 spike-specific CD4 or CD8 T cells between patients with moderate or severe disease (<i>P</i> = 0.3 and <i>P</i> = 0.36, respectively). Also, no associations were found between the frequency of spike-specific CD4 or CD8 T cells and days post-PCR positivity (<i>P</i> = 0.20, r= 0.28 and <i>P</i> = 0.1, r = 0.24, respectively) or days since symptom onset in patients recruited during the first wave (<i>P</i> = 0.22, r = 0.28 and <i>P</i> = 0.77, r = 0.07, respectively). Lastly, the polyfunctional profiles of SARS-CoV-2 spike-specific CD4 or CD8 T cells were similar between first and second wave patients, with approximately one third of CD4 cells expressing at least two cytokines, while CD8 response was mostly IFN-γ monofunctional (<a ><b>Fig. 1E and F</b></a>).</div><div >To ascertain whether similar patterns were maintained in convalescent COVID-19 donors, we compared the frequency of ancestral SARS-CoV-2 spike-, nucleocapsid (N)- and membrane (M)-specific CD4 and CD8 T cells in convalescent COVID-19 patients infected during the first wave with the ancestral strain (n = 10) or during the second wave, when Beta dominated (n = 14) (<a ><b>Fig. 2A</b></a>). As for acute COVID-19 patients, the magnitude and polyfunctional profiles of ancestral SARS-CoV-2 spike-specific CD4 and CD8 T cell responses were comparable between convalescent individuals infected during the first or the second wave (<a ><b>Fig. 2B, C and D</b></a>). Similar results were observed for CD4 responses against the SARS-CoV-2 N and M proteins (<a ><b>Fig. 2B</b></a>). We also compared the profiles of spike-specific T cell responses cross-sectionally between acute and convalescent COVID-19 patients. Our data show that the frequency of spike-specific CD4 T cells is significantly lower in convalescent compared to acutely infected patients, regardless of the infecting strains (<i>P</i> = 0.03 for WT and <i>P</i> &lt; 0.0001 for Beta) (<b>Fig. S2A</b>), which is likely related to the contraction of antigen-specific responses following viral clearance (<a ><i>26</i></a>). For spike-specific CD8 T cell responses, a lower frequency was observed only between acute and convalescent patients from the second wave (<i>P</i> = 0.034). Lastly, an increase in the polyfunctional profile of both spike-specific CD4 and CD8 T cells was observed in convalescent COVID-19 patients compared to those in the acute phase of infection, characterized by a substantial increase in IFN-γ, TNF-α and IL-2 co-expressing cells for spike-specific CD4 T cells and a significant reduction of IFN-γ monofunctional cells for spike-specific CD8 T cells (<b>Fig. S2B and C</b>). Overall, these data are in accordance with a recent report showing that T cell responses directed at the SARS-CoV-2 spike protein in convalescent COVID-19 donors infected with SARS-CoV-2 ancestral strain were not substantially affected by mutations found in SARS-CoV-2 variants (<a ><i>24</i></a>), and we further show that there is no overall dampening of T cell responses or change in functional profiles to the three immunogenic structural proteins of SARS-CoV-2 in those infected with Beta.</div></section><section ><h3>CD4 T cell targeting of variant spike epitopes</h3><div >Since Beta-associated mutations occur only at a few residues of the spike protein, we assessed the recognition of peptide pools selectively spanning the variable regions of spike, one composed of the ancestral peptides (‘WT pool’) and the other Beta-mutated peptides (‘Beta pool’) (<b>Table S1</b>). Sample availability enabled us to perform these experiments in the acute COVID-19 cohort. Due to elevated TNF-α background observed in unstimulated cells (<a ><b>Fig. 1C</b></a>), we focused on IFN-γ producing cells to measure T cell response to the smaller peptide pools. We previously described that acute COVID-19 patients had SARS-CoV-2-specific CD4 T cells characterized by elevated expression of PD-1 (<a ><i>27</i></a>). Thus, PD-1 was included in our flow cytometry panel to ensure that the phenotypic profile of CD4 T cells responding to the variable spike epitopes were consistent with our previous findings. In patients recruited during the first wave, IFN-γ CD4 T cell responses to the WT pool were detectable in 54.5% (12/22) patients (<a ><b>Fig. 3A and B</b></a>). In those who mounted responses, the magnitude of the WT pool response was ~ 6.4-fold lower than full spike responses (median: 0.0075% vs 0.048%, respectively, <i>P</i> &lt; 0.0001). In the 12 participants responding to the WT pool, the overall median relative contribution of WT epitopes located at spike mutation sites to the total spike-specific CD4 T cell response was 15.7%, ranging from 5.7% to 24%. This suggests that the majority of SARS-CoV-2 spike-specific CD4 T cell responses are directed against conserved epitopes between the ancestral and Beta lineage. When we tested the corresponding Beta pool, all 12 of the first wave WT pool responders failed to cross-react with the mutated peptides from Beta (<a ><b>Fig. 3B</b></a><b>,</b> left panel). These results show that Beta-mutated epitopes were no longer recognized by CD4 T cells targeting WT epitopes, demonstrating that this loss of recognition is likely mediated by variant mutations. This is broadly consistent with recent data from mRNA vaccinees, where full spike pools containing Beta mutated peptides detected T cell responses that were diminished by 30% compared to ancestral spike, revealing that the mutated sequences mediate differential recognition but make up a minor contribution to the overall spike-specific T cell response (<a ><i>24</i></a>).</div><div >We next measured peptide responses in patients infected with the Beta lineage. The Beta pool was not readily recognized by patients infected with the homologous variant (2/22; 9.1%) (<a ><b>Fig. 3B</b></a><b>,</b> right panel). A single donor had a detectable response to the WT but not Beta pool. These data suggest that mutations in Beta spike epitopes likely alter epitope binding to restricting HLA molecules, consistent with the loss of recognition of Beta-mutated peptides by T cells in first wave patients.</div><div >In order to obtain an overall measure of immune escape in our participants, we measured their neutralizing antibody responses to the ancestral and Beta spike proteins (<a ><b>Fig. 3C and D</b></a>). As we showed previously (<a ><i>13</i></a>)<i>,</i> in patients infected with the ancestral strains (first wave), a considerable loss of neutralization activity was observed against Beta (median fold change: 12.7, IQR: 7.3-18.8). In contrast, patients infected with Beta (second wave) retained a substantial capacity to neutralize ancestral virus, as shown by a moderate reduction in neutralizing activity (median: 2.3, IQR: 1.3-3.9). Of note, in the six first wave patients where loss of cross-neutralization was profound (titer &lt;100), it is reassuring that the T cell response was relatively intact. We found no association between the frequency of SARS-CoV-2 spike-specific CD4 T cell responses and neutralizing activity (<b>Fig. S3A</b>), consistent with an earlier study (<a ><i>28</i></a>). Moreover, comparable frequencies of SARS-CoV-2-specific CD4 T cells were observed, irrespective of the extent of the loss of neutralizing activity against heterologous virus (<b>Fig. S3B</b>).</div></section><section ><h3>CD8 T cell targeting of variant spike epitopes</h3><div >We next defined the recognition of WT and Beta peptide pools by CD8 T cells (<a ><b>Fig. 4A</b></a>). Regardless of the infecting SARS-CoV-2 lineage, peptides covering the spike mutation sites were rarely recognized by CD8 T cells, with only 3/44 (6.8%) patients exhibiting a CD8 response, one in the first wave cohort and two in the second wave cohort. Thus, in contrast to CD4 T cells, the regions in which Beta mutations occur are not commonly targeted by CD8 T cells. Moreover, in these three patients, the frequency of IFN-γ-producing CD8 T cells was comparable between WT and Beta pool stimulation, indicating that mutations did not affect epitope recognition (<a ><b>Fig. 4B</b></a>). Overall, these data indicate that Beta mutations do not affect CD8 T cell responses in our cohort.</div></section><section ><h3>Mapping of spike variable epitopes targeted by T cells</h3><div >To gain deeper insight into the recognition of variable spike epitopes by CD4 cells in patients responding to the WT pool, responses to individual epitopes were measured in first wave COVID-19 patients (<a ><b>Fig. 5A</b></a>). Amongst the six tested patients, a response to the spike 206-225 region (containing D215) was observed in 5 out of 6 patients, two of which also displayed a response to spike 6-25 region (containing L18). Moreover, a response toward the spike 73-92 region (containing D80) was detected in one participant (<a ><b>Fig. 5B</b></a>). Mutation of these regions (L18F, D80A and D215G) resulted in a loss of CD4 response (<a ><b>Fig. 3B</b></a> and <a ><b>Fig. 5A</b></a>). No CD4 T cell responses to epitopes containing the K417, E484, N501 or A701 residues were observed (<a ><b>Fig. 5B</b> and <b>C</b></a>).</div><div >To identify the potential HLA restriction associated with the recognition of the L18, D80 and D215 epitopes, predicted HLA class II restriction for each epitope was defined <i>in silico</i> (<b>Table S2</b>) and compared to HLA class II molecules expressed in our study cohort (<b>Table S3</b>). We identified that the D215 epitope was restricted by DRB1*03:01, DRB1*03:02 or DRB1*13:01; and the D215G mutation is predicted to be associated with a loss of response in those three alleles (<b>Data file S1</b>), as previously reported (<a ><i>29</i></a>). Nine first wave patients carried one of these alleles, eight of whom exhibited a response to the D215 epitopes (n = 5) or the WT pool (n = 3). No matching alleles were predicted for the L18 and D80 epitopes, despite CD4 responses to the spike regions 6-20, 11-25 and 78-92 having been previously reported previously (<a ><i>30</i></a>, <a ><i>31</i></a>).</div><div >Due to limited availability of samples, we could not test all WT pool responders for single epitope responses. However, based on predicted HLA class II restriction, we hypothesized that the peptide <sup>236</sup>TRFQTLLALHRSYLT<sup>250</sup> (WT version of the 242-244del/R246I) may be an immunogenetic epitope, as previously described (<a ><i>30</i></a>, <a ><i>32</i></a>, <a ><i>33</i></a>) restricted by DRB1*15:01, DRB1*15:03, DRB1*01:01 or DRB1*14:25 (<b>Table S4</b>). The 242-244del/R246I mutation is predicted to be associated with a loss of response to three of those alleles (DRB1*15:01, DRB1*15:03, and DRB1*14:25), while DRB1*01:01 retains its ability to bind the Beta-mutated epitope (<sup>236</sup>TRFQTLHISYLTPGD<sup>250</sup>, 242-244del/R246I) based on the predicted IC50 and percentile rank value (<b>Data file S1</b>). Of note, 4 out of 6 alleles of interest (DRB1*03:01, DRB1*03:02, DRB1*13:01, DRB1*15:01, DRB1*15:03) exhibited comparable frequency distributions in first and second wave patients, while DRB1*01:01 and DRB1*14:25 were identified in only two patients from wave 1 (<b>Data file S2</b>). Of note, in first wave patients who did not mount a response to the WT pool (n = 10 out of 22, <a ><b>Fig. 4B</b></a>), only two expressed an HLA-DRB1 allele associated with the recognition of the D215 or R246 epitopes. The absence of response in these two donors could be due to the limited sensitivity of the flow cytometry assay used to measure T cell responses in this study.</div><div >In patients infected with Beta, three individuals exhibited a response to the WT pool, two of whom also responded to the Beta pool. Based solely on <i>in silico</i> predicted HLA class II restriction analysis, it was not possible to infer potential targeted peptides, as no specific epitopes could be associated with the HLA class II alleles carried by these patients. Of note, the viral sequence of all three did not have the L18A mutation (maintaining a lysine in position 18, characteristic of the WT strain). Additionally, in one of these responders, no D215G substitution was observed, but this specific individual did not carry any of the alleles associated with the recognition of the D215-containing epitope (<b>Table S4)</b>.</div><div >Regarding specific spike epitopes recognized by CD8 T cells, only three individuals exhibited a CD8 T cell response to the WT pool and comparable responses were obtained with the Beta pool (<a ><b>Fig. 4</b></a>). All epitopes were tested <i>in silico</i> for predictive binding to HLA class I variants (HLA-A and HLA-B) expressed in the cohort (<b>Table S5</b>). The epitope <sup>84</sup>LPFNDGVYF<sup>92</sup> showed the highest ranking for HLA-B*53:01, HLA-B*35:05 and HLA-B*35:30. Since CD8 responding participants carried the HLA-B*53:01 (SA2-016) or HLA-B*35:05 (SA1-098 and SA2-084) allele (<b>Data file S3</b>), this strongly suggests that the <sup>84</sup>LPFNDGVYF<sup>92</sup> epitope is recognized by those participants. This confirms results reported by Tarke <i>et al</i>. (<a ><i>31</i></a>) and further demonstrates that <sup>84</sup>LPFNDGVYF<sup>92</sup> is also restricted by HLA-B*35:05. Moreover, as this predicted 9mer epitope is conserved between the ancestral strain and Beta variant and does not include the beta-mutated residue (D80A), it is unsurprising that the observed CD8 response is comparable when stimulation is performed using the WT or the Beta pool. Finally, these two alleles (B*53:01 and HLA-B*35:05) were found in only four participants (<b>Table S5</b>), three of whom exhibited a CD8 response to the WT and Beta pool.</div></section></section><section ><h2>DISCUSSION</h2><div >We demonstrate that infection with the Beta variant results in robust T cell responses, comparable to responses elicited to ancestral strains. We also demonstrate that the recognition of epitopes by CD4 T cells targeting variable spike regions is affected by Beta spike mutations in patients infected with ancestral lineages. However, the loss of recognition of Beta mutated spike epitopes had a minor impact on the overall CD4 Th1 cell response. Moreover, CD8 T cell responses to spike were unaffected by mutations in Beta.</div><div >We focused our analysis on spike, because specific mutations or deletions within or outside of T cell epitopes can lead to lack of cross-recognition, or loss of presentation, and may have important implications for vaccine protection. However, recent studies have revealed a more global strategy employed by SARS-CoV-2 variants to potentially evade immunity. The suppression of innate immune responses was demonstrated for the Alpha variant, as well as interferon resistance in vitro (<a ><i>34</i></a>, <a ><i>35</i></a>). Thus, given the possibility that variant mutations may have broader effects on adaptive responses, we also examined T cell responses to other dominant targets, namely the nucleocapsid and membrane proteins (<a ><i>26</i></a>, <a ><i>28</i></a>, <a ><i>31</i></a>, <a ><i>36</i></a>). We detected similar T cell response frequencies between first and second wave convalescent donors for both CD4 and CD8 T cells, irrespective of the SARS-CoV-2 protein examined, suggesting that there was not a general dampening of T cell responses to Beta. Altogether, we confirm that infection with Beta does not significantly affect the overall recognition or functional profile of T cell responses to the ancestral virus in either acute or chronic infection.</div><div >It is of interest to determine whether specific mutations in SARS-CoV-2 variants may lead to evasion of cellular immunity, as has been demonstrated for neutralizing antibodies. Having demonstrated that ancestral versions of peptides mutated in Beta were targeted by CD4 T cells from first wave participants, and there was a loss of recognition of the Beta peptides, we reasoned that one or more epitopes in the Beta pool may be affected by variant mutations. We identified three epitopes containing the D215, L18, or D80 residues that were specifically recognized by CD4 T cells, and mutated versions in Beta were associated with a loss of response. HLA genotyping revealed the predicted MHC class II alleles restricting the D215 epitope, and <i>in silico</i> analyses confirmed that mutations would no longer be restricted by those alleles. This provides important information regarding mutations occurring in SARS-CoV-2 variants, the predicted epitopes within which they are located, immune evasion properties associated with them, and their restricting alleles. Of note, the L18F mutation is of importance as it is a frequently observed mutation, with a 4% cumulative prevalence in all SARS-CoV-2 sequences in GISAID (<a ><i>37</i></a>)<i>,</i> present in Gamma and in a number of other lineages, in particular B.1.177 that circulated widely in Europe (<a ><i>38</i></a>). L18F is expected to have a detrimental impact on antibody binding, thus the mutation could result from selective pressure from both antibodies and T cells. D215, located in the epitope most frequently targeted by first wave patients of the three epitopes we identified, is mutated to G in Beta, which is shared by the C.1.2 variant (<a ><i>39</i></a>), a highly mutated variant under monitoring, as well as B.1.616 and AT.1 lineages, all of which occur at frequencies &lt;0.5% worldwide (<a ><i>40</i></a>). These observations further underscore the limited impact these mutations may have on the CD4 T cell response at a global level.</div><div >We were unable to confirm class II HLA restriction of the peptides containing the L18 and D80 residues, with the predicted HLA molecules for the L18 epitope not matching those expressed in our cohort, and no restricting alleles predicted for the D80-containing peptide. Epitopes containing these residues have been described in other studies, without presenting HLA restriction (<a ><i>30</i></a>, <a ><i>31</i></a>).This is likely due to the limited accuracy of Class II prediction algorithms. An additional CD4 epitope containing the R246 residue is a likely target for which HLA binding is abrogated in the Beta variant for particular Class II alleles, and may have also contributed to targeting of the WT pool. However, limited cell availability prevented us from experimentally confirming the targeting of this epitope in our cohort, but several studies have confirmed targeting of this region (<a ><i>30</i></a>, <a ><i>32</i></a>, <a ><i>33</i></a>).</div><div >We found that spike-specific CD8 responses were not affected by mutations in Beta in our cohort. A single epitope (residues 84-94 of spike) was predicted to account for the CD8 response to the WT or Beta pool in three individuals in the cohort. Consistent with the recognition of both WT and mutated pools, the mutation fell outside the core binding motif for the predicted restricting Class I HLA molecules expressed by these donors. Overall, our results emphasize that the HLA repertoire in individuals determined whether they were impacted by mutations in variant epitopes, rather than the mutated epitopes dictating population-wide effects, as observed with certain key neutralizing antibody epitopes in variants of concern. These observations further emphasize that HLA polymorphism will likely limit the impact of T cell escape on SARS-CoV-2 immunity to viral variants. Two possible scenarios could change this: 1) the mutation of dominant epitopes (<a ><i>32</i></a>) or those broadly restricted (‘promiscuous epitopes’) by multiple commonly-expressed alleles (<a ><i>29</i></a>), or 2) if accumulation of mutations associated with T cell evasion occurs in variants. To date, neither of these have occurred.</div><div >This work extends our recent findings characterizing neutralizing antibody responses elicited by Beta (<a ><i>13</i></a>, <a ><i>41</i></a>). Neutralization resistance for Beta, Gamma and Delta confers the ability to evade antibodies after infection and vaccination, to varying degrees (<a ><i>11</i></a>, <a ><i>42</i></a>–<a ><i>44</i></a>). Beta is approximately 10-fold more resistant to convalescent plasma and sera from vaccinated individuals than ancestral SARS-CoV-2 (<a ><i>14</i></a>, <a ><i>15</i></a>, <a ><i>45</i></a>). Comparative analyses of SARS-CoV-2 variants demonstrated that Beta is the most refractory to neutralization of all the VOC that have emerged to date (<a ><i>12</i></a>, <a ><i>46</i></a>, <a ><i>47</i></a>), however early indications are that Omicron will result in greater escape from neutralization (<a ><i>48</i></a>).</div><div >Recent studies examining vaccine-induced neutralizing antibodies (nAb) and vaccine efficacy demonstrate that nAb titers are a correlate of protection (<a ><i>49</i></a>, <a ><i>50</i></a>). The demonstration of an antibody correlate does not preclude a contribution from other immune components for protection. CD4 T cell responses are required for strong Ab responses, and CD8 T cells play an important role in the context of sub-optimal antibody titers in a macaque model (<a ><i>51</i></a>). Multiple mechanisms, involving nAb, CD4 and CD8 T cells acting in a coordinated manner appear to effectively control established infection (<a ><i>52</i></a>).</div><div >In contrast to neutralizing antibody epitopes, T cell epitopes are abundantly located across the spike protein (<a ><i>30</i></a>, <a ><i>31</i></a>, <a ><i>53</i></a>–<a ><i>55</i></a>). Regions in spike most frequently targeted by CD4 T cells are the N-terminal domain of both the S1 and S2 subunits, with the receptor binding domain (RBD) being relatively epitope-poor (<a ><i>31</i></a>). This is consistent with the three CD4 epitopes we identified in this study. In contrast, CD8 T cell epitopes are broadly distributed across spike (<a ><i>31</i></a>, <a ><i>53</i></a>). Sustained efforts to map epitopes in spike, particularly in a range of populations encompassing greater HLA diversity will be beneficial for evaluating the effect on T cell immunity for mutations that may arise in future VOC. Thus, it is unsurprising that Beta retains the ability to generate strong T cell immune responses, as Beta spike mutations are limited to a few residues.</div><div >Viral evasion of cytotoxic T lymphocyte or T helper recognition may result in delayed clearance of infected cells, or inadequate help provided to B cells, influencing the antibody response. Viral escape from specific SARS-CoV-2 CD8 epitopes has recently been described, in spike, nucleocapsid and ORF3a (<a ><i>20</i></a>, <a ><i>21</i></a>, <a ><i>23</i></a>). Both CD4 and CD8 T cells can exert selective pressure on viruses resulting in mutational escape, thereby driving viral evolution. In addition to their role in supporting the maturation of B cells and CD8 T cell responses, CD4 T cells may play additional antiviral roles, including directly lysing infected cells (<a ><i>56</i></a>). Indeed, transcriptomic profiles of SARS-CoV-2-specific CD4 T cells demonstrated a subset expressing transcripts for cytotoxic molecules (<a ><i>57</i></a>). Abundant populations of cytotoxic CD4 have been described in the lungs in COVID-19 patients (<a ><i>58</i></a>), where they may participate in viral clearance. In addition to direct selective pressure, mutations occurring in response to immune pressure from neutralizing antibodies or associated with increased viral infectivity (<a ><i>23</i></a>) could coincide with T cell epitopes, thus representing ‘collateral damage’ for the T cell response.</div><div >Our study had several limitations. Although convenient for mapping approaches, it has been demonstrated that 15mer peptides are not optimal for all HLA class I-restricted T cells (<a ><i>59</i></a>). Approaches using optimal CD8 epitopes (<a ><i>25</i></a>, <a ><i>53</i></a>) may have yielded greater sensitivity to detect CD8 responses. Furthermore, examining responses to Beta in the context of full mutated spike (<a ><i>22</i></a>, <a ><i>24</i></a>) would corroborate our findings regarding the degree to which the overall spike T cell response is affected by mutations.</div><div >In conclusion, although Beta no longer has significant prevalence compared to Delta and the highly mutated Omicron in residues that are key for antibody recognition, these results are relevant in advancing our understanding of the cross-reactive potential of T cell immunity in the context of viral variability and highlight the importance of monitoring both antibody and T cell responses to emerging SARS-CoV-2 variants. We demonstrate a limited effect of viral mutations on T cell immunity which may explain why, despite substantial loss of neutralizing antibody activity against Beta and Delta, vaccines have retained the ability to protect against severe COVID-19. We and others have shown that vaccine-induced T cell immunity effectively recognizes SARS-CoV-2 variants (<a ><i>24</i></a>, <a ><i>60</i></a>–<a ><i>63</i></a>). While second generation vaccines based on SARS-CoV-2 variants are desirable, they may not be needed to generate improved T cell responses.</div></section><section ><h2>MATERIALS AND METHODS</h2><section ><h3>Study Design</h3><div >Hospitalized patients with PCR-confirmed acute COVID-19 were enrolled at Groote Schuur Hospital (Cape Town, Western Cape, South Africa) between June 11<sup>th</sup> and August 21<sup>st</sup>, 2020 (first wave, n = 22) and between December 31<sup>st</sup>, 2020 and January 15<sup>th</sup>, 2021 (second wave, n = 22). The clinical characteristics of participants are summarized in <a ><b>Fig. 1A</b></a>. Clinical folders were consulted for all second wave patients and none showed evidence of prior symptomatic COVID-19. Blood samples were obtained a median of 4.5 days [interquartile range (IQR): 3-7] after a positive PCR test for SARS-CoV-2 for first wave patients, and 8 days [IQR: 4-16] for second wave patients. Viral sequences were available for 19/22 s wave participants (<b>Fig. S1</b>). T cell responses were assessed by stimulating PBMC with peptide pools spanning full-length spike or smaller pools covering the regions mutated in Beta, followed by intracellular cytokine staining and flow cytometry (<b>Fig. S4</b>). Additionally, convalescent COVID-19 patients infected with the ancestral SARS-CoV-2 strain or Beta were included in this study. Samples were obtained a median of 98 days [IQR: 79-110] after a positive PCR test for first wave participants, and 67 days [IQR: 54-105] for second wave participants (<b>Fig. S2A</b>). The study was approved by the University of Cape Town Human Research Ethics Committee (HREC: 207/2020 and R021/2020) and written informed consent was obtained from all participants.</div></section><section ><h3>SARS-CoV-2 spike whole genome sequencing</h3><div >Whole genome sequencing of SARS-CoV-2 was performed using nasopharyngeal swabs obtained from 19 of the hospitalized patients recruited during the second wave.</div><div >Sequencing was performed as previously published (<a ><i>41</i></a>). Briefly, cDNA was synthesized from RNA extracted from swabs using the Superscript IV First Strand synthesis system (Life Technologies) and random hexamer primers. Whole genome amplification was performed by multiplex PCR using the ARTIC V3 protocol (https://www.protocols.io/view/ncov-2019-sequencing-protocol-v3-locost-bh42j8ye). PCR products were purified with AMPure XP magnetic beads (Beckman Coulter) and quantified using the Qubit dsDNA High Sensitivity assay on the Qubit 3.0 instrument (Life Technologies). The Illumina® DNA Prep kit was used to prepare indexed paired end libraries of genomic DNA. Sequencing libraries were normalized to 4 nM, pooled, and denatured with 0.2 N sodium hydroxide. Libraries were sequenced on the Illumina MiSeq instrument. The quality control checks on raw sequence data and the genome assembly were performed using Genome Detective 1.132 (<a >https://www.genomedetective.com</a>) and the Coronavirus Typing Tool (<a ><i>64</i></a>). The initial assembly was polished by aligning mapped reads to the references and filtering out low-quality mutations using bcftools 1.7-2 mpileup method. Mutations were confirmed visually with bam files using Geneious software (Biomatters Ltd). Phylogenetic clade classification of the genomes in this study consisted of analyzing them against a global reference dataset using a custom pipeline based on a local version of NextStrain (<a >https://github.com/nextstrain/ncov</a>) (<a ><i>65</i></a>). The workflow performs alignment of genomes, phylogenetic tree inference, tree dating and ancestral state construction and annotation. Phylogenetic trees were visualized using ggplot and ggtree (<a ><i>66</i></a>). GISAID accession numbers are as follows: EPI_ISL_1040644, 1040645, 1040646, 1040650, 1040654, 1040656, 1040659, 1040672, 1040683, 1040692, 1040696, 1040697, 1040698, 1040707, 1040714, 1040716, 1040754, 1040758, 1534362.</div></section><section ><h3>Ancestral (wild type) and Beta variant SARS-CoV-2 peptides</h3><div >To assess the response to the full length SARS-CoV-2 spike protein, we combined two commercially available peptide pools (PepTivator®, Miltenyi Biotech) including: i) a pool of peptides (15mers with 11 aa overlap) covering the ancestral N-terminal S1 domain of SARS-CoV-2 (GenBank MN908947.3, Protein QHD43416.1) from aa 1 to 692 and ii) a pool of peptides(15mers with 11 aa overlap) covering the immunodominant sequence domains of the ancestral C-terminal S2 domain of SARS-CoV-2 (GenBank MN908947.3, Protein QHD43416.1) including aa 683-707, aa 741-770, aa 785-802, and aa 885-1273. Pools were resuspended in distilled water at 50 μg/mL. Individual peptides (15mers with 11 aa overlap) spanning ancestral or Beta spike mutation sites (L18F, D80A, D215G, del 242-244, R246I, K417N, E484K, N501Y and A701V) were synthesized (GenScript) and individually resuspended in dimethyl sulfoxide (DMSO; Sigma-Aldrich) at 20 μg/mL. Peptide sequences are provided in <b>Table S1</b>, which also indicates where their recognition has been previously described (<a ><i>30</i></a>, <a ><i>31</i></a>, <a ><i>55</i></a>). Ancestral or Beta pools (16 peptides) selectively spanning the mutated regions were created by pooling aliquots of these individual peptides at a final concentration of 160 μg/mL. To assess T cell responses to SARS-CoV-2 nucleocapsid and membrane proteins, commercially available peptide pools (15mers with 11 aa overlap, PepTivator®, Miltenyi) covering the complete sequence of the SARS-CoV-2 membrane glycoprotein (M, GenBank MN908947.3, Protein QHD43419.1) or nucleocapsid (N, GenBank MN908947.3, Protein QHD43423.2) were used.</div></section><section ><h3>Isolation of peripheral blood mononuclear cells (PBMC)</h3><div >Blood was collected in heparin tubes and processed within 3 hours. PBMC were isolated by density gradient sedimentation using Ficoll-Paque (Amersham Biosciences) as per the manufacturer’s instructions and cryopreserved in freezing media consisting of heat-inactivated fetal bovine serum (FBS, Thermo Fisher Scientific) containing 10% DMSO and stored in liquid nitrogen.</div></section><section ><h3>Cell stimulation and flow cytometry staining</h3><div >Cryopreserved PBMC were thawed, washed and rested in RPMI 1640 containing 10% heat-inactivated FBS for 4 hours. PBMC were seeded in a 96-well V-bottom plate at ~2 × 10<sup>6</sup> PBMC per well and stimulated with SARS-CoV-2 M or N peptide pools (4 μg/mL), SARS-CoV-2 spike peptide pools: full spike pool (4 μg/mL), and ancestral and Beta pools selectively spanning the mutated regions (4 μg/mL). All stimulations were performed in the presence of Brefeldin A (10 μg/mL, Sigma-Aldrich) and co-stimulatory antibodies against CD28 (clone 28.2) and CD49d (clone L25) (1 μg/mL each; BD Biosciences). As a negative control, PBMC were incubated with co-stimulatory antibodies, Brefeldin A and an equimolar amount of DMSO (0.15%).</div><div >After 16 hours of stimulation, cells were washed, stained with LIVE/DEAD Fixable Near-IR Stain (Invitrogen) and subsequently surface stained with the following antibodies: CD4 BV785 (OKT4, Biolegend), CD8 BV510 (RPA-8, Biolegend), PD-1 PE (J105, eBioscience). Cells were then fixed and permeabilized using a Transcription Factor Fixation buffer (eBioscience) and stained with CD3 BV650 (OKT3), IFN-γ BV711 (4S.B3), TNF-α PE-cy7 (MAB11) and IL-2 PE-Dazzle (MQ1-17H12) from Biolegend. Finally, cells were washed and fixed in 1% formaldehyde in PBS. Samples were acquired on a BD LSR-II flow cytometer and analyzed using FlowJo (v9.9.6, FlowJo LLC). The gating strategy is presented in <b>Fig. S5.</b> A cytokine response was defined as positive when the frequency of cytokine produced in stimulated wells was at least twice the background of unstimulated cells. All summary data are presented after background subtraction. For the identification of specific spike epitopes, five acute COVID-19 patients and one convalescent donor were tested.</div></section><section ><h3>SARS-CoV-2 pseudovirus based neutralization assay</h3><div >SARS-CoV-2 pseudotyped lentiviruses were prepared by co-transfecting the HEK 293T cell line with the SARS-CoV-2 614G spike (D614G) or SARS-CoV-2 Beta spike (L18F, D80A, D215G, K417N, E484K, N501Y, A701V, 242-244 del) plasmids with a firefly luciferase encoding lentivirus backbone plasmid. The parental plasmids were provided by Drs Elise Landais and Devin Sok (IAVI). For the neutralization assays, heat-inactivated plasma samples were incubated with SARS-CoV-2 pseudotyped virus for 1 hour at 37°C, 5% CO<sub>2</sub>. Subsequently, 1x10<sup>4</sup> HEK293T cells engineered to overexpress ACE-2, provided by Dr Michael Farzan (Scripps Research Institute), were added and the incubated at 37°C, 5% CO<sub>2</sub> for 72 hours, upon which the luminescence of the luciferase gene was measured. CB6 and CA1 monoclonal antibodies were used as controls.</div></section><section ><h3>HLA typing</h3><div >Genomic DNA was isolated from PBMC using standard techniques (Qiagen). Amplicons for class I (HLA-A, B and C) and II (DRB1, DQB1 and DPB1) HLA loci were generated using the NGSgo®-MX6-1 multiplex PCR (GenDX), according to the manufacturer’s instructions. Sequencing libraries were prepared using the NGSgo-LibrX kit (GenDX), dual indexed using the NGSgo-IndX kit (GenDX) and pooled, according to the manufacturer’s instructions. Pooled libraries were loaded at 12 pM on a MiSeq Micro flow cell (Illumina) and run using a MiSeq reagent kit V2 (Illumina). Paired-end sequencing was performed on the MiSeq NGS platform (Illumina), 151 cycles in each direction. HLA typing calls were made using the NGS-engine HLA typing software package (Version 2.22, GenDX) along with the 3.44.1 version of the IPD-IMGT/HLA database. HLA class II and class I genotypes are presented in <b>Table S3</b> and <b>Table S5</b>. The frequency distributions of HLA-DRB1, HLA-A and HLA-B alleles were comparable between patients recruited during first or second wave of the COVID-19 epidemic (<b>Data file S2</b>).</div></section><section ><h3>HLA class I and HLA class II binding prediction for T cell epitopes</h3><div >Putative HLA restrictions were inferred using the Immune Epitope Database (IEDB, <a >http://tools.iedb.org/main/</a>). For HLA class I, all peptides included in the WT and Beta pools (<b>Table S1</b>) were submitted to Tepitool (<a >http://tools.iedb.org/tepitool/</a>) using the NetMHCpan method, including all HLA-A and HLA-B alleles identified in the study cohort (<b>Data file S2</b>). The epitopes that had a predicted IC50 &gt; 50 nM were excluded and sequences ordered by percentile rank (<a ><i>67</i></a>). For class II, the same peptides were submitted to the IEDB MHC class II epitope prediction tool (<a >http://tools.iedb.org/mhcii/</a>) including all HLA-DP, DQ and DR alleles identified in the cohort (<b>Data file S1</b>). HLA class II binding predictions were performed using two methodologies: first, NetMHCIIpan 3.2 (<a ><i>68</i></a>, <a ><i>69</i></a>) was used to extract IC50 predicted values, then the IEDB recommended 2.22 methodology (combining the comblib (<a ><i>70</i></a>), SMM (<a ><i>71</i></a>), NN (<a ><i>68</i></a>) and Sturniolo (<a ><i>72</i></a>) algorithms was used and rank percentile values were extracted. Only epitopes with a predicted IC50 &lt; 500 nM and percentile rank ≤ 20 were selected.</div></section><section ><h3>Statistical analyses</h3><div >Analyses were performed in Prism (v9; GraphPad). Non-parametric tests were used for all comparisons. The Mann-Whitney and Wilcoxon tests were used for unmatched and paired samples, respectively. <i>P</i> values less than 0.05 were considered to indicate statistical significance. All data used to compile figures can be found in <b>Data file S4</b>.</div></section></section><section ><h2>Acknowledgments</h2><div >We thank the study participants and their families, and the clinical staff and personnel at Groote Schuur Hospital for their support and dedication. We thank the informal Variant consortium of South Africa, chaired by Drs Willem Hanekom and Tulio de Oliveira, for suggestions and discussion of data. For the purposes of open access, the authors have applied a CC BY public copyright license to any author-accepted version arising from this submission.</div><div ><b>Funding:</b> This research was supported by the South African Medical Research Council, with funds received from the South African Department of Science and Innovation (DSI), and the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), which is supported by core funding from the Wellcome Trust [203135/Z/16/Z]. CR and WAB are supported by the EDCTP2 program of the European Union (EU)’s Horizon 2020 program (TMA2017SF-1951-TB-SPEC to CR and TMA2016SF-1535-CaTCH-22 to WAB). This work is further supported by the National Institutes of Health (R21AI148027 to CR), Francis Crick Institute, which receives funding from Wellcome FC0010218, UKRI FC0010218 and CRUK FC0010218 and the Rosetrees Trust grant M926 (to CR and RJW). PLM is supported by the South African Research Chairs Initiative of the DSI and the National Research Foundation (Grant No 9834). NABN acknowledges funding from the SA-MRC, MRC UK, NRF, and the Lily and Ernst Hausmann Trust.</div><div ><b>Author contributions:</b> WAB, CR, PLM, NABN and RJW conceived and designed the study, acquired funding and supervised the work. LRC, MM, SS, EdB and CS recruited the study participants. CR, RK, RB, HM, MBT and NB performed the T cell experiments. TH, TM-G and PK performed the neutralizing assays. ZV-O and MS performed HLA typing. HT, DD, LT, AI, GM, CW and TdO performed the sequencing and phylogenetic analyses. CR and WAB analyzed the data and wrote the manuscript, with all authors contributing by providing critical feedback and final review.</div><div ><b>Competing interests:</b> The authors declare that they have no competing interests.</div><div ><b>Data and materials availability:</b> All data are available in the main text or the supplementary materials. All materials used in this manuscript are commercially available.</div><div >This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit <a >https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.</div></section> </div></section><section ><div ><section ><h2>Supplementary Materials</h2><section ><h3>This PDF file includes:</h3><div ><div ><div>Figs. S1 to S5</div><div>Tables S1 to S5</div><div>List of members of the South African cellular immunity network (SA-CIN)</div></div><div ><a >Download (772.12 KB)</a></div></div></section><section ><h3>Other Supplementary Material for this manuscript includes the following:</h3><div ><div ><div>Data files S1 to S4</div></div><div ><a >Download (81.32 KB)</a></div></div><div ><div ><div>MDAR Reproducibility Checklist</div></div><div ><a >Download (68.17 KB)</a></div></div></section></section><section ><h2>References and Notes</h2><div ><div >1</div><div ><div ><div >J. A. Plante, B. M. Mitchell, K. S. Plante, K. Debbink, S. C. Weaver, V. D. Menachery, The variant gambit: COVID-19's next move. Cell Host Microbe <b>29</b>, 508–515 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >2</div><div ><div ><div >Centers for Disease Control and Prevention, 2021. <a >https://covid.cdc.gov/covid-data-tracker/#datatracker-home</a>. <i>Accessed 10 September 2021</i>.</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >3</div><div ><div ><div >European Centre for Disease Prevention and Control, 2021. <a >https://www.ecdc.europa.eu/en/covid-19/variants-concern</a>. <i>Accessed 10 September 2021</i>.</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >4</div><div ><div ><div >S. Cherian, V. Potdar, S. Jadhav, P. Yadav, N. Gupta, M. Das, P. Rakshit, S. Singh, P. Abraham, S. Panda, N. Team, SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms <b>9</b>, 1542 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >5</div><div ><div ><div >H. Tegally, E. Wilkinson, M. Giovanetti, A. Iranzadeh, V. Fonseca, J. Giandhari, D. Doolabh, S. Pillay, E. J. San, N. Msomi, K. Mlisana, A. von Gottberg, S. Walaza, M. Allam, A. Ismail, T. Mohale, A. J. Glass, S. Engelbrecht, G. Van Zyl, W. Preiser, F. Petruccione, A. Sigal, D. Hardie, G. Marais, N. Y. Hsiao, S. Korsman, M.-A. Davies, L. Tyers, I. Mudau, D. York, C. Maslo, D. Goedhals, S. Abrahams, O. Laguda-Akingba, A. Alisoltani-Dehkordi, A. Godzik, C. K. Wibmer, B. T. Sewell, J. Lourenço, L. C. J. Alcantara, S. L. Kosakovsky Pond, S. Weaver, D. Martin, R. J. Lessells, J. N. Bhiman, C. Williamson, T. de Oliveira, Detection of a SARS-CoV-2 variant of concern in South Africa. Nature <b>592</b>, 438–443 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >6</div><div ><div ><div >E. Wilkinson, M. Giovanetti, H. Tegally, J. E. San, R. Lessells, D. Cuadros, D. P. Martin, D. A. Rasmussen, A. N. Zekri, A. K. Sangare, A. S. Ouedraogo, A. K. Sesay, A. Priscilla, A. S. Kemi, A. M. Olubusuyi, A. O. O. Oluwapelumi, A. Hammami, A. A. Amuri, A. Sayed, A. E. O. Ouma, A. Elargoubi, N. A. Ajayi, A. F. Victoria, A. Kazeem, A. George, A. J. Trotter, A. A. Yahaya, A. K. Keita, A. Diallo, A. Kone, A. Souissi, A. Chtourou, A. V. Gutierrez, A. J. Page, A. Vinze, A. Iranzadeh, A. Lambisia, A. Ismail, A. Rosemary, A. Sylverken, A. Femi, A. Ibrahimi, B. Marycelin, B. S. Oderinde, B. Bolajoko, B. Dhaala, B. L. Herring, B. M. Njanpop-Lafourcade, B. Kleinhans, B. McInnis, B. Tegomoh, C. Brook, C. B. Pratt, C. Scheepers, C. G. Akoua-Koffi, C. N. Agoti, C. Peyrefitte, C. Daubenberger, C. M. Morang’a, D. J. Nokes, D. G. Amoako, D. L. Bugembe, D. Park, D. Baker, D. Doolabh, D. Ssemwanga, D. Tshiabuila, D. Bassirou, D. S. Y. Amuzu, D. Goedhals, D. O. Omuoyo, D. Maruapula, E. Foster-Nyarko, E. K. Lusamaki, E. Simulundu, E. M. Ong’era, E. N. Ngabana, E. Shumba, E. El Fahime, E. Lokilo, E. Mukantwari, E. Philomena, E. Belarbi, E. Simon-Loriere, E. A. Anoh, F. Leendertz, F. Ajili, F. O. Enoch, F. Wasfi, F. Abdelmoula, F. S. Mosha, F. T. Takawira, F. Derrar, F. Bouzid, F. Onikepe, F. Adeola, F. M. Muyembe, F. Tanser, F. A. Dratibi, G. K. Mbunsu, G. Thilliez, G. L. Kay, G. Githinji, G. van Zyl, G. A. Awandare, G. Schubert, G. P. Maphalala, H. C. Ranaivoson, H. Lemriss, H. Anise, H. Abe, H. H. Karray, H. Nansumba, H. A. Elgahzaly, H. Gumbo, I. Smeti, I. B. Ayed, I. Odia, I. B. Ben Boubaker, I. Gaaloul, I. Gazy, I. Mudau, I. Ssewanyana, I. Konstantinus, J. B. Lekana-Douk, J. C. Makangara, J. M. Tamfum, J. M. Heraud, J. G. Shaffer, J. Giandhari, J. Li, J. Yasuda, J. Q. Mends, J. Kiconco, J. M. Morobe, J. O. Gyapong, J. C. Okolie, J. T. Kayiwa, J. A. Edwards, J. Gyamfi, J. Farah, J. Nakaseegu, J. M. Ngoi, J. Namulondo, J. C. Andeko, J. J. Lutwama, J. O’Grady, K. Siddle, K. T. Adeyemi, K. A. Tumedi, K. M. Said, K. Hae-Young, K. O. Duedu, L. Belyamani, L. Fki-Berrajah, L. Singh, L. O. Martins, L. Tyers, M. Ramuth, M. Mastouri, M. Aouni, M. El Hefnawi, M. I. Matsheka, M. Kebabonye, M. Diop, M. Turki, M. Paye, M. M. Nyaga, M. Mareka, M. M. Damaris, M. W. Mburu, M. Mpina, M. Nwando, M. Owusu, M. R. Wiley, M. T. Youtchou, M. O. Ayekaba, M. Abouelhoda, M. G. Seadawy, M. K. Khalifa, M. Sekhele, M. Ouadghiri, M. M. Diagne, M. Mwenda, M. Allam, M. V. T. Phan, N. Abid, N. Touil, N. Rujeni, N. Kharrat, N. Ismael, N. Dia, N. Mabunda, N. Y. Hsiao, N. B. Silochi, N. Nsenga, N. Gumede, N. Mulder, N. Ndodo, N. H. Razanajatovo, N. Iguosadolo, O. Judith, O. C. Kingsley, O. Sylvanus, O. Peter, O. Femi, O. Idowu, O. Testimony, O. E. Chukwuma, O. E. Ogah, C. K. Onwuamah, O. Cyril, O. Faye, O. Tomori, P. Ondoa, P. Combe, P. Semanda, P. E. Oluniyi, P. Arnaldo, P. K. Quashie, P. Dussart, P. A. Bester, P. K. Mbala, R. Ayivor-Djanie, R. Njouom, R. O. Phillips, R. Gorman, R. A. Kingsley, R. A. A. Carr, S. El Kabbaj, S. Gargouri, S. Masmoudi, S. Sankhe, S. B. Lawal, S. Kassim, S. Trabelsi, S. Metha, S. Kammoun, S. Lemriss, S. H. A. Agwa, S. Calvignac-Spencer, S. F. Schaffner, S. Doumbia, S. M. Mandanda, S. Aryeetey, S. S. Ahmed, S. Elhamoumi, S. Andriamandimby, S. Tope, S. Lekana-Douki, S. Prosolek, S. Ouangraoua, S. A. Mundeke, S. Rudder, S. Panji, S. Pillay, S. Engelbrecht, S. Nabadda, S. Behillil, S. L. Budiaki, S. van der Werf, T. Mashe, T. Aanniz, T. Mohale, T. Le-Viet, T. Schindler, U. J. Anyaneji, U. Chinedu, U. Ramphal, U. Jessica, U. George, V. Fonseca, V. Enouf, V. Gorova, W. H. Roshdy, W. K. Ampofo, W. Preiser, W. T. Choga, Y. Bediako, Y. Naidoo, Y. Butera, Z. R. de Laurent, A. A. Sall, A. Rebai, A. von Gottberg, B. Kouriba, C. Williamson, D. J. Bridges, I. Chikwe, J. N. Bhiman, M. Mine, M. Cotten, S. Moyo, S. Gaseitsiwe, N. Saasa, P. C. Sabeti, P. Kaleebu, Y. K. Tebeje, S. K. Tessema, C. Happi, J. Nkengasong, T. de Oliveira, A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. Science <b>374</b>, 423–431 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >7</div><div ><div ><div >S. S. A. Karim, Q. A. Karim, Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic. Lancet <b>398</b>, 2126–2128 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >8</div><div ><div ><div >A. J. Spencer, S. Morris, M. Ulaszewska, C. Powers, R. Kaliath, C. D. Bissett, A. Truby, N. Thakur, J. Newman, E. R. Allen, I. Rudiansyah, C. Lui, W. Dejnirattisai, J. Mongkolsapaya, H. Davies, F. R. Donnellan, D. Pulido, T. P. Peacock, W. S. Barclay, H. Bright, K. Ren, G. Screaton, P. McTammy, D. Bailey, S. C. Gilbert, T. Lambe, The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 B.1.351 and other variants of concern in preclinical studies, Biorxiv, 2021.06.08.447308 (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >9</div><div ><div ><div >K. Wu, A. Choi, M. Koch, L. Ma, A. Hill, N. Nunna, W. Huang, J. Oestreicher, T. Colpitts, H. Bennett, H. Legault, Y. Paila, B. Nestorova, B. Ding, R. Pajon, J. M. Miller, B. Leav, A. Carfi, R. McPhee, D. K. Edwards, Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster, Medrxiv, 2021.05.05.21256716 (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >10</div><div ><div ><div >S. Cele, I. Gazy, L. Jackson, S.-H. Hwa, H. Tegally, G. Lustig, J. Giandhari, S. Pillay, E. Wilkinson, Y. Naidoo, F. Karim, Y. Ganga, K. Khan, M. Bernstein, A. B. Balazs, B. I. Gosnell, W. Hanekom, M. S. Moosa, R. J. Lessells, T. de Oliveira, A. Sigal; Network for Genomic Surveillance in South Africa; COMMIT-KZN Team, Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature <b>593</b>, 142–146 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >11</div><div ><div ><div >R. E. Chen, X. Zhang, J. B. Case, E. S. Winkler, Y. Liu, L. A. VanBlargan, J. Liu, J. M. Errico, X. Xie, N. Suryadevara, P. Gilchuk, S. J. Zost, S. Tahan, L. Droit, J. S. Turner, W. Kim, A. J. Schmitz, M. Thapa, D. Wang, A. C. M. Boon, R. M. Presti, J. A. O’Halloran, A. H. J. Kim, P. Deepak, D. Pinto, D. H. Fremont, J. E. Crowe Jr., D. Corti, H. W. Virgin, A. H. Ellebedy, P.-Y. Shi, M. S. Diamond, Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. <b>27</b>, 717–726 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >12</div><div ><div ><div >W. F. Garcia-Beltran, E. C. Lam, K. St Denis, A. D. Nitido, Z. H. Garcia, B. M. Hauser, J. Feldman, M. N. Pavlovic, D. J. Gregory, M. C. Poznansky, A. Sigal, A. G. Schmidt, A. J. Iafrate, V. Naranbhai, A. B. Balazs, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell <b>184</b>, 2523 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >13</div><div ><div ><div >C. K. Wibmer, F. Ayres, T. Hermanus, M. Madzivhandila, P. Kgagudi, B. Oosthuysen, B. E. Lambson, T. de Oliveira, M. Vermeulen, K. van der Berg, T. Rossouw, M. Boswell, V. Ueckermann, S. Meiring, A. von Gottberg, C. Cohen, L. Morris, J. N. Bhiman, P. L. Moore, SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat. Med. <b>27</b>, 622–625 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >14</div><div ><div ><div >P. Wang, M. S. Nair, L. Liu, S. Iketani, Y. Luo, Y. Guo, M. Wang, J. Yu, B. Zhang, P. D. Kwong, B. S. Graham, J. R. Mascola, J. Y. Chang, M. T. Yin, M. Sobieszczyk, C. A. Kyratsous, L. Shapiro, Z. Sheng, Y. Huang, D. D. Ho, Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature <b>593</b>, 130–135 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >15</div><div ><div ><div >D. Zhou, W. Dejnirattisai, P. Supasa, C. Liu, A. J. Mentzer, H. M. Ginn, Y. Zhao, H. M. E. Duyvesteyn, A. Tuekprakhon, R. Nutalai, B. Wang, G. C. Paesen, C. Lopez-Camacho, J. Slon-Campos, B. Hallis, N. Coombes, K. Bewley, S. Charlton, T. S. Walter, D. Skelly, S. F. Lumley, C. Dold, R. Levin, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. Gilbert, W. James, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell <b>184</b>, 2348–2361.e6 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >16</div><div ><div ><div >S. A. Madhi, V. Baillie, C. L. Cutland, M. Voysey, A. L. Koen, L. Fairlie, S. D. Padayachee, K. Dheda, S. L. Barnabas, Q. E. Bhorat, C. Briner, G. Kwatra, K. Ahmed, P. Aley, S. Bhikha, J. N. Bhiman, A. E. Bhorat, J. du Plessis, A. Esmail, M. Groenewald, E. Horne, S.-H. Hwa, A. Jose, T. Lambe, M. Laubscher, M. Malahleha, M. Masenya, M. Masilela, S. McKenzie, K. Molapo, A. Moultrie, S. Oelofse, F. Patel, S. Pillay, S. Rhead, H. Rodel, L. Rossouw, C. Taoushanis, H. Tegally, A. Thombrayil, S. van Eck, C. K. Wibmer, N. M. Durham, E. J. Kelly, T. L. Villafana, S. Gilbert, A. J. Pollard, T. de Oliveira, P. L. Moore, A. Sigal, A. Izu; NGS-SA Group; Wits-VIDA COVID Group, Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N. Engl. J. Med. <b>384</b>, 1885–1898 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >17</div><div ><div ><div >J. Sadoff, G. Gray, A. Vandebosch, V. Cárdenas, G. Shukarev, B. Grinsztejn, P. A. Goepfert, C. Truyers, H. Fennema, B. Spiessens, K. Offergeld, G. Scheper, K. L. Taylor, M. L. Robb, J. Treanor, D. H. Barouch, J. Stoddard, M. F. Ryser, M. A. Marovich, K. M. Neuzil, L. Corey, N. Cauwenberghs, T. Tanner, K. Hardt, J. Ruiz-Guiñazú, M. Le Gars, H. Schuitemaker, J. Van Hoof, F. Struyf, M. Douoguih; ENSEMBLE Study Group, Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N. Engl. J. Med. <b>384</b>, 2187–2201 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >18</div><div ><div ><div >V. Shinde, S. Bhikha, Z. Hoosain, M. Archary, Q. Bhorat, L. Fairlie, U. Lalloo, M. S. L. Masilela, D. Moodley, S. Hanley, L. Fouche, C. Louw, M. Tameris, N. Singh, A. Goga, K. Dheda, C. Grobbelaar, G. Kruger, N. Carrim-Ganey, V. Baillie, T. de Oliveira, A. Lombard Koen, J. J. Lombaard, R. Mngqibisa, A. E. Bhorat, G. Benadé, N. Lalloo, A. Pitsi, P.-L. Vollgraaff, A. Luabeya, A. Esmail, F. G. Petrick, A. Oommen-Jose, S. Foulkes, K. Ahmed, A. Thombrayil, L. Fries, S. Cloney-Clark, M. Zhu, C. Bennett, G. Albert, E. Faust, J. S. Plested, A. Robertson, S. Neal, I. Cho, G. M. Glenn, F. Dubovsky, S. A. Madhi; 2019nCoV-501 Study Group, Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N. Engl. J. Med. <b>384</b>, 1899–1909 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >19</div><div ><div ><div >L. J. Abu-Raddad, H. Chemaitelly, A. A. Butt; National Study Group for COVID-19 Vaccination, Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N. Engl. J. Med. <b>385</b>, 187–189 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >20</div><div ><div ><div >B. Agerer, M. Koblischke, V. Gudipati, L. F. Montaño-Gutierrez, M. Smyth, A. Popa, J.-W. Genger, L. Endler, D. M. Florian, V. Mühlgrabner, M. Graninger, S. W. Aberle, A.-M. Husa, L. E. Shaw, A. Lercher, P. Gattinger, R. Torralba-Gombau, D. Trapin, T. Penz, D. Barreca, I. Fae, S. Wenda, M. Traugott, G. Walder, W. F. Pickl, V. Thiel, F. Allerberger, H. Stockinger, E. Puchhammer-Stöckl, W. Weninger, G. Fischer, W. Hoepler, E. Pawelka, A. Zoufaly, R. Valenta, C. Bock, W. Paster, R. Geyeregger, M. Farlik, F. Halbritter, J. B. Huppa, J. H. Aberle, A. Bergthaler, SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8<sup>+</sup> T cell responses. Sci. Immunol. <b>6</b>, eabg6461 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >21</div><div ><div ><div >T. I. de Silva, G. Liu, B. B. Lindsey, D. Dong, D. Shah, A. J. Mentzer, A. Angyal, R. Brown, M. D. Parker, Z. Ying, X. Yao, L. Turtle, S. Dunachie, C.-19 G. U. (COG-U. Consortium, M. K. Maini, G. Ogg, J. C. Knight, Y. Peng, S. L. Rowland-Jones, T. Dong, The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells, Biorxiv, 2021.04.08.438904 (2021).</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >22</div><div ><div ><div >K. M. E. Gallagher, M. B. Leick, R. C. Larson, T. R. Berger, K. Katsis, J. Y. Yam, G. Brini, K. Grauwet, M. C.-19 C. P. Team, M. V. Maus, SARS -CoV-2 T-cell immunity to variants of concern following vaccination, Biorxiv<i>,</i> 2021.05.03.442455 (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >23</div><div ><div ><div >C. Motozono, M. Toyoda, J. Zahradnik, A. Saito, H. Nasser, T. S. Tan, I. Ngare, I. Kimura, K. Uriu, Y. Kosugi, Y. Yue, R. Shimizu, J. Ito, S. Torii, A. Yonekawa, N. Shimono, Y. Nagasaki, R. Minami, T. Toya, N. Sekiya, T. Fukuhara, Y. Matsuura, G. Schreiber, T. Ikeda, S. Nakagawa, T. Ueno, K. Sato; Genotype to Phenotype Japan (G2P-Japan) Consortium, SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe <b>29</b>, 1124–1136.e11 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >24</div><div ><div ><div >A. Tarke, J. Sidney, N. Methot, E. D. Yu, Y. Zhang, J. M. Dan, B. Goodwin, P. Rubiro, A. Sutherland, E. Wang, A. Frazier, S. I. Ramirez, S. A. Rawlings, D. M. Smith, R. da Silva Antunes, B. Peters, R. H. Scheuermann, D. Weiskopf, S. Crotty, A. Grifoni, A. Sette, Impact of SARS-CoV-2 variants on the total CD4<sup>+</sup> and CD8<sup>+</sup> T cell reactivity in infected or vaccinated individuals. Cell Rep Med <b>2</b>, 100355 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >25</div><div ><div ><div >A. Grifoni, D. Weiskopf, S. I. Ramirez, J. Mateus, J. M. Dan, C. R. Moderbacher, S. A. Rawlings, A. Sutherland, L. Premkumar, R. S. Jadi, D. Marrama, A. M. de Silva, A. Frazier, A. F. Carlin, J. A. Greenbaum, B. Peters, F. Krammer, D. M. Smith, S. Crotty, A. Sette, Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell <b>181</b>, 1489–1501.e15 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >26</div><div ><div ><div >J. M. Dan, J. Mateus, Y. Kato, K. M. Hastie, E. D. Yu, C. E. Faliti, A. Grifoni, S. I. Ramirez, S. Haupt, A. Frazier, C. Nakao, V. Rayaprolu, S. A. Rawlings, B. Peters, F. Krammer, V. Simon, E. O. Saphire, D. M. Smith, D. Weiskopf, A. Sette, S. Crotty, Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science <b>371</b>, eabf4063 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >27</div><div ><div ><div >C. Riou, E. du Bruyn, C. Stek, R. Daroowala, R. T. Goliath, F. Abrahams, Q. Said-Hartley, B. W. Allwood, N.-Y. Hsiao, K. A. Wilkinson, C. S. L. Arlehamn, A. Sette, S. Wasserman, R. J. Wilkinson; HIATUS consortium, Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. J. Clin. Invest. <b>131</b>, e149125 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >28</div><div ><div ><div >K. W. Cohen, S. L. Linderman, Z. Moodie, J. Czartoski, L. Lai, G. Mantus, C. Norwood, L. E. Nyhoff, V. V. Edara, K. Floyd, S. C. De Rosa, H. Ahmed, R. Whaley, S. N. Patel, B. Prigmore, M. P. Lemos, C. W. Davis, S. Furth, J. B. O’Keefe, M. P. Gharpure, S. Gunisetty, K. Stephens, R. Antia, V. I. Zarnitsyna, D. S. Stephens, S. Edupuganti, N. Rouphael, E. J. Anderson, A. K. Mehta, J. Wrammert, M. S. Suthar, R. Ahmed, M. J. McElrath, Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med <b>2</b>, 100354 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >29</div><div ><div ><div >D. M. Altmann, R. J. Boyton, R. Beale, Immunity to SARS-CoV-2 variants of concern. Science <b>371</b>, 1103–1104 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >30</div><div ><div ><div >J. Mateus, A. Grifoni, A. Tarke, J. Sidney, S. I. Ramirez, J. M. Dan, Z. C. Burger, S. A. Rawlings, D. M. Smith, E. Phillips, S. Mallal, M. Lammers, P. Rubiro, L. Quiambao, A. Sutherland, E. D. Yu, R. da Silva Antunes, J. Greenbaum, A. Frazier, A. J. Markmann, L. Premkumar, A. de Silva, B. Peters, S. Crotty, A. Sette, D. Weiskopf, Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science <b>370</b>, 89–94 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >31</div><div ><div ><div >A. Tarke, J. Sidney, C. K. Kidd, J. M. Dan, S. I. Ramirez, E. D. Yu, J. Mateus, R. da Silva Antunes, E. Moore, P. Rubiro, N. Methot, E. Phillips, S. Mallal, A. Frazier, S. A. Rawlings, J. A. Greenbaum, B. Peters, D. M. Smith, S. Crotty, D. Weiskopf, A. Grifoni, A. Sette, Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports Medicine <b>2</b>, 100204 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >32</div><div ><div ><div >A. Nelde, T. Bilich, J. S. Heitmann, Y. Maringer, H. R. Salih, M. Roerden, M. Lübke, J. Bauer, J. Rieth, M. Wacker, A. Peter, S. Hörber, B. Traenkle, P. D. Kaiser, U. Rothbauer, M. Becker, D. Junker, G. Krause, M. Strengert, N. Schneiderhan-Marra, M. F. Templin, T. O. Joos, D. J. Kowalewski, V. Stos-Zweifel, M. Fehr, A. Rabsteyn, V. Mirakaj, J. Karbach, E. Jäger, M. Graf, L.-C. Gruber, D. Rachfalski, B. Preuß, I. Hagelstein, M. Märklin, T. Bakchoul, C. Gouttefangeas, O. Kohlbacher, R. Klein, S. Stevanović, H.-G. Rammensee, J. S. Walz, SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. <b>22</b>, 74–85 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >33</div><div ><div ><div >V. Oberhardt, H. Luxenburger, J. Kemming, I. Schulien, K. Ciminski, S. Giese, B. Csernalabics, J. Lang-Meli, I. Janowska, J. Staniek, K. Wild, K. Basho, M. S. Marinescu, J. Fuchs, F. Topfstedt, A. Janda, O. Sogukpinar, H. Hilger, K. Stete, F. Emmerich, B. Bengsch, C. F. Waller, S. Rieg, T. Sagar, T. Boettler, K. Zoldan, G. Kochs, M. Schwemmle, M. Rizzi, R. Thimme, C. Neumann-Haefelin, M. Hofmann, Rapid and stable mobilization of CD8<sup>+</sup> T cells by SARS-CoV-2 mRNA vaccine. Nature <b>597</b>, 268–273 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >34</div><div ><div ><div >L. G. Thorne, M. Bouhaddou, A.-K. Reuschl, L. Zuliani-Alvarez, B. Polacco, A. Pelin, J. Batra, M. V. X. Whelan, M. Ummadi, A. Rojc, J. Turner, K. Obernier, H. Braberg, M. Soucheray, A. Richards, K.-H. Chen, B. Harjai, D. Memon, M. Hosmillo, J. Hiatt, A. Jahun, I. G. Goodfellow, J. M. Fabius, K. Shokat, N. Jura, K. Verba, M. Noursadeghi, P. Beltrao, D. L. Swaney, A. Garcia-Sastre, C. Jolly, G. J. Towers, N. J. Krogan, Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant, Biorxiv, 2021.06.06.446826 (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >35</div><div ><div ><div >K. Guo, B. S. Barrett, K. L. Mickens, K. J. Hasenkrug, M. L. Santiago, Interferon Resistance of Emerging SARS-CoV-2 Variants, Biorxiv, 2021.03.20.436257 (2021).</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >36</div><div ><div ><div >C. J. Thieme, M. Anft, K. Paniskaki, A. Blazquez-Navarro, A. Doevelaar, F. S. Seibert, B. Hoelzer, M. J. Konik, M. M. Berger, T. Brenner, C. Tempfer, C. Watzl, T. L. Meister, S. Pfaender, E. Steinmann, S. Dolff, U. Dittmer, T. H. Westhoff, O. Witzke, U. Stervbo, T. Roch, N. Babel, Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients. Cell Reports Medicine <b>1</b>, 100092 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >37</div><div ><div ><div >A. Abdel Latif, J. L. Mullen, M. Alkuzweny, G. Tsueng, M. Cano, E. Haag, J. Zhou, M. Zeller, E. Hufbauer, N. Matteson, C. Wu, K. G. Anderson, A. I. Su, K. Gangavarapu, L. D. Hughes, and the Center for Viral Systems Biology, S:L18F Mutation Report. Outbreak.info, (available at <a >https://outbreak.info/situation-reports?pangomuts=S%3AL18F</a>). Accessed 4 December 2021.</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >38</div><div ><div ><div >W. T. Harvey, A. M. Carabelli, B. Jackson, R. K. Gupta, E. C. Thomson, E. M. Harrison, C. Ludden, R. Reeve, A. Rambaut, S. J. Peacock, D. L. Robertson; COVID-19 Genomics UK (COG-UK) Consortium, SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. <b>19</b>, 409–424 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >39</div><div ><div ><div >C. Scheepers, J. Everatt, D. G. Amoako, A. Mnguni, A. Ismail, B. Mahlangu, C. K. Wibmer, E. Wilkinson, H. Tegally, J. E. San, J. Giandhari, N. Ntuli, S. Pillay, T. Mohale, Y. Naidoo, Z. T. Khumalo, Z. Makatini, NGS-SA, A. Sigal, C. Williamson, F. Treurnicht, K. Mlisana, M. Venter, N. Hsiao, N. Wolter, N. Msomi, R. Lessells, T. Maponga, W. Preiser, P. L. Moore, A. von Gottberg, T. de Oliveira, J. N. Bhiman, The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection, Medrxiv, 2021.08.20.21262342 (2021).</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >40</div><div ><div ><div >A. Abdel Latif, J. L. Mullen, M. Alkuzweny, G. Tsueng, M. Cano, E. Haag, J. Zhou, M. Zeller, E. Hufbauer, N. Matteson, C. Wu, K. G. Andersen, A. I. Su, K. Gangavarapu, L. D. Hughes, and Center for Viral Systems Biology. outbreak.info, (available at <a >https://outbreak.info/situation-reports</a>), <i>Accessed 10 September 2021</i><i>.</i></div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >41</div><div ><div ><div >T. Moyo-Gwete, M. Madzivhandila, Z. Makhado, F. Ayres, D. Mhlanga, B. Oosthuysen, B. E. Lambson, P. Kgagudi, H. Tegally, A. Iranzadeh, D. Doolabh, L. Tyers, L. R. Chinhoyi, M. Mennen, S. Skelem, G. Marais, C. K. Wibmer, J. N. Bhiman, V. Ueckermann, T. Rossouw, M. Boswell, T. de Oliveira, C. Williamson, W. A. Burgers, N. Ntusi, L. Morris, P. L. Moore, Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351). N. Engl. J. Med. <b>384</b>, 2161–2163 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >42</div><div ><div ><div >M. Hoffmann, P. Arora, R. Groß, A. Seidel, B. F. Hörnich, A. S. Hahn, N. Krüger, L. Graichen, H. Hofmann-Winkler, A. Kempf, M. S. Winkler, S. Schulz, H.-M. Jäck, B. Jahrsdörfer, H. Schrezenmeier, M. Müller, A. Kleger, J. Münch, S. Pöhlmann, SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell <b>184</b>, 2384–2393.e12 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >43</div><div ><div ><div >C. Liu, H. M. Ginn, W. Dejnirattisai, P. Supasa, B. Wang, A. Tuekprakhon, R. Nutalai, D. Zhou, A. J. Mentzer, Y. Zhao, H. M. E. Duyvesteyn, C. López-Camacho, J. Slon-Campos, T. S. Walter, D. Skelly, S. A. Johnson, T. G. Ritter, C. Mason, S. A. Costa Clemens, F. Gomes Naveca, V. Nascimento, F. Nascimento, C. Fernandes da Costa, P. C. Resende, A. Pauvolid-Correa, M. M. Siqueira, C. Dold, N. Temperton, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. C. Gilbert, T. Malik, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, V. Baillie, N. Serafin, Z. Ditse, K. Da Silva, N. G. Paterson, M. A. Williams, D. R. Hall, S. Madhi, M. C. Nunes, P. Goulder, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell <b>184</b>, 4220–4236.e13 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >44</div><div ><div ><div >D. Planas, D. Veyer, A. Baidaliuk, I. Staropoli, F. Guivel-Benhassine, M. M. Rajah, C. Planchais, F. Porrot, N. Robillard, J. Puech, M. Prot, F. Gallais, P. Gantner, A. Velay, J. Le Guen, N. Kassis-Chikhani, D. Edriss, L. Belec, A. Seve, L. Courtellemont, H. Péré, L. Hocqueloux, S. Fafi-Kremer, T. Prazuck, H. Mouquet, T. Bruel, E. Simon-Lorière, F. A. Rey, O. Schwartz, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature <b>596</b>, 276–280 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >45</div><div ><div ><div >D. Planas, D. Veyer, A. Baidaliuk, I. Staropoli, F. Guivel-Benhassine, M. M. Rajah, C. Planchais, F. Porrot, N. Robillard, J. Puech, M. Prot, F. Gallais, P. Gantner, A. Velay, J. Le Guen, N. Kassis-Chikhani, D. Edriss, L. Belec, A. Seve, L. Courtellemont, H. Péré, L. Hocqueloux, S. Fafi-Kremer, T. Prazuck, H. Mouquet, T. Bruel, E. Simon-Lorière, F. A. Rey, O. Schwartz, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature <b>596</b>, 276–280 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >46</div><div ><div ><div >L. Dupont, L. B. Snell, C. Graham, J. Seow, B. Merrick, T. Lechmere, T. J. A. Maguire, S. R. Hallett, S. Pickering, T. Charalampous, A. Alcolea-Medina, I. Huettner, J. M. Jimenez-Guardeño, S. Acors, N. Almeida, D. Cox, R. E. Dickenson, R. P. Galao, N. Kouphou, M. J. Lista, A. M. Ortega-Prieto, H. Wilson, H. Winstone, C. Fairhead, J. Z. Su, G. Nebbia, R. Batra, S. Neil, M. Shankar-Hari, J. D. Edgeworth, M. H. Malim, K. J. Doores, Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern. Nat. Microbiol. <b>6</b>, 1433–1442 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >47</div><div ><div ><div >E. C. Wall, M. Wu, R. Harvey, G. Kelly, S. Warchal, C. Sawyer, R. Daniels, P. Hobson, E. Hatipoglu, Y. Ngai, S. Hussain, J. Nicod, R. Goldstone, K. Ambrose, S. Hindmarsh, R. Beale, A. Riddell, S. Gamblin, M. Howell, G. Kassiotis, V. Libri, B. Williams, C. Swanton, S. Gandhi, D. L. Bauer, Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet <b>397</b>, 2331–2333 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >48</div><div ><div ><div >S. Cele, L. Jackson, K. Khan, D. Khoury, T. Moyo-Gwete, H. Tegally, C. Scheepers, D. Amoako, F. Karim, M. Bernstein, G. Lustig, D. Archary, M. Smith, Y. Ganga, Z. Jule, K. Reedoy, J. Emmanuel San, S.-H. Hwa, J. Giandhari, J. M. Blackburn, B. I. Gosnell, S. A. Karim, W. Hanekom, NGS-SA, COMMIT-KZN Team, A. von Gottberg, J. Bhiman, R. J. Lessells, M.-Y. S. Moosa, M. Davenport, T. de Oliveira, P. L. Moore, A. Sigal. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. MedRXiv (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >49</div><div ><div ><div >D. S. Khoury, D. Cromer, A. Reynaldi, T. E. Schlub, A. K. Wheatley, J. A. Juno, K. Subbarao, S. J. Kent, J. A. Triccas, M. P. Davenport, Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. <b>27</b>, 1205–1211 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >50</div><div ><div ><div >K. A. Earle, D. M. Ambrosino, A. Fiore-Gartland, D. Goldblatt, P. B. Gilbert, G. R. Siber, P. Dull, S. A. Plotkin, Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine <b>39</b>, 4423–4428 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >51</div><div ><div ><div >K. McMahan, J. Yu, N. B. Mercado, C. Loos, L. H. Tostanoski, A. Chandrashekar, J. Liu, L. Peter, C. Atyeo, A. Zhu, E. A. Bondzie, G. Dagotto, M. S. Gebre, C. Jacob-Dolan, Z. Li, F. Nampanya, S. Patel, L. Pessaint, A. Van Ry, K. Blade, J. Yalley-Ogunro, M. Cabus, R. Brown, A. Cook, E. Teow, H. Andersen, M. G. Lewis, D. A. Lauffenburger, G. Alter, D. H. Barouch, Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature <b>590</b>, 630–634 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >52</div><div ><div ><div >C. Rydyznski Moderbacher, S. I. Ramirez, J. M. Dan, A. Grifoni, K. M. Hastie, D. Weiskopf, S. Belanger, R. K. Abbott, C. Kim, J. Choi, Y. Kato, E. G. Crotty, C. Kim, S. A. Rawlings, J. Mateus, L. P. V. Tse, A. Frazier, R. Baric, B. Peters, J. Greenbaum, E. Ollmann Saphire, D. M. Smith, A. Sette, S. Crotty, Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell <b>183</b>, 996–1012.e19 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >53</div><div ><div ><div >S. K. Saini, D. S. Hersby, T. Tamhane, H. R. Povlsen, S. P. Amaya Hernandez, M. Nielsen, A. O. Gang, S. R. Hadrup, SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8<sup>+</sup> T cell activation in COVID-19 patients. Sci. Immunol. <b>6</b>, eabf7550 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >54</div><div ><div ><div >R. Parker, T. Partridge, C. Wormald, R. Kawahara, V. Stalls, M. Aggelakopoulou, J. Parker, R. Powell Doherty, Y. Ariosa Morejon, E. Lee, K. Saunders, B. F. Haynes, P. Acharya, M. Thaysen-Andersen, P. Borrow, N. Ternette, Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Cell Rep. <b>35</b>, 109179 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >55</div><div ><div ><div >Y. Peng, A. J. Mentzer, G. Liu, X. Yao, Z. Yin, D. Dong, W. Dejnirattisai, T. Rostron, P. Supasa, C. Liu, C. López-Camacho, J. Slon-Campos, Y. Zhao, D. I. Stuart, G. C. Paesen, J. M. Grimes, A. A. Antson, O. W. Bayfield, D. E. D. P. Hawkins, D.-S. Ker, B. Wang, L. Turtle, K. Subramaniam, P. Thomson, P. Zhang, C. Dold, J. Ratcliff, P. Simmonds, T. de Silva, P. Sopp, D. Wellington, U. Rajapaksa, Y.-L. Chen, M. Salio, G. Napolitani, W. Paes, P. Borrow, B. M. Kessler, J. W. Fry, N. F. Schwabe, M. G. Semple, J. K. Baillie, S. C. Moore, P. J. M. Openshaw, M. A. Ansari, S. Dunachie, E. Barnes, J. Frater, G. Kerr, P. Goulder, T. Lockett, R. Levin, Y. Zhang, R. Jing, L.-P. Ho, R. J. Cornall, C. P. Conlon, P. Klenerman, G. R. Screaton, J. Mongkolsapaya, A. McMichael, J. C. Knight, G. Ogg, T. Dong; Oxford Immunology Network Covid-19 Response T cell Consortium; ISARIC4C Investigators, Broad and strong memory CD4<sup>+</sup> and CD8<sup>+</sup> T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. <b>21</b>, 1336–1345 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >56</div><div ><div ><div >J. A. Juno, D. van Bockel, S. J. Kent, A. D. Kelleher, J. J. Zaunders, C. M. L. Munier, Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? Front. Immunol. <b>8</b>, 19 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >57</div><div ><div ><div >B. J. Meckiff, C. Ramírez-Suástegui, V. Fajardo, S. J. Chee, A. Kusnadi, H. Simon, S. Eschweiler, A. Grifoni, E. Pelosi, D. Weiskopf, A. Sette, F. Ay, G. Seumois, C. H. Ottensmeier, P. Vijayanand, Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4<sup>+</sup> T Cells in COVID-19. Cell <b>183</b>, 1340–1353.e16 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >58</div><div ><div ><div >N. Kaneko, J. Boucau, H.-H. Kuo, C. Perugino, V. S. Mahajan, J. R. Farmer, H. Liu, T. J. Diefenbach, A. Piechocka-Trocha, K. Lefteri, M. T. Waring, K. R. Premo, B. D. Walker, J. Z. Li, G. Gaiha, X. G. Yu, M. Lichterfeld, R. F. Padera, S. Pillai, Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19, Medrxiv, 2021.03.23.21253885 (2021).</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >59</div><div ><div ><div >A. Fiore-Gartland, B. A. Manso, D. P. Friedrich, E. E. Gabriel, G. Finak, Z. Moodie, T. Hertz, S. C. De Rosa, N. Frahm, P. B. Gilbert, M. J. McElrath, Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials. PLOS ONE <b>11</b>, e0147812 (2016).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >60</div><div ><div ><div >R. Keeton, S. I. Richardson, T. Moyo-Gwete, T. Hermanus, M. B. Tincho, N. Benede, N. P. Manamela, R, Baguma, Z. Makhado, A. Ngomti, T. Motlou, M. Mennen, L. Chinhoyi, S. Skelem, H. Maboreke, D. Doolabh, A. Iranzadeh, A. D. Otter, T. Brooks, M. Noursadeghi, J. Moon, J. Blackburn, N-Y. Hsiao, C. Williamson, C. Riou, A. Goga, N. Garrett, L-G. Bekker, G. Gray, N. A. B. Ntusi, P. L. Moore, W. A. Burgers, Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner, Medrxiv, 2021.07.24.21261037 (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >61</div><div ><div ><div >A. Tarke, J. Sidney, N. Methot, E. D. Yu, Y. Zhang, J. M. Dan, B. Goodwin, P. Rubiro, A. Sutherland, E. Wang, A. Frazier, S. I. Ramirez, S. A. Rawlings, D. M. Smith, R. da Silva Antunes, B. Peters, R. H. Scheuermann, D. Weiskopf, S. Crotty, A. Grifoni, A. Sette, Impact of SARS-CoV-2 variants on the total CD4<sup>+</sup> and CD8<sup>+</sup> T cell reactivity in infected or vaccinated individuals. Cell Reports Medicine <b>2</b>, 100355 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >62</div><div ><div ><div >D. Geers, M. C. Shamier, S. Bogers, G. den Hartog, L. Gommers, N. N. Nieuwkoop, K. S. Schmitz, L. C. Rijsbergen, J. A. T. van Osch, E. Dijkhuizen, G. Smits, A. Comvalius, D. van Mourik, T. G. Caniels, M. J. van Gils, R. W. Sanders, B. B. Oude Munnink, R. Molenkamp, H. J. de Jager, B. L. Haagmans, R. L. de Swart, M. P. G. Koopmans, R. S. van Binnendijk, R. D. de Vries, C. H. GeurtsvanKessel, SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci. Immunol. <b>6</b>, eabj1750 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >63</div><div ><div ><div >C. J. Reynolds, C. Pade, J. M. Gibbons, D. K. Butler, A. D. Otter, K. Menacho, M. Fontana, A. Smit, J. E. Sackville-West, T. Cutino-Moguel, M. K. Maini, B. Chain, M. Noursadeghi, T. Brooks, A. Semper, C. Manisty, T. A. Treibel, J. C. Moon, A. M. Valdes, Á. McKnight, D. M. Altmann, R. Boyton; UK COVIDsortium Immune Correlates Network; UK COVIDsortium Investigators, Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science <b>•••</b>, eabh1282 (2021).</div><div ><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >64</div><div ><div ><div >S. Cleemput, W. Dumon, V. Fonseca, W. Abdool Karim, M. Giovanetti, L. C. Alcantara, K. Deforche, T. de Oliveira, Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes. Bioinformatics <b>36</b>, 3552–3555 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >65</div><div ><div ><div >J. Hadfield, C. Megill, S. M. Bell, J. Huddleston, B. Potter, C. Callender, P. Sagulenko, T. Bedford, R. A. Neher, Nextstrain: Real-time tracking of pathogen evolution. Bioinformatics <b>34</b>, 4121–4123 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >66</div><div ><div ><div >G. Yu, D. K. Smith, H. Zhu, Y. Guan, T. T. Lam, ggtree: An r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. <b>8</b>, 28–36 (2017).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >67</div><div ><div ><div >S. Paul, J. Sidney, A. Sette, B. Peters, TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates, <i>Curr Protoc Immunol</i> <b>114</b>, 18.19.1-18.19.24 (2016). </div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >68</div><div ><div ><div >K. K. Jensen, M. Andreatta, P. Marcatili, S. Buus, J. A. Greenbaum, Z. Yan, A. Sette, B. Peters, M. Nielsen, Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology <b>154</b>, 394–406 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >69</div><div ><div ><div >M. Andreatta, E. Karosiene, M. Rasmussen, A. Stryhn, S. Buus, M. Nielsen, Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics <b>67</b>, 641–650 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >70</div><div ><div ><div >J. Sidney, E. Assarsson, C. Moore, S. Ngo, C. Pinilla, A. Sette, B. Peters, Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. <b>4</b>, 2 (2008).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >71</div><div ><div ><div >M. Nielsen, C. Lundegaard, O. Lund, Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics <b>8</b>, 238 (2007).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >72</div><div ><div ><div >T. Sturniolo, E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia, J. Hammer, Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. <b>17</b>, 555–561 (1999).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div></section></div></section><div ><div ><header><h2>Information Authors</h2></header><section ><h3>Information</h3><section ><h4>Published In</h4><div > <div ><div >Science Translational Medicine</div><div >First Release</div></div></div></section><section ><h4>Copyright</h4><div >Copyright © 2021, American Association for the Advancement of Science.</div><div >https://creativecommons.org/licenses/by/4.0/ </div><div >This is an open-access article distributed under the terms of the <a >Creative Commons Attribution license</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></section><section ><h4>Submission history</h4><div><b >Received</b>: 31 May 2021</div><div><b >Accepted</b>: 15 December 2021</div></section><section ><h4>Permissions</h4><div>Request permissions for this article.</div><div><a >Request Permissions</a></div></section><section ><h4>Acknowledgments</h4><div >We thank the study participants and their families, and the clinical staff and personnel at Groote Schuur Hospital for their support and dedication. We thank the informal Variant consortium of South Africa, chaired by Drs Willem Hanekom and Tulio de Oliveira, for suggestions and discussion of data. For the purposes of open access, the authors have applied a CC BY public copyright license to any author-accepted version arising from this submission.</div><div ><b>Funding:</b> This research was supported by the South African Medical Research Council, with funds received from the South African Department of Science and Innovation (DSI), and the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), which is supported by core funding from the Wellcome Trust [203135/Z/16/Z]. CR and WAB are supported by the EDCTP2 program of the European Union (EU)’s Horizon 2020 program (TMA2017SF-1951-TB-SPEC to CR and TMA2016SF-1535-CaTCH-22 to WAB). This work is further supported by the National Institutes of Health (R21AI148027 to CR), Francis Crick Institute, which receives funding from Wellcome FC0010218, UKRI FC0010218 and CRUK FC0010218 and the Rosetrees Trust grant M926 (to CR and RJW). PLM is supported by the South African Research Chairs Initiative of the DSI and the National Research Foundation (Grant No 9834). NABN acknowledges funding from the SA-MRC, MRC UK, NRF, and the Lily and Ernst Hausmann Trust.</div><div ><b>Author contributions:</b> WAB, CR, PLM, NABN and RJW conceived and designed the study, acquired funding and supervised the work. LRC, MM, SS, EdB and CS recruited the study participants. CR, RK, RB, HM, MBT and NB performed the T cell experiments. TH, TM-G and PK performed the neutralizing assays. ZV-O and MS performed HLA typing. HT, DD, LT, AI, GM, CW and TdO performed the sequencing and phylogenetic analyses. CR and WAB analyzed the data and wrote the manuscript, with all authors contributing by providing critical feedback and final review.</div><div ><b>Competing interests:</b> The authors declare that they have no competing interests.</div><div ><b>Data and materials availability:</b> All data are available in the main text or the supplementary materials. All materials used in this manuscript are commercially available.</div><div >This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit <a >https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.</div></section></section><section ><h3>Authors</h3><section ><h4>Affiliations</h4><div ><div >Catherine Riou<sup >*</sup> <a >https://orcid.org/0000-0001-9679-0745</a> <a >[email protected]</a></div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Roanne Keeton https://orcid.org/0000-0003-4808-9756</div><div ><div ><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Thandeka Moyo-Gwete https://orcid.org/0000-0002-4269-9281</div><div ><div ><div >National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div >MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Tandile Hermanus https://orcid.org/0000-0003-4734-1980</div><div ><div ><div >National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div >MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Prudence Kgagudi</div><div ><div ><div >National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div >MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Richard Baguma https://orcid.org/0000-0002-5106-021X</div><div ><div ><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Ziyaad Valley-Omar https://orcid.org/0000-0003-4804-3774</div><div ><div ><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Mikhail Smith</div><div ><div ><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Houriiyah Tegally https://orcid.org/0000-0002-7102-8540</div><div ><div ><div >KwaZulu-Natal Research Innovation and Sequencing Platform; Durban, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Deelan Doolabh</div><div ><div ><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Arash Iranzadeh</div><div ><div ><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Lynn Tyers https://orcid.org/0000-0002-0535-9165</div><div ><div ><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Hygon Mutavhatsindi https://orcid.org/0000-0001-6605-6275</div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Marius B. Tincho https://orcid.org/0000-0002-1293-5933</div><div ><div ><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Ntombi Benede https://orcid.org/0000-0002-3319-8215</div><div ><div ><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Gert Marais https://orcid.org/0000-0003-1477-6101</div><div ><div ><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div><div >Groote Schuur Hospital Medical Virology Laboratory of the National Health Laboratory Service; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Lionel R. Chinhoyi https://orcid.org/0000-0002-5266-4613</div><div ><div ><div >Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div >Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Mathilda Mennen</div><div ><div ><div >Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div >Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Sango Skelem</div><div ><div ><div >Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div >Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Elsa du Bruyn https://orcid.org/0000-0002-5088-2158</div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Cari Stek</div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div >Department of Infectious Diseases, Imperial College London; W12 0NN, UK.</div></div><div >View all articles by this author</div></div></div><div ><div >SA-CIN<a ><sup>†</sup></a></div></div><div ><div >Tulio de Oliveira https://orcid.org/0000-0002-3027-5254</div><div ><div ><div >KwaZulu-Natal Research Innovation and Sequencing Platform; Durban, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Carolyn Williamson https://orcid.org/0000-0003-0125-1226</div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Penny L. Moore https://orcid.org/0000-0001-8719-4028</div><div ><div ><div >National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div >MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Robert J. Wilkinson</div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div >Department of Infectious Diseases, Imperial College London; W12 0NN, UK.</div><div >The Francis Crick Institute; London, NW1 1AT, UK.</div></div><div >View all articles by this author</div></div></div><div ><div >Ntobeko A. B. Ntusi https://orcid.org/0000-0003-2347-7883</div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div >Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div><div ><div >Wendy A. Burgers<sup >*</sup> https://orcid.org/0000-0003-3396-9398 [email protected]</div><div ><div ><div >Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div >Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div >Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div >View all articles by this author</div></div></div></section><section ><h4>Funding Information</h4><div >National Institutes of Health: R21AI148027</div><div >ASCRS Research Foundation: </div><div ><a >University of Kentucky</a>: </div><div ><a >Wellcome</a>: 203135/Z/16/Z</div><div ><a >Wellcome</a>: 222754</div><div ><a >Francis Crick Institute</a>: Wellcome FC0010218, UKRI FC0010218 and CRUK FC0010218</div><div ><a >National Research Foundation</a>: 129614</div><div ><a >Norsk Revmatikerforbund</a>: 203135/Z/16/Z</div><div ><a >Norsk Revmatikerforbund</a>: EDCTP2</div><div ><a >Norsk Revmatikerforbund</a>: TMA2017SF-1951-TB-SPEC</div><div ><a >Norsk Revmatikerforbund</a>: TMA2016SF-1535-C</div><div ><a >Norsk Revmatikerforbund</a>: R21AI148027</div><div ><a >Norsk Revmatikerforbund</a>: FC0010218</div><div ><a >Norsk Revmatikerforbund</a>: UKRI FC0010218</div><div ><a >Norsk Revmatikerforbund</a>: CRUK FC0010218</div><div ><a >Computational Renewables</a>: </div><div ><a >Defence Science Institute</a>: </div><div ><a >South African Medical Research Council</a>: </div><div ><a >European and Developing Countries Clinical Trials Partnership</a>: TMA2016SF-1535-CaTCH-22</div><div ><a >European and Developing Countries Clinical Trials Partnership</a>: TMA2017SF-1951-TB-SPEC</div><div ><a >Rosetrees Trust</a>: M926</div><div ><a >Medical Research Centre</a>: </div><div ><a >Norsk Revmatikerforbund</a>: </div><div >South African Research Chairs Initiative of the Department of Science and Innovation and the National Research Foundation: 9834</div></section><section ><h4>Notes</h4><div >*Corresponding authors. Catherine Riou; email: <a >[email protected]</a>; Wendy Burgers; email: <a >[email protected]</a></div><div ><div ><sup>†</sup></div><div >South African Cellular Immunology Network (SA-CIN) collaborators and affiliations are listed in the supplementary materials.</div></div></section></section></div><div ><header><h2>Metrics Citations</h2></header><section ><h3>Metrics</h3><section > <h5 > Article Usage </h5> </section><section > <h5 > Altmetrics </h5> </section></section><section ><h3>Citations</h3><section > <div > <h5 >Export citation</h5> <p>Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div ><header><h2>View Options</h2></header><div ><h3>View options</h3><section ><h4>PDF format</h4><p>Download this article as a PDF file</p><a >Download PDF</a></section></div><div ><h3>Get Access</h3><section > <div ><h5>Log in to view the full text</h5> <p><a >AAAS Log in</a></p> <p>AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul > <li >Become a AAAS Member</li> <li ><a >Activate your Account</a></li> <li ><a >Purchase Access to Other Journals in the Science Family</a></li> <li><a >Account Help</a></li> </ul> <div > <div >Log in via OpenAthens. <div ><a >via OpenAthens</a></div> </div> <div >Log in via Shibboleth. <div ><a >via Shibboleth</a></div> </div> </div> </div> <div ><h4>More options</h4><p><a >Purchase digital access to this article</a></p><p >Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div></div><div ><header><h2>Media</h2></header><section ><h3>Figures</h3></section><section ><h3>Multimedia</h3></section></div><div ><header><h2>Tables</h2></header></div><div ><header><h2>Share</h2></header><h3>Share</h3><div ><section ><h4>Share article link</h4><div ><a >Copy Link</a><div ><p >Copied!</p><p >Copying failed.</p></div></div></section><section ><h4>Share on social media</h4><div ><a >facebook</a><a >twitter</a><a >linkedin</a><a >email</a></div></section></div></div></div></article><section ><div ><div ><div ><div ><h3 >Submit a Response to This Article</h3></div></div></div></div> <div > <div > <h2 >(0)eLetters</h2> </div> <p >eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p >No eLetters have been published for this article yet.</p> </div> </section> <div ><a >View Full Text</a><a >Download PDF</a></div> </div></div></div></div><div ><div ><div ><div ><section><div ><h4 > Current Issue </h4><div ><div > <div ><div><article ><div ><div ><h3 ><a >Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</a></h3><ul ><li >By<ul > <li >Jay-Hyun Jo</li> <li >Catriona P. Harkins</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h3><ul ><li >By<ul > <li >Qian Zhang</li> <li >Morgan E. Hresko</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h3><ul ><li >By<ul > <li >Paul-Joseph Aspuria</li> <li >Sandro Vivona</li> <li >et al.</li> </ul> </li></ul></div></div></article></div><div >Table of Contents</div></div> </div></div></div></section><section > <h4 >LATEST NEWS</h4> <div > <div ><div > <article > <div > <div > News<time >30 Dec 2021</time> </div> <div > Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article > <div > <div > ScienceInsider<time >29 Dec 2021</time> </div> <div > <a > Once a ‘crazy idea,’ patent-pooling nonprofit will help bring COVID-19 pills to world’s poor </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > The natural world loses two of its biggest advocates </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > <a > What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >25 Dec 2021</time> </div> <div > NASA’s Webb telescope takes flight—a Christmas gift to astronomers everywhere </div> </div> </article> <article > <div > <div > News<time >23 Dec 2021</time> </div> <div > <a > More than a virus: Science’s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <div class="valid" valid="valid" title="valid: True, node: 5, tag: div, level: 5" node_number="5"> <div class="valid" valid="valid" title="valid: True, node: 6, tag: div, level: 6" node_number="6"> <div class="valid" valid="valid" title="valid: True, node: 7, tag: div, level: 7" node_number="7"> <div class="valid" valid="valid" title="valid: True, node: 8, tag: div, level: 8" node_number="8"> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 9" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 10" node_number="10"> <div class="valid" valid="valid" title="valid: True, node: 11, tag: div, level: 11" node_number="11"> <span class="valid" valid="valid" title="valid: True, node: 12, tag: span, level: 12" node_number="12">Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header class="valid" valid="valid" title="valid: True, node: 13, tag: header, level: 5" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 6" node_number="14"><div class="valid" valid="valid" title="valid: True, node: 15, tag: div, level: 7" node_number="15"><div class="valid" valid="valid" title="valid: True, node: 16, tag: div, level: 8" node_number="16"><div class="valid" valid="valid" title="valid: True, node: 17, tag: div, level: 9" node_number="17"><div class="valid" valid="valid" title="valid: True, node: 18, tag: div, level: 10" node_number="18"><div class="valid" valid="valid" title="valid: True, node: 19, tag: div, level: 11" node_number="19"><div class="valid" valid="valid" title="valid: True, node: 20, tag: div, level: 12" node_number="20"><a class="valid" valid="valid" title="valid: True, node: 21, tag: a, level: 13" node_number="21"><div class="valid" valid="valid" title="valid: True, node: 22, tag: div, level: 14" node_number="22">science</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 23, tag: div, level: 11" node_number="23"><div class="valid" valid="valid" title="valid: True, node: 24, tag: div, level: 12" node_number="24"><a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 13" node_number="25"><div class="valid" valid="valid" title="valid: True, node: 26, tag: div, level: 14" node_number="26">science advances</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 27, tag: div, level: 11" node_number="27"><div class="valid" valid="valid" title="valid: True, node: 28, tag: div, level: 12" node_number="28"><a class="valid" valid="valid" title="valid: True, node: 29, tag: a, level: 13" node_number="29"><div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 14" node_number="30">science immunology</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 11" node_number="31"><div class="valid" valid="valid" title="valid: True, node: 32, tag: div, level: 12" node_number="32"><a class="valid" valid="valid" title="valid: True, node: 33, tag: a, level: 13" node_number="33"><div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 14" node_number="34">science robotics</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 11" node_number="35"><div class="valid" valid="valid" title="valid: True, node: 36, tag: div, level: 12" node_number="36"><a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 13" node_number="37"><div class="valid" valid="valid" title="valid: True, node: 38, tag: div, level: 14" node_number="38">science signaling</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 39, tag: div, level: 11" node_number="39"><div class="valid" valid="valid" title="valid: True, node: 40, tag: div, level: 12" node_number="40"><a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 13" node_number="41"><div class="valid" valid="valid" title="valid: True, node: 42, tag: div, level: 14" node_number="42">science translational medicine</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 43, tag: div, level: 11" node_number="43"><div class="valid" valid="valid" title="valid: True, node: 44, tag: div, level: 12" node_number="44"><a class="valid" valid="valid" title="valid: True, node: 45, tag: a, level: 13" node_number="45"><div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 14" node_number="46">science partner journals</div></a></div></div></div></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 47, tag: div, level: 6" node_number="47"> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 7" node_number="48"> <div class="valid" valid="valid" title="valid: True, node: 49, tag: div, level: 8" node_number="49"> <div class="valid" valid="valid" title="valid: True, node: 50, tag: div, level: 9" node_number="50"> <div class="valid" valid="valid" title="valid: True, node: 51, tag: div, level: 10" node_number="51"><div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 11" node_number="52"><div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 12" node_number="53"><label class="valid" valid="valid" title="valid: True, node: 54, tag: label, level: 13" node_number="54">Searching:</label><div class="valid" valid="valid" title="valid: True, node: 55, tag: div, level: 13" node_number="55"><div class="valid" valid="valid" title="valid: True, node: 56, tag: div, level: 14" node_number="56"><div title="valid: False, node: 57, tag: div, level: 15" node_number="57">AnywhereScienceScience AdvancesScience ImmunologyScience RoboticsScience SignalingScience Translational Medicine</div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 58, tag: div, level: 12" node_number="58"> <a class="valid" valid="valid" title="valid: True, node: 59, tag: a, level: 13" node_number="59"><u class="valid" valid="valid" title="valid: True, node: 60, tag: u, level: 14" node_number="60">Advanced Search</u></a> </div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 61, tag: div, level: 7" node_number="61"> <div class="valid" valid="valid" title="valid: True, node: 62, tag: div, level: 8" node_number="62"> <div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 9" node_number="63"> <h6 class="valid" valid="valid" title="valid: True, node: 64, tag: h6, level: 10" node_number="64">Trending Terms:</h6> <ul class="valid" valid="valid" title="valid: True, node: 65, tag: ul, level: 10" node_number="65"> <li class="valid" valid="valid" title="valid: True, node: 66, tag: li, level: 11" node_number="66"> covid-19 </li> <li class="valid" valid="valid" title="valid: True, node: 67, tag: li, level: 11" node_number="67"> climate </li> <li class="valid" valid="valid" title="valid: True, node: 68, tag: li, level: 11" node_number="68"> science policy </li> <li class="valid" valid="valid" title="valid: True, node: 69, tag: li, level: 11" node_number="69"> genome editing </li> <li class="valid" valid="valid" title="valid: True, node: 70, tag: li, level: 11" node_number="70"> batteries </li> </ul> </div> </div> </div> </div> </header><div class="valid" valid="valid" title="valid: True, node: 71, tag: div, level: 5" node_number="71"><div class="valid" valid="valid" title="valid: True, node: 72, tag: div, level: 6" node_number="72"><div class="valid" valid="valid" title="valid: True, node: 73, tag: div, level: 7" node_number="73"> <div class="valid" valid="valid" title="valid: True, node: 74, tag: div, level: 8" node_number="74"> <div class="valid" valid="valid" title="valid: True, node: 75, tag: div, level: 9" node_number="75"> <ul class="valid" valid="valid" title="valid: True, node: 76, tag: ul, level: 10" node_number="76"> <li class="valid" valid="valid" title="valid: True, node: 77, tag: li, level: 11" node_number="77"> Current Issue </li> <li class="valid" valid="valid" title="valid: True, node: 78, tag: li, level: 11" node_number="78"> First release papers </li> <li class="valid" valid="valid" title="valid: True, node: 79, tag: li, level: 11" node_number="79"> Archive </li> <li class="valid" valid="valid" title="valid: True, node: 80, tag: li, level: 11" node_number="80"> <div class="valid" valid="valid" title="valid: True, node: 81, tag: div, level: 12" node_number="81"> About <div class="valid" valid="valid" title="valid: True, node: 82, tag: div, level: 13" node_number="82"> About Science Translational Medicine Mission Scope Editors and Advisory Boards Editorial Policies Information for Authors Information for Reviewers Journal Metrics Staff Contact Us Subscribe Free Sample Articles </div> </div> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 83, tag: div, level: 9" node_number="83"> <ul class="valid" valid="valid" title="valid: True, node: 84, tag: ul, level: 10" node_number="84"> <li class="valid" valid="valid" title="valid: True, node: 85, tag: li, level: 11" node_number="85"> Submit manuscript </li> <li class="valid" valid="valid" title="valid: True, node: 86, tag: li, level: 11" node_number="86"> <div class="valid" valid="valid" title="valid: True, node: 87, tag: div, level: 12" node_number="87"> More </div> </li> </ul> </div> </div> GET OUR E-ALERTS </div></div></div> <main class="valid" valid="valid" title="valid: True, node: 88, tag: main, level: 5" node_number="88"> <div class="valid" valid="valid" title="valid: True, node: 89, tag: div, level: 6" node_number="89"><div class="valid" valid="valid" title="valid: True, node: 90, tag: div, level: 7" node_number="90"><div class="valid" valid="valid" title="valid: True, node: 91, tag: div, level: 8" node_number="91"><div class="valid" valid="valid" title="valid: True, node: 92, tag: div, level: 9" node_number="92"><div class="valid" valid="valid" title="valid: True, node: 93, tag: div, level: 10" node_number="93"> <div class="valid" valid="valid" title="valid: True, node: 94, tag: div, level: 11" node_number="94">HomeScience Translational MedicineFirst ReleaseEscape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity</div><div class="valid" valid="valid" title="valid: True, node: 95, tag: div, level: 11" node_number="95">Back To First Release</div> </div> <article class="valid" valid="valid" title="valid: True, node: 96, tag: article, level: 10" node_number="96"><section class="valid" valid="valid" title="valid: True, node: 97, tag: section, level: 11" node_number="97"><header class="valid" valid="valid" title="valid: True, node: 98, tag: header, level: 12" node_number="98"><div class="valid" valid="valid" title="valid: True, node: 99, tag: div, level: 13" node_number="99"><div class="valid" valid="valid" title="valid: True, node: 100, tag: div, level: 14" node_number="100"><div title="valid: False, node: 101, tag: div, level: 15" node_number="101"><div title="valid: False, node: 102, tag: div, level: 16" node_number="102">OPEN ACCESS</div><div title="valid: False, node: 103, tag: div, level: 16" node_number="103">Research Article</div><div title="valid: False, node: 104, tag: div, level: 16" node_number="104">CORONAVIRUS</div></div><div title="valid: False, node: 105, tag: div, level: 15" node_number="105"><div title="valid: False, node: 106, tag: div, level: 16" node_number="106"> <div title="valid: False, node: 107, tag: div, level: 17" node_number="107">Share on</div> </div></div></div><h1 class="valid" valid="valid" title="valid: True, node: 108, tag: h1, level: 14" node_number="108">Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity</h1><div class="valid" valid="valid" title="valid: True, node: 109, tag: div, level: 14" node_number="109"><span title="valid: False, node: 110, tag: span, level: 15" node_number="110"><span title="valid: False, node: 111, tag: span, level: 16" node_number="111">Catherine Riou https://orcid.org/0000-0001-9679-0745 [email&#160;protected], Roanne Keeton https://orcid.org/0000-0003-4808-9756, Thandeka Moyo-Gwete https://orcid.org/0000-0002-4269-9281, Tandile Hermanus https://orcid.org/0000-0003-4734-1980, Prudence Kgagudi, Richard Baguma https://orcid.org/0000-0002-5106-021X, Ziyaad Valley-Omar https://orcid.org/0000-0003-4804-3774, &#8230; Show All &#8230; , Mikhail Smith, Houriiyah Tegally https://orcid.org/0000-0002-7102-8540, Deelan Doolabh, Arash Iranzadeh, Lynn Tyers https://orcid.org/0000-0002-0535-9165, Hygon Mutavhatsindi https://orcid.org/0000-0001-6605-6275, Marius B. Tincho https://orcid.org/0000-0002-1293-5933, Ntombi Benede https://orcid.org/0000-0002-3319-8215, Gert Marais https://orcid.org/0000-0003-1477-6101, Lionel R. Chinhoyi https://orcid.org/0000-0002-5266-4613, Mathilda Mennen, Sango Skelem, Elsa du Bruyn https://orcid.org/0000-0002-5088-2158, Cari Stek<span title="valid: False, node: 112, tag: span, level: 17" node_number="112">, <span title="valid: False, node: 113, tag: span, level: 18" node_number="113">SA-CIN<a title="valid: False, node: 114, tag: a, level: 19" node_number="114"><sup title="valid: False, node: 115, tag: sup, level: 20" node_number="115">&#8224;</sup></a></span></span>, Tulio de Oliveira https://orcid.org/0000-0002-3027-5254, Carolyn Williamson https://orcid.org/0000-0003-0125-1226, Penny L. Moore https://orcid.org/0000-0001-8719-4028, Robert J. Wilkinson, Ntobeko A. B. Ntusi https://orcid.org/0000-0003-2347-7883, and Wendy A. Burgers https://orcid.org/0000-0003-3396-9398 [email&#160;protected] Show Fewer</span></span></div><div class="valid" valid="valid" title="valid: True, node: 116, tag: div, level: 14" node_number="116">Science Translational Medicine &#8226; 21 Dec 2021 &#8226; First Release &#8226; DOI: 10.1126/scitranslmed.abj6824</div><div class="valid" valid="valid" title="valid: True, node: 117, tag: div, level: 14" node_number="117"><div title="valid: False, node: 118, tag: div, level: 15" node_number="118"> <div title="valid: False, node: 119, tag: div, level: 16" node_number="119"> <a title="valid: False, node: 120, tag: a, level: 17" node_number="120"><div title="valid: False, node: 121, tag: div, level: 18" node_number="121"><div title="valid: False, node: 122, tag: div, level: 19" node_number="122"><h6 title="valid: False, node: 123, tag: h6, level: 20" node_number="123">PREVIOUS ARTICLE</h6><div title="valid: False, node: 124, tag: div, level: 20" node_number="124">A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus</div></div></div>Previous</a><a title="valid: False, node: 125, tag: a, level: 17" node_number="125"><div title="valid: False, node: 126, tag: div, level: 18" node_number="126"><div title="valid: False, node: 127, tag: div, level: 19" node_number="127"><h6 title="valid: False, node: 128, tag: h6, level: 20" node_number="128">NEXT ARTICLE</h6><div title="valid: False, node: 129, tag: div, level: 20" node_number="129">A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates</div></div></div>Next</a> </div> </div></div></div></header><div class="valid" valid="valid" title="valid: True, node: 130, tag: div, level: 12" node_number="130"><div class="valid" valid="valid" title="valid: True, node: 131, tag: div, level: 13" node_number="131"><section class="valid" valid="valid" title="valid: True, node: 132, tag: section, level: 14" node_number="132"><h2 title="valid: False, node: 133, tag: h2, level: 15" node_number="133">Abstract</h2><div title="valid: False, node: 134, tag: div, level: 15" node_number="134">SARS-CoV-2 variants have emerged that escape neutralization and potentially impact vaccine efficacy. T cell responses play a role in protection from reinfection and severe disease, but the potential for spike mutations to affect T cell immunity is incompletely understood. We assessed neutralizing antibody and T cell responses in 44 South African COVID-19 patients infected either with the Beta variant (dominant from November 2020 to May 2021) or infected prior to its emergence (first wave, Wuhan strain), to provide an overall measure of immune evasion. We show that robust spike-specific CD4 and CD8 T cell responses were detectable in Beta-infected patients, similar to first wave patients. Using peptides spanning the Beta-mutated regions, we identified CD4 T cell responses targeting the wild type peptides in 12/22 first wave patients, all of whom failed to recognize corresponding Beta-mutated peptides. However, responses to mutated regions formed only a small proportion (15.7%) of the overall CD4 response, and few patients (3/44) mounted CD8 responses that targeted the mutated regions. Among the spike epitopes tested, we identified three epitopes containing the D215, L18, or D80 residues that were specifically recognized by CD4 T cells, and their mutated versions were associated with a loss of response. This study shows that in spite of loss of recognition of immunogenic CD4 epitopes, CD4 and CD8 T cell responses to Beta are preserved overall. These observations may explain why several vaccines have retained the ability to protect against severe COVID-19 even with substantial loss of neutralizing antibody activity against Beta.</div></section></div></div></section><section class="valid" valid="valid" title="valid: True, node: 135, tag: section, level: 11" node_number="135"><div class="valid" valid="valid" title="valid: True, node: 136, tag: div, level: 12" node_number="136"><section class="valid" valid="valid" title="valid: True, node: 137, tag: section, level: 13" node_number="137"><h2 class="valid" valid="valid" title="valid: True, node: 138, tag: h2, level: 14" node_number="138">INTRODUCTION</h2><div class="valid" valid="valid" title="valid: True, node: 139, tag: div, level: 14" node_number="139">High levels of ongoing SARS-CoV-2 transmission have led to the emergence of successive new viral variants, which now dominate the pandemic. Variants of concern have been characterized as having increased transmissibility, potentially greater pathogenicity, and the ability to evade host immunity (<a title="valid: False, node: 140, tag: a, level: 15" node_number="140"><i title="valid: False, node: 141, tag: i, level: 16" node_number="141">1</i></a>). Five such variants of concern have circulated around the world, namely Alpha, Beta, Gamma, Delta, the latter widely replacing many other variants, and more recently Omicron (<a title="valid: False, node: 142, tag: a, level: 15" node_number="142"><i title="valid: False, node: 143, tag: i, level: 16" node_number="143">2</i></a>&#8211;<a title="valid: False, node: 144, tag: a, level: 15" node_number="144"><i title="valid: False, node: 145, tag: i, level: 16" node_number="145">7</i></a>). A primary concern is whether the immune response generated against ancestral SARS-CoV-2 strains, upon which all approved first generation vaccines are based, still confers protection against variants. The potential threat of reduced vaccine efficacy has prompted swift action from vaccine manufacturers, and adapted vaccines based on other variants have been developed and tested in preclinical and clinical trials (<a title="valid: False, node: 146, tag: a, level: 15" node_number="146"><i title="valid: False, node: 147, tag: i, level: 16" node_number="147">8</i></a>, <a title="valid: False, node: 148, tag: a, level: 15" node_number="148"><i title="valid: False, node: 149, tag: i, level: 16" node_number="149">9</i></a>).</div><div class="valid" valid="valid" title="valid: True, node: 150, tag: div, level: 14" node_number="150">Before the recent emergence of the SARS-CoV-2 Delta variant, the Beta variant, which was first described in South Africa in October 2020 (<a title="valid: False, node: 151, tag: a, level: 15" node_number="151"><i title="valid: False, node: 152, tag: i, level: 16" node_number="152">5</i></a>), was responsible for &gt;95% of infections in the country and has spread across much of southern Africa (<a title="valid: False, node: 153, tag: a, level: 15" node_number="153"><i title="valid: False, node: 154, tag: i, level: 16" node_number="154">6</i></a>). It was a concerning variant from an immunological perspective, demonstrating the greatest reduction in neutralization sensitivity to COVID-19 convalescent and vaccinee plasma (<a title="valid: False, node: 155, tag: a, level: 15" node_number="155"><i title="valid: False, node: 156, tag: i, level: 16" node_number="156">10</i></a>&#8211;<a title="valid: False, node: 157, tag: a, level: 15" node_number="157"><i title="valid: False, node: 158, tag: i, level: 16" node_number="158">15</i></a>), as well as reduced vaccine efficacy (<a title="valid: False, node: 159, tag: a, level: 15" node_number="159"><i title="valid: False, node: 160, tag: i, level: 16" node_number="160">16</i></a>&#8211;<a title="valid: False, node: 161, tag: a, level: 15" node_number="161"><i title="valid: False, node: 162, tag: i, level: 16" node_number="162">18</i></a>). However, some vaccines have still demonstrated high efficacy against severe COVID-19 after Beta infection (<a title="valid: False, node: 163, tag: a, level: 15" node_number="163"><i title="valid: False, node: 164, tag: i, level: 16" node_number="164">19</i></a>), suggesting that T cell immunity plays an important role in immune protection, and may mitigate the effect of reduced neutralizing antibody activity.</div><div class="valid" valid="valid" title="valid: True, node: 165, tag: div, level: 14" node_number="165">To date, efforts to characterize immune evasion by SARS-CoV-2 variants have focused mainly on their ability to escape neutralization (<a title="valid: False, node: 166, tag: a, level: 15" node_number="166"><i title="valid: False, node: 167, tag: i, level: 16" node_number="167">10</i></a>&#8211;<a title="valid: False, node: 168, tag: a, level: 15" node_number="168"><i title="valid: False, node: 169, tag: i, level: 16" node_number="169">15</i></a>). There is limited data addressing whether SARS-CoV-2 variants can evade T cell immunity (<a title="valid: False, node: 170, tag: a, level: 15" node_number="170"><i title="valid: False, node: 171, tag: i, level: 16" node_number="171">20</i></a>&#8211;<a title="valid: False, node: 172, tag: a, level: 15" node_number="172"><i title="valid: False, node: 173, tag: i, level: 16" node_number="173">24</i></a>) in natural infection or after vaccination. Furthermore, spike-specific T cell responses in COVID-19 patients infected with variant lineages have not been investigated. Here, we determined whether Beta spike mutations affect the recognition of T cell epitopes in patients infected with the ancestral or Beta SARS-CoV-2 lineages. We demonstrate that loss of CD4 T cell recognition does indeed occur in Beta-mutated spike regions, although the majority of the T cell response is maintained. Furthermore, Beta-infected patients mounted comparable spike responses as those infected with earlier strains. These results have important implications for reinfection and vaccine efficacy.</div></section><section class="valid" valid="valid" title="valid: True, node: 174, tag: section, level: 13" node_number="174"><h2 class="valid" valid="valid" title="valid: True, node: 175, tag: h2, level: 14" node_number="175">RESULTS</h2><section class="valid" valid="valid" title="valid: True, node: 176, tag: section, level: 14" node_number="176"><h3 title="valid: False, node: 177, tag: h3, level: 15" node_number="177">T cell responses in patients infected with ancestral strains or Beta</h3><div title="valid: False, node: 178, tag: div, level: 15" node_number="178">SARS-CoV-2 spike-specific neutralizing antibody and T cell responses were measured in hospitalized COVID-19 patients enrolled at Groote Schuur Hospital (Western Cape, South Africa) during the first wave of the COVID-19 pandemic (n = 22), prior to the emergence of the Beta variant, and during the second wave of the pandemic (n = 22), after the Beta variant became the dominant lineage (<a title="valid: False, node: 179, tag: a, level: 16" node_number="179"><b title="valid: False, node: 180, tag: b, level: 17" node_number="180">Fig. 1A</b></a>). During the first wave, all sequenced virus corresponded to ancestral SARS-CoV-2 lineages (Wuhan and D614G). Conversely, during the second wave, the Beta lineage accounted for &gt;95% of reported SARS-CoV-2 infections at the time of sample collection (<a title="valid: False, node: 181, tag: a, level: 16" node_number="181"><b title="valid: False, node: 182, tag: b, level: 17" node_number="182">Fig. 1B</b></a><b title="valid: False, node: 183, tag: b, level: 16" node_number="183">)</b>. Beta is defined by nine amino acid changes in the spike protein, and all second wave participants that we sequenced (19/22) had confirmed infection with Beta and harbored 7 to 8 changes associated with the Beta lineage (<a title="valid: False, node: 184, tag: a, level: 16" node_number="184"><i title="valid: False, node: 185, tag: i, level: 17" node_number="185">5</i></a>) (<b title="valid: False, node: 186, tag: b, level: 16" node_number="186">Fig. S1</b>). Although SARS-CoV-2 viral sequences were not available for patients recruited in June to August 2020 during the first wave, we assumed that all participants were infected with a virus closely related to the ancestral virus, since Beta was first detected in October 2020 in the Western Cape.</div><div title="valid: False, node: 187, tag: div, level: 15" node_number="187">First, we compared the magnitude of CD4 and CD8 T cell responses directed at the spike protein of SARS-CoV-2 in first and second wave patients. Using flow cytometry, we measured the production of IFN-&#947;, TNF-&#945; or IL-2 in response to a peptide pool covering the full ancestral spike protein (&#8216;Full spike&#8217;) (<a title="valid: False, node: 188, tag: a, level: 16" node_number="188"><b title="valid: False, node: 189, tag: b, level: 17" node_number="189">Fig. 1C</b></a>). All participants tested exhibited a CD4 response, with a comparable frequency of spike specific-CD4 T cells in first and second wave patients (<i title="valid: False, node: 190, tag: i, level: 16" node_number="190">P</i> = 0.072, <a title="valid: False, node: 191, tag: a, level: 16" node_number="191"><b title="valid: False, node: 192, tag: b, level: 17" node_number="192">Fig. 1D</b></a>). A detectable spike CD8 response was observed in 63.6% (14/22) of first wave patients and 81.8% (18/22) of second wave patients (<i title="valid: False, node: 193, tag: i, level: 16" node_number="193">P</i> = 0.31, Fisher's exact test). Amongst CD8 responders, the frequency of SARS-CoV-2 spike-specific CD8 T cell response was not significantly different between first and second wave patients (<i title="valid: False, node: 194, tag: i, level: 16" node_number="194">P</i> = 0.054). As previously reported (<a title="valid: False, node: 195, tag: a, level: 16" node_number="195"><i title="valid: False, node: 196, tag: i, level: 17" node_number="196">25</i></a>), the magnitude of the SARS-CoV-2 spike-specific CD8 T cell response was significantly lower compared to the CD4 response in both first and second wave patients (<i title="valid: False, node: 197, tag: i, level: 16" node_number="197">P</i> = 0.0005 and <i title="valid: False, node: 198, tag: i, level: 16" node_number="198">P</i> = 0.007, respectively). Moreover, there were no significant differences in the frequency of SARS-CoV-2 spike-specific CD4 or CD8 T cells between patients with moderate or severe disease (<i title="valid: False, node: 199, tag: i, level: 16" node_number="199">P</i> = 0.3 and <i title="valid: False, node: 200, tag: i, level: 16" node_number="200">P</i> = 0.36, respectively). Also, no associations were found between the frequency of spike-specific CD4 or CD8 T cells and days post-PCR positivity (<i title="valid: False, node: 201, tag: i, level: 16" node_number="201">P</i> = 0.20, r= 0.28 and <i title="valid: False, node: 202, tag: i, level: 16" node_number="202">P</i> = 0.1, r = 0.24, respectively) or days since symptom onset in patients recruited during the first wave (<i title="valid: False, node: 203, tag: i, level: 16" node_number="203">P</i> = 0.22, r = 0.28 and <i title="valid: False, node: 204, tag: i, level: 16" node_number="204">P</i> = 0.77, r = 0.07, respectively). Lastly, the polyfunctional profiles of SARS-CoV-2 spike-specific CD4 or CD8 T cells were similar between first and second wave patients, with approximately one third of CD4 cells expressing at least two cytokines, while CD8 response was mostly IFN-&#947; monofunctional (<a title="valid: False, node: 205, tag: a, level: 16" node_number="205"><b title="valid: False, node: 206, tag: b, level: 17" node_number="206">Fig. 1E and F</b></a>).</div><div title="valid: False, node: 207, tag: div, level: 15" node_number="207">To ascertain whether similar patterns were maintained in convalescent COVID-19 donors, we compared the frequency of ancestral SARS-CoV-2 spike-, nucleocapsid (N)- and membrane (M)-specific CD4 and CD8 T cells in convalescent COVID-19 patients infected during the first wave with the ancestral strain (n = 10) or during the second wave, when Beta dominated (n = 14) (<a title="valid: False, node: 208, tag: a, level: 16" node_number="208"><b title="valid: False, node: 209, tag: b, level: 17" node_number="209">Fig. 2A</b></a>). As for acute COVID-19 patients, the magnitude and polyfunctional profiles of ancestral SARS-CoV-2 spike-specific CD4 and CD8 T cell responses were comparable between convalescent individuals infected during the first or the second wave (<a title="valid: False, node: 210, tag: a, level: 16" node_number="210"><b title="valid: False, node: 211, tag: b, level: 17" node_number="211">Fig. 2B, C and D</b></a>). Similar results were observed for CD4 responses against the SARS-CoV-2 N and M proteins (<a title="valid: False, node: 212, tag: a, level: 16" node_number="212"><b title="valid: False, node: 213, tag: b, level: 17" node_number="213">Fig. 2B</b></a>). We also compared the profiles of spike-specific T cell responses cross-sectionally between acute and convalescent COVID-19 patients. Our data show that the frequency of spike-specific CD4 T cells is significantly lower in convalescent compared to acutely infected patients, regardless of the infecting strains (<i title="valid: False, node: 214, tag: i, level: 16" node_number="214">P</i> = 0.03 for WT and <i title="valid: False, node: 215, tag: i, level: 16" node_number="215">P</i> &lt; 0.0001 for Beta) (<b title="valid: False, node: 216, tag: b, level: 16" node_number="216">Fig. S2A</b>), which is likely related to the contraction of antigen-specific responses following viral clearance (<a title="valid: False, node: 217, tag: a, level: 16" node_number="217"><i title="valid: False, node: 218, tag: i, level: 17" node_number="218">26</i></a>). For spike-specific CD8 T cell responses, a lower frequency was observed only between acute and convalescent patients from the second wave (<i title="valid: False, node: 219, tag: i, level: 16" node_number="219">P</i> = 0.034). Lastly, an increase in the polyfunctional profile of both spike-specific CD4 and CD8 T cells was observed in convalescent COVID-19 patients compared to those in the acute phase of infection, characterized by a substantial increase in IFN-&#947;, TNF-&#945; and IL-2 co-expressing cells for spike-specific CD4 T cells and a significant reduction of IFN-&#947; monofunctional cells for spike-specific CD8 T cells (<b title="valid: False, node: 220, tag: b, level: 16" node_number="220">Fig. S2B and C</b>). Overall, these data are in accordance with a recent report showing that T cell responses directed at the SARS-CoV-2 spike protein in convalescent COVID-19 donors infected with SARS-CoV-2 ancestral strain were not substantially affected by mutations found in SARS-CoV-2 variants (<a title="valid: False, node: 221, tag: a, level: 16" node_number="221"><i title="valid: False, node: 222, tag: i, level: 17" node_number="222">24</i></a>), and we further show that there is no overall dampening of T cell responses or change in functional profiles to the three immunogenic structural proteins of SARS-CoV-2 in those infected with Beta.</div></section><section class="valid" valid="valid" title="valid: True, node: 223, tag: section, level: 14" node_number="223"><h3 title="valid: False, node: 224, tag: h3, level: 15" node_number="224">CD4 T cell targeting of variant spike epitopes</h3><div title="valid: False, node: 225, tag: div, level: 15" node_number="225">Since Beta-associated mutations occur only at a few residues of the spike protein, we assessed the recognition of peptide pools selectively spanning the variable regions of spike, one composed of the ancestral peptides (&#8216;WT pool&#8217;) and the other Beta-mutated peptides (&#8216;Beta pool&#8217;) (<b title="valid: False, node: 226, tag: b, level: 16" node_number="226">Table S1</b>). Sample availability enabled us to perform these experiments in the acute COVID-19 cohort. Due to elevated TNF-&#945; background observed in unstimulated cells (<a title="valid: False, node: 227, tag: a, level: 16" node_number="227"><b title="valid: False, node: 228, tag: b, level: 17" node_number="228">Fig. 1C</b></a>), we focused on IFN-&#947; producing cells to measure T cell response to the smaller peptide pools. We previously described that acute COVID-19 patients had SARS-CoV-2-specific CD4 T cells characterized by elevated expression of PD-1 (<a title="valid: False, node: 229, tag: a, level: 16" node_number="229"><i title="valid: False, node: 230, tag: i, level: 17" node_number="230">27</i></a>). Thus, PD-1 was included in our flow cytometry panel to ensure that the phenotypic profile of CD4 T cells responding to the variable spike epitopes were consistent with our previous findings. In patients recruited during the first wave, IFN-&#947; CD4 T cell responses to the WT pool were detectable in 54.5% (12/22) patients (<a title="valid: False, node: 231, tag: a, level: 16" node_number="231"><b title="valid: False, node: 232, tag: b, level: 17" node_number="232">Fig. 3A and B</b></a>). In those who mounted responses, the magnitude of the WT pool response was ~ 6.4-fold lower than full spike responses (median: 0.0075% vs 0.048%, respectively, <i title="valid: False, node: 233, tag: i, level: 16" node_number="233">P</i> &lt; 0.0001). In the 12 participants responding to the WT pool, the overall median relative contribution of WT epitopes located at spike mutation sites to the total spike-specific CD4 T cell response was 15.7%, ranging from 5.7% to 24%. This suggests that the majority of SARS-CoV-2 spike-specific CD4 T cell responses are directed against conserved epitopes between the ancestral and Beta lineage. When we tested the corresponding Beta pool, all 12 of the first wave WT pool responders failed to cross-react with the mutated peptides from Beta (<a title="valid: False, node: 234, tag: a, level: 16" node_number="234"><b title="valid: False, node: 235, tag: b, level: 17" node_number="235">Fig. 3B</b></a><b title="valid: False, node: 236, tag: b, level: 16" node_number="236">,</b> left panel). These results show that Beta-mutated epitopes were no longer recognized by CD4 T cells targeting WT epitopes, demonstrating that this loss of recognition is likely mediated by variant mutations. This is broadly consistent with recent data from mRNA vaccinees, where full spike pools containing Beta mutated peptides detected T cell responses that were diminished by 30% compared to ancestral spike, revealing that the mutated sequences mediate differential recognition but make up a minor contribution to the overall spike-specific T cell response (<a title="valid: False, node: 237, tag: a, level: 16" node_number="237"><i title="valid: False, node: 238, tag: i, level: 17" node_number="238">24</i></a>).</div><div title="valid: False, node: 239, tag: div, level: 15" node_number="239">We next measured peptide responses in patients infected with the Beta lineage. The Beta pool was not readily recognized by patients infected with the homologous variant (2/22; 9.1%) (<a title="valid: False, node: 240, tag: a, level: 16" node_number="240"><b title="valid: False, node: 241, tag: b, level: 17" node_number="241">Fig. 3B</b></a><b title="valid: False, node: 242, tag: b, level: 16" node_number="242">,</b> right panel). A single donor had a detectable response to the WT but not Beta pool. These data suggest that mutations in Beta spike epitopes likely alter epitope binding to restricting HLA molecules, consistent with the loss of recognition of Beta-mutated peptides by T cells in first wave patients.</div><div title="valid: False, node: 243, tag: div, level: 15" node_number="243">In order to obtain an overall measure of immune escape in our participants, we measured their neutralizing antibody responses to the ancestral and Beta spike proteins (<a title="valid: False, node: 244, tag: a, level: 16" node_number="244"><b title="valid: False, node: 245, tag: b, level: 17" node_number="245">Fig. 3C and D</b></a>). As we showed previously (<a title="valid: False, node: 246, tag: a, level: 16" node_number="246"><i title="valid: False, node: 247, tag: i, level: 17" node_number="247">13</i></a>)<i title="valid: False, node: 248, tag: i, level: 16" node_number="248">,</i> in patients infected with the ancestral strains (first wave), a considerable loss of neutralization activity was observed against Beta (median fold change: 12.7, IQR: 7.3-18.8). In contrast, patients infected with Beta (second wave) retained a substantial capacity to neutralize ancestral virus, as shown by a moderate reduction in neutralizing activity (median: 2.3, IQR: 1.3-3.9). Of note, in the six first wave patients where loss of cross-neutralization was profound (titer &lt;100), it is reassuring that the T cell response was relatively intact. We found no association between the frequency of SARS-CoV-2 spike-specific CD4 T cell responses and neutralizing activity (<b title="valid: False, node: 249, tag: b, level: 16" node_number="249">Fig. S3A</b>), consistent with an earlier study (<a title="valid: False, node: 250, tag: a, level: 16" node_number="250"><i title="valid: False, node: 251, tag: i, level: 17" node_number="251">28</i></a>). Moreover, comparable frequencies of SARS-CoV-2-specific CD4 T cells were observed, irrespective of the extent of the loss of neutralizing activity against heterologous virus (<b title="valid: False, node: 252, tag: b, level: 16" node_number="252">Fig. S3B</b>).</div></section><section class="valid" valid="valid" title="valid: True, node: 253, tag: section, level: 14" node_number="253"><h3 title="valid: False, node: 254, tag: h3, level: 15" node_number="254">CD8 T cell targeting of variant spike epitopes</h3><div title="valid: False, node: 255, tag: div, level: 15" node_number="255">We next defined the recognition of WT and Beta peptide pools by CD8 T cells (<a title="valid: False, node: 256, tag: a, level: 16" node_number="256"><b title="valid: False, node: 257, tag: b, level: 17" node_number="257">Fig. 4A</b></a>). Regardless of the infecting SARS-CoV-2 lineage, peptides covering the spike mutation sites were rarely recognized by CD8 T cells, with only 3/44 (6.8%) patients exhibiting a CD8 response, one in the first wave cohort and two in the second wave cohort. Thus, in contrast to CD4 T cells, the regions in which Beta mutations occur are not commonly targeted by CD8 T cells. Moreover, in these three patients, the frequency of IFN-&#947;-producing CD8 T cells was comparable between WT and Beta pool stimulation, indicating that mutations did not affect epitope recognition (<a title="valid: False, node: 258, tag: a, level: 16" node_number="258"><b title="valid: False, node: 259, tag: b, level: 17" node_number="259">Fig. 4B</b></a>). Overall, these data indicate that Beta mutations do not affect CD8 T cell responses in our cohort.</div></section><section class="valid" valid="valid" title="valid: True, node: 260, tag: section, level: 14" node_number="260"><h3 title="valid: False, node: 261, tag: h3, level: 15" node_number="261">Mapping of spike variable epitopes targeted by T cells</h3><div title="valid: False, node: 262, tag: div, level: 15" node_number="262">To gain deeper insight into the recognition of variable spike epitopes by CD4 cells in patients responding to the WT pool, responses to individual epitopes were measured in first wave COVID-19 patients (<a title="valid: False, node: 263, tag: a, level: 16" node_number="263"><b title="valid: False, node: 264, tag: b, level: 17" node_number="264">Fig. 5A</b></a>). Amongst the six tested patients, a response to the spike 206-225 region (containing D215) was observed in 5 out of 6 patients, two of which also displayed a response to spike 6-25 region (containing L18). Moreover, a response toward the spike 73-92 region (containing D80) was detected in one participant (<a title="valid: False, node: 265, tag: a, level: 16" node_number="265"><b title="valid: False, node: 266, tag: b, level: 17" node_number="266">Fig. 5B</b></a>). Mutation of these regions (L18F, D80A and D215G) resulted in a loss of CD4 response (<a title="valid: False, node: 267, tag: a, level: 16" node_number="267"><b title="valid: False, node: 268, tag: b, level: 17" node_number="268">Fig. 3B</b></a> and <a title="valid: False, node: 269, tag: a, level: 16" node_number="269"><b title="valid: False, node: 270, tag: b, level: 17" node_number="270">Fig. 5A</b></a>). No CD4 T cell responses to epitopes containing the K417, E484, N501 or A701 residues were observed (<a title="valid: False, node: 271, tag: a, level: 16" node_number="271"><b title="valid: False, node: 272, tag: b, level: 17" node_number="272">Fig. 5B</b> and <b title="valid: False, node: 273, tag: b, level: 17" node_number="273">C</b></a>).</div><div title="valid: False, node: 274, tag: div, level: 15" node_number="274">To identify the potential HLA restriction associated with the recognition of the L18, D80 and D215 epitopes, predicted HLA class II restriction for each epitope was defined <i title="valid: False, node: 275, tag: i, level: 16" node_number="275">in silico</i> (<b title="valid: False, node: 276, tag: b, level: 16" node_number="276">Table S2</b>) and compared to HLA class II molecules expressed in our study cohort (<b title="valid: False, node: 277, tag: b, level: 16" node_number="277">Table S3</b>). We identified that the D215 epitope was restricted by DRB1*03:01, DRB1*03:02 or DRB1*13:01; and the D215G mutation is predicted to be associated with a loss of response in those three alleles (<b title="valid: False, node: 278, tag: b, level: 16" node_number="278">Data file S1</b>), as previously reported (<a title="valid: False, node: 279, tag: a, level: 16" node_number="279"><i title="valid: False, node: 280, tag: i, level: 17" node_number="280">29</i></a>). Nine first wave patients carried one of these alleles, eight of whom exhibited a response to the D215 epitopes (n = 5) or the WT pool (n = 3). No matching alleles were predicted for the L18 and D80 epitopes, despite CD4 responses to the spike regions 6-20, 11-25 and 78-92 having been previously reported previously (<a title="valid: False, node: 281, tag: a, level: 16" node_number="281"><i title="valid: False, node: 282, tag: i, level: 17" node_number="282">30</i></a>, <a title="valid: False, node: 283, tag: a, level: 16" node_number="283"><i title="valid: False, node: 284, tag: i, level: 17" node_number="284">31</i></a>).</div><div title="valid: False, node: 285, tag: div, level: 15" node_number="285">Due to limited availability of samples, we could not test all WT pool responders for single epitope responses. However, based on predicted HLA class II restriction, we hypothesized that the peptide <sup title="valid: False, node: 286, tag: sup, level: 16" node_number="286">236</sup>TRFQTLLALHRSYLT<sup title="valid: False, node: 287, tag: sup, level: 16" node_number="287">250</sup> (WT version of the 242-244del/R246I) may be an immunogenetic epitope, as previously described (<a title="valid: False, node: 288, tag: a, level: 16" node_number="288"><i title="valid: False, node: 289, tag: i, level: 17" node_number="289">30</i></a>, <a title="valid: False, node: 290, tag: a, level: 16" node_number="290"><i title="valid: False, node: 291, tag: i, level: 17" node_number="291">32</i></a>, <a title="valid: False, node: 292, tag: a, level: 16" node_number="292"><i title="valid: False, node: 293, tag: i, level: 17" node_number="293">33</i></a>) restricted by DRB1*15:01, DRB1*15:03, DRB1*01:01 or DRB1*14:25 (<b title="valid: False, node: 294, tag: b, level: 16" node_number="294">Table S4</b>). The 242-244del/R246I mutation is predicted to be associated with a loss of response to three of those alleles (DRB1*15:01, DRB1*15:03, and DRB1*14:25), while DRB1*01:01 retains its ability to bind the Beta-mutated epitope (<sup title="valid: False, node: 295, tag: sup, level: 16" node_number="295">236</sup>TRFQTLHISYLTPGD<sup title="valid: False, node: 296, tag: sup, level: 16" node_number="296">250</sup>, 242-244del/R246I) based on the predicted IC50 and percentile rank value (<b title="valid: False, node: 297, tag: b, level: 16" node_number="297">Data file S1</b>). Of note, 4 out of 6 alleles of interest (DRB1*03:01, DRB1*03:02, DRB1*13:01, DRB1*15:01, DRB1*15:03) exhibited comparable frequency distributions in first and second wave patients, while DRB1*01:01 and DRB1*14:25 were identified in only two patients from wave 1 (<b title="valid: False, node: 298, tag: b, level: 16" node_number="298">Data file S2</b>). Of note, in first wave patients who did not mount a response to the WT pool (n = 10 out of 22, <a title="valid: False, node: 299, tag: a, level: 16" node_number="299"><b title="valid: False, node: 300, tag: b, level: 17" node_number="300">Fig. 4B</b></a>), only two expressed an HLA-DRB1 allele associated with the recognition of the D215 or R246 epitopes. The absence of response in these two donors could be due to the limited sensitivity of the flow cytometry assay used to measure T cell responses in this study.</div><div title="valid: False, node: 301, tag: div, level: 15" node_number="301">In patients infected with Beta, three individuals exhibited a response to the WT pool, two of whom also responded to the Beta pool. Based solely on <i title="valid: False, node: 302, tag: i, level: 16" node_number="302">in silico</i> predicted HLA class II restriction analysis, it was not possible to infer potential targeted peptides, as no specific epitopes could be associated with the HLA class II alleles carried by these patients. Of note, the viral sequence of all three did not have the L18A mutation (maintaining a lysine in position 18, characteristic of the WT strain). Additionally, in one of these responders, no D215G substitution was observed, but this specific individual did not carry any of the alleles associated with the recognition of the D215-containing epitope (<b title="valid: False, node: 303, tag: b, level: 16" node_number="303">Table S4)</b>.</div><div title="valid: False, node: 304, tag: div, level: 15" node_number="304">Regarding specific spike epitopes recognized by CD8 T cells, only three individuals exhibited a CD8 T cell response to the WT pool and comparable responses were obtained with the Beta pool (<a title="valid: False, node: 305, tag: a, level: 16" node_number="305"><b title="valid: False, node: 306, tag: b, level: 17" node_number="306">Fig. 4</b></a>). All epitopes were tested <i title="valid: False, node: 307, tag: i, level: 16" node_number="307">in silico</i> for predictive binding to HLA class I variants (HLA-A and HLA-B) expressed in the cohort (<b title="valid: False, node: 308, tag: b, level: 16" node_number="308">Table S5</b>). The epitope <sup title="valid: False, node: 309, tag: sup, level: 16" node_number="309">84</sup>LPFNDGVYF<sup title="valid: False, node: 310, tag: sup, level: 16" node_number="310">92</sup> showed the highest ranking for HLA-B*53:01, HLA-B*35:05 and HLA-B*35:30. Since CD8 responding participants carried the HLA-B*53:01 (SA2-016) or HLA-B*35:05 (SA1-098 and SA2-084) allele (<b title="valid: False, node: 311, tag: b, level: 16" node_number="311">Data file S3</b>), this strongly suggests that the <sup title="valid: False, node: 312, tag: sup, level: 16" node_number="312">84</sup>LPFNDGVYF<sup title="valid: False, node: 313, tag: sup, level: 16" node_number="313">92</sup> epitope is recognized by those participants. This confirms results reported by Tarke <i title="valid: False, node: 314, tag: i, level: 16" node_number="314">et al</i>. (<a title="valid: False, node: 315, tag: a, level: 16" node_number="315"><i title="valid: False, node: 316, tag: i, level: 17" node_number="316">31</i></a>) and further demonstrates that <sup title="valid: False, node: 317, tag: sup, level: 16" node_number="317">84</sup>LPFNDGVYF<sup title="valid: False, node: 318, tag: sup, level: 16" node_number="318">92</sup> is also restricted by HLA-B*35:05. Moreover, as this predicted 9mer epitope is conserved between the ancestral strain and Beta variant and does not include the beta-mutated residue (D80A), it is unsurprising that the observed CD8 response is comparable when stimulation is performed using the WT or the Beta pool. Finally, these two alleles (B*53:01 and HLA-B*35:05) were found in only four participants (<b title="valid: False, node: 319, tag: b, level: 16" node_number="319">Table S5</b>), three of whom exhibited a CD8 response to the WT and Beta pool.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 320, tag: section, level: 13" node_number="320"><h2 class="valid" valid="valid" title="valid: True, node: 321, tag: h2, level: 14" node_number="321">DISCUSSION</h2><div class="valid" valid="valid" title="valid: True, node: 322, tag: div, level: 14" node_number="322">We demonstrate that infection with the Beta variant results in robust T cell responses, comparable to responses elicited to ancestral strains. We also demonstrate that the recognition of epitopes by CD4 T cells targeting variable spike regions is affected by Beta spike mutations in patients infected with ancestral lineages. However, the loss of recognition of Beta mutated spike epitopes had a minor impact on the overall CD4 Th1 cell response. Moreover, CD8 T cell responses to spike were unaffected by mutations in Beta.</div><div class="valid" valid="valid" title="valid: True, node: 323, tag: div, level: 14" node_number="323">We focused our analysis on spike, because specific mutations or deletions within or outside of T cell epitopes can lead to lack of cross-recognition, or loss of presentation, and may have important implications for vaccine protection. However, recent studies have revealed a more global strategy employed by SARS-CoV-2 variants to potentially evade immunity. The suppression of innate immune responses was demonstrated for the Alpha variant, as well as interferon resistance in vitro (<a title="valid: False, node: 324, tag: a, level: 15" node_number="324"><i title="valid: False, node: 325, tag: i, level: 16" node_number="325">34</i></a>, <a title="valid: False, node: 326, tag: a, level: 15" node_number="326"><i title="valid: False, node: 327, tag: i, level: 16" node_number="327">35</i></a>). Thus, given the possibility that variant mutations may have broader effects on adaptive responses, we also examined T cell responses to other dominant targets, namely the nucleocapsid and membrane proteins (<a title="valid: False, node: 328, tag: a, level: 15" node_number="328"><i title="valid: False, node: 329, tag: i, level: 16" node_number="329">26</i></a>, <a title="valid: False, node: 330, tag: a, level: 15" node_number="330"><i title="valid: False, node: 331, tag: i, level: 16" node_number="331">28</i></a>, <a title="valid: False, node: 332, tag: a, level: 15" node_number="332"><i title="valid: False, node: 333, tag: i, level: 16" node_number="333">31</i></a>, <a title="valid: False, node: 334, tag: a, level: 15" node_number="334"><i title="valid: False, node: 335, tag: i, level: 16" node_number="335">36</i></a>). We detected similar T cell response frequencies between first and second wave convalescent donors for both CD4 and CD8 T cells, irrespective of the SARS-CoV-2 protein examined, suggesting that there was not a general dampening of T cell responses to Beta. Altogether, we confirm that infection with Beta does not significantly affect the overall recognition or functional profile of T cell responses to the ancestral virus in either acute or chronic infection.</div><div class="valid" valid="valid" title="valid: True, node: 336, tag: div, level: 14" node_number="336">It is of interest to determine whether specific mutations in SARS-CoV-2 variants may lead to evasion of cellular immunity, as has been demonstrated for neutralizing antibodies. Having demonstrated that ancestral versions of peptides mutated in Beta were targeted by CD4 T cells from first wave participants, and there was a loss of recognition of the Beta peptides, we reasoned that one or more epitopes in the Beta pool may be affected by variant mutations. We identified three epitopes containing the D215, L18, or D80 residues that were specifically recognized by CD4 T cells, and mutated versions in Beta were associated with a loss of response. HLA genotyping revealed the predicted MHC class II alleles restricting the D215 epitope, and <i title="valid: False, node: 337, tag: i, level: 15" node_number="337">in silico</i> analyses confirmed that mutations would no longer be restricted by those alleles. This provides important information regarding mutations occurring in SARS-CoV-2 variants, the predicted epitopes within which they are located, immune evasion properties associated with them, and their restricting alleles. Of note, the L18F mutation is of importance as it is a frequently observed mutation, with a 4% cumulative prevalence in all SARS-CoV-2 sequences in GISAID (<a title="valid: False, node: 338, tag: a, level: 15" node_number="338"><i title="valid: False, node: 339, tag: i, level: 16" node_number="339">37</i></a>)<i title="valid: False, node: 340, tag: i, level: 15" node_number="340">,</i> present in Gamma and in a number of other lineages, in particular B.1.177 that circulated widely in Europe (<a title="valid: False, node: 341, tag: a, level: 15" node_number="341"><i title="valid: False, node: 342, tag: i, level: 16" node_number="342">38</i></a>). L18F is expected to have a detrimental impact on antibody binding, thus the mutation could result from selective pressure from both antibodies and T cells. D215, located in the epitope most frequently targeted by first wave patients of the three epitopes we identified, is mutated to G in Beta, which is shared by the C.1.2 variant (<a title="valid: False, node: 343, tag: a, level: 15" node_number="343"><i title="valid: False, node: 344, tag: i, level: 16" node_number="344">39</i></a>), a highly mutated variant under monitoring, as well as B.1.616 and AT.1 lineages, all of which occur at frequencies &lt;0.5% worldwide (<a title="valid: False, node: 345, tag: a, level: 15" node_number="345"><i title="valid: False, node: 346, tag: i, level: 16" node_number="346">40</i></a>). These observations further underscore the limited impact these mutations may have on the CD4 T cell response at a global level.</div><div class="valid" valid="valid" title="valid: True, node: 347, tag: div, level: 14" node_number="347">We were unable to confirm class II HLA restriction of the peptides containing the L18 and D80 residues, with the predicted HLA molecules for the L18 epitope not matching those expressed in our cohort, and no restricting alleles predicted for the D80-containing peptide. Epitopes containing these residues have been described in other studies, without presenting HLA restriction (<a title="valid: False, node: 348, tag: a, level: 15" node_number="348"><i title="valid: False, node: 349, tag: i, level: 16" node_number="349">30</i></a>, <a title="valid: False, node: 350, tag: a, level: 15" node_number="350"><i title="valid: False, node: 351, tag: i, level: 16" node_number="351">31</i></a>).This is likely due to the limited accuracy of Class II prediction algorithms. An additional CD4 epitope containing the R246 residue is a likely target for which HLA binding is abrogated in the Beta variant for particular Class II alleles, and may have also contributed to targeting of the WT pool. However, limited cell availability prevented us from experimentally confirming the targeting of this epitope in our cohort, but several studies have confirmed targeting of this region (<a title="valid: False, node: 352, tag: a, level: 15" node_number="352"><i title="valid: False, node: 353, tag: i, level: 16" node_number="353">30</i></a>, <a title="valid: False, node: 354, tag: a, level: 15" node_number="354"><i title="valid: False, node: 355, tag: i, level: 16" node_number="355">32</i></a>, <a title="valid: False, node: 356, tag: a, level: 15" node_number="356"><i title="valid: False, node: 357, tag: i, level: 16" node_number="357">33</i></a>).</div><div class="valid" valid="valid" title="valid: True, node: 358, tag: div, level: 14" node_number="358">We found that spike-specific CD8 responses were not affected by mutations in Beta in our cohort. A single epitope (residues 84-94 of spike) was predicted to account for the CD8 response to the WT or Beta pool in three individuals in the cohort. Consistent with the recognition of both WT and mutated pools, the mutation fell outside the core binding motif for the predicted restricting Class I HLA molecules expressed by these donors. Overall, our results emphasize that the HLA repertoire in individuals determined whether they were impacted by mutations in variant epitopes, rather than the mutated epitopes dictating population-wide effects, as observed with certain key neutralizing antibody epitopes in variants of concern. These observations further emphasize that HLA polymorphism will likely limit the impact of T cell escape on SARS-CoV-2 immunity to viral variants. Two possible scenarios could change this: 1) the mutation of dominant epitopes (<a title="valid: False, node: 359, tag: a, level: 15" node_number="359"><i title="valid: False, node: 360, tag: i, level: 16" node_number="360">32</i></a>) or those broadly restricted (&#8216;promiscuous epitopes&#8217;) by multiple commonly-expressed alleles (<a title="valid: False, node: 361, tag: a, level: 15" node_number="361"><i title="valid: False, node: 362, tag: i, level: 16" node_number="362">29</i></a>), or 2) if accumulation of mutations associated with T cell evasion occurs in variants. To date, neither of these have occurred.</div><div class="valid" valid="valid" title="valid: True, node: 363, tag: div, level: 14" node_number="363">This work extends our recent findings characterizing neutralizing antibody responses elicited by Beta (<a title="valid: False, node: 364, tag: a, level: 15" node_number="364"><i title="valid: False, node: 365, tag: i, level: 16" node_number="365">13</i></a>, <a title="valid: False, node: 366, tag: a, level: 15" node_number="366"><i title="valid: False, node: 367, tag: i, level: 16" node_number="367">41</i></a>). Neutralization resistance for Beta, Gamma and Delta confers the ability to evade antibodies after infection and vaccination, to varying degrees (<a title="valid: False, node: 368, tag: a, level: 15" node_number="368"><i title="valid: False, node: 369, tag: i, level: 16" node_number="369">11</i></a>, <a title="valid: False, node: 370, tag: a, level: 15" node_number="370"><i title="valid: False, node: 371, tag: i, level: 16" node_number="371">42</i></a>&#8211;<a title="valid: False, node: 372, tag: a, level: 15" node_number="372"><i title="valid: False, node: 373, tag: i, level: 16" node_number="373">44</i></a>). Beta is approximately 10-fold more resistant to convalescent plasma and sera from vaccinated individuals than ancestral SARS-CoV-2 (<a title="valid: False, node: 374, tag: a, level: 15" node_number="374"><i title="valid: False, node: 375, tag: i, level: 16" node_number="375">14</i></a>, <a title="valid: False, node: 376, tag: a, level: 15" node_number="376"><i title="valid: False, node: 377, tag: i, level: 16" node_number="377">15</i></a>, <a title="valid: False, node: 378, tag: a, level: 15" node_number="378"><i title="valid: False, node: 379, tag: i, level: 16" node_number="379">45</i></a>). Comparative analyses of SARS-CoV-2 variants demonstrated that Beta is the most refractory to neutralization of all the VOC that have emerged to date (<a title="valid: False, node: 380, tag: a, level: 15" node_number="380"><i title="valid: False, node: 381, tag: i, level: 16" node_number="381">12</i></a>, <a title="valid: False, node: 382, tag: a, level: 15" node_number="382"><i title="valid: False, node: 383, tag: i, level: 16" node_number="383">46</i></a>, <a title="valid: False, node: 384, tag: a, level: 15" node_number="384"><i title="valid: False, node: 385, tag: i, level: 16" node_number="385">47</i></a>), however early indications are that Omicron will result in greater escape from neutralization (<a title="valid: False, node: 386, tag: a, level: 15" node_number="386"><i title="valid: False, node: 387, tag: i, level: 16" node_number="387">48</i></a>).</div><div class="valid" valid="valid" title="valid: True, node: 388, tag: div, level: 14" node_number="388">Recent studies examining vaccine-induced neutralizing antibodies (nAb) and vaccine efficacy demonstrate that nAb titers are a correlate of protection (<a title="valid: False, node: 389, tag: a, level: 15" node_number="389"><i title="valid: False, node: 390, tag: i, level: 16" node_number="390">49</i></a>, <a title="valid: False, node: 391, tag: a, level: 15" node_number="391"><i title="valid: False, node: 392, tag: i, level: 16" node_number="392">50</i></a>). The demonstration of an antibody correlate does not preclude a contribution from other immune components for protection. CD4 T cell responses are required for strong Ab responses, and CD8 T cells play an important role in the context of sub-optimal antibody titers in a macaque model (<a title="valid: False, node: 393, tag: a, level: 15" node_number="393"><i title="valid: False, node: 394, tag: i, level: 16" node_number="394">51</i></a>). Multiple mechanisms, involving nAb, CD4 and CD8 T cells acting in a coordinated manner appear to effectively control established infection (<a title="valid: False, node: 395, tag: a, level: 15" node_number="395"><i title="valid: False, node: 396, tag: i, level: 16" node_number="396">52</i></a>).</div><div class="valid" valid="valid" title="valid: True, node: 397, tag: div, level: 14" node_number="397">In contrast to neutralizing antibody epitopes, T cell epitopes are abundantly located across the spike protein (<a title="valid: False, node: 398, tag: a, level: 15" node_number="398"><i title="valid: False, node: 399, tag: i, level: 16" node_number="399">30</i></a>, <a title="valid: False, node: 400, tag: a, level: 15" node_number="400"><i title="valid: False, node: 401, tag: i, level: 16" node_number="401">31</i></a>, <a title="valid: False, node: 402, tag: a, level: 15" node_number="402"><i title="valid: False, node: 403, tag: i, level: 16" node_number="403">53</i></a>&#8211;<a title="valid: False, node: 404, tag: a, level: 15" node_number="404"><i title="valid: False, node: 405, tag: i, level: 16" node_number="405">55</i></a>). Regions in spike most frequently targeted by CD4 T cells are the N-terminal domain of both the S1 and S2 subunits, with the receptor binding domain (RBD) being relatively epitope-poor (<a title="valid: False, node: 406, tag: a, level: 15" node_number="406"><i title="valid: False, node: 407, tag: i, level: 16" node_number="407">31</i></a>). This is consistent with the three CD4 epitopes we identified in this study. In contrast, CD8 T cell epitopes are broadly distributed across spike (<a title="valid: False, node: 408, tag: a, level: 15" node_number="408"><i title="valid: False, node: 409, tag: i, level: 16" node_number="409">31</i></a>, <a title="valid: False, node: 410, tag: a, level: 15" node_number="410"><i title="valid: False, node: 411, tag: i, level: 16" node_number="411">53</i></a>). Sustained efforts to map epitopes in spike, particularly in a range of populations encompassing greater HLA diversity will be beneficial for evaluating the effect on T cell immunity for mutations that may arise in future VOC. Thus, it is unsurprising that Beta retains the ability to generate strong T cell immune responses, as Beta spike mutations are limited to a few residues.</div><div class="valid" valid="valid" title="valid: True, node: 412, tag: div, level: 14" node_number="412">Viral evasion of cytotoxic T lymphocyte or T helper recognition may result in delayed clearance of infected cells, or inadequate help provided to B cells, influencing the antibody response. Viral escape from specific SARS-CoV-2 CD8 epitopes has recently been described, in spike, nucleocapsid and ORF3a (<a title="valid: False, node: 413, tag: a, level: 15" node_number="413"><i title="valid: False, node: 414, tag: i, level: 16" node_number="414">20</i></a>, <a title="valid: False, node: 415, tag: a, level: 15" node_number="415"><i title="valid: False, node: 416, tag: i, level: 16" node_number="416">21</i></a>, <a title="valid: False, node: 417, tag: a, level: 15" node_number="417"><i title="valid: False, node: 418, tag: i, level: 16" node_number="418">23</i></a>). Both CD4 and CD8 T cells can exert selective pressure on viruses resulting in mutational escape, thereby driving viral evolution. In addition to their role in supporting the maturation of B cells and CD8 T cell responses, CD4 T cells may play additional antiviral roles, including directly lysing infected cells (<a title="valid: False, node: 419, tag: a, level: 15" node_number="419"><i title="valid: False, node: 420, tag: i, level: 16" node_number="420">56</i></a>). Indeed, transcriptomic profiles of SARS-CoV-2-specific CD4 T cells demonstrated a subset expressing transcripts for cytotoxic molecules (<a title="valid: False, node: 421, tag: a, level: 15" node_number="421"><i title="valid: False, node: 422, tag: i, level: 16" node_number="422">57</i></a>). Abundant populations of cytotoxic CD4 have been described in the lungs in COVID-19 patients (<a title="valid: False, node: 423, tag: a, level: 15" node_number="423"><i title="valid: False, node: 424, tag: i, level: 16" node_number="424">58</i></a>), where they may participate in viral clearance. In addition to direct selective pressure, mutations occurring in response to immune pressure from neutralizing antibodies or associated with increased viral infectivity (<a title="valid: False, node: 425, tag: a, level: 15" node_number="425"><i title="valid: False, node: 426, tag: i, level: 16" node_number="426">23</i></a>) could coincide with T cell epitopes, thus representing &#8216;collateral damage&#8217; for the T cell response.</div><div class="valid" valid="valid" title="valid: True, node: 427, tag: div, level: 14" node_number="427">Our study had several limitations. Although convenient for mapping approaches, it has been demonstrated that 15mer peptides are not optimal for all HLA class I-restricted T cells (<a title="valid: False, node: 428, tag: a, level: 15" node_number="428"><i title="valid: False, node: 429, tag: i, level: 16" node_number="429">59</i></a>). Approaches using optimal CD8 epitopes (<a title="valid: False, node: 430, tag: a, level: 15" node_number="430"><i title="valid: False, node: 431, tag: i, level: 16" node_number="431">25</i></a>, <a title="valid: False, node: 432, tag: a, level: 15" node_number="432"><i title="valid: False, node: 433, tag: i, level: 16" node_number="433">53</i></a>) may have yielded greater sensitivity to detect CD8 responses. Furthermore, examining responses to Beta in the context of full mutated spike (<a title="valid: False, node: 434, tag: a, level: 15" node_number="434"><i title="valid: False, node: 435, tag: i, level: 16" node_number="435">22</i></a>, <a title="valid: False, node: 436, tag: a, level: 15" node_number="436"><i title="valid: False, node: 437, tag: i, level: 16" node_number="437">24</i></a>) would corroborate our findings regarding the degree to which the overall spike T cell response is affected by mutations.</div><div class="valid" valid="valid" title="valid: True, node: 438, tag: div, level: 14" node_number="438">In conclusion, although Beta no longer has significant prevalence compared to Delta and the highly mutated Omicron in residues that are key for antibody recognition, these results are relevant in advancing our understanding of the cross-reactive potential of T cell immunity in the context of viral variability and highlight the importance of monitoring both antibody and T cell responses to emerging SARS-CoV-2 variants. We demonstrate a limited effect of viral mutations on T cell immunity which may explain why, despite substantial loss of neutralizing antibody activity against Beta and Delta, vaccines have retained the ability to protect against severe COVID-19. We and others have shown that vaccine-induced T cell immunity effectively recognizes SARS-CoV-2 variants (<a title="valid: False, node: 439, tag: a, level: 15" node_number="439"><i title="valid: False, node: 440, tag: i, level: 16" node_number="440">24</i></a>, <a title="valid: False, node: 441, tag: a, level: 15" node_number="441"><i title="valid: False, node: 442, tag: i, level: 16" node_number="442">60</i></a>&#8211;<a title="valid: False, node: 443, tag: a, level: 15" node_number="443"><i title="valid: False, node: 444, tag: i, level: 16" node_number="444">63</i></a>). While second generation vaccines based on SARS-CoV-2 variants are desirable, they may not be needed to generate improved T cell responses.</div></section><section class="valid" valid="valid" title="valid: True, node: 445, tag: section, level: 13" node_number="445"><h2 class="valid" valid="valid" title="valid: True, node: 446, tag: h2, level: 14" node_number="446">MATERIALS AND METHODS</h2><section class="valid" valid="valid" title="valid: True, node: 447, tag: section, level: 14" node_number="447"><h3 title="valid: False, node: 448, tag: h3, level: 15" node_number="448">Study Design</h3><div title="valid: False, node: 449, tag: div, level: 15" node_number="449">Hospitalized patients with PCR-confirmed acute COVID-19 were enrolled at Groote Schuur Hospital (Cape Town, Western Cape, South Africa) between June 11<sup title="valid: False, node: 450, tag: sup, level: 16" node_number="450">th</sup> and August 21<sup title="valid: False, node: 451, tag: sup, level: 16" node_number="451">st</sup>, 2020 (first wave, n = 22) and between December 31<sup title="valid: False, node: 452, tag: sup, level: 16" node_number="452">st</sup>, 2020 and January 15<sup title="valid: False, node: 453, tag: sup, level: 16" node_number="453">th</sup>, 2021 (second wave, n = 22). The clinical characteristics of participants are summarized in <a title="valid: False, node: 454, tag: a, level: 16" node_number="454"><b title="valid: False, node: 455, tag: b, level: 17" node_number="455">Fig. 1A</b></a>. Clinical folders were consulted for all second wave patients and none showed evidence of prior symptomatic COVID-19. Blood samples were obtained a median of 4.5 days [interquartile range (IQR): 3-7] after a positive PCR test for SARS-CoV-2 for first wave patients, and 8 days [IQR: 4-16] for second wave patients. Viral sequences were available for 19/22 s wave participants (<b title="valid: False, node: 456, tag: b, level: 16" node_number="456">Fig. S1</b>). T cell responses were assessed by stimulating PBMC with peptide pools spanning full-length spike or smaller pools covering the regions mutated in Beta, followed by intracellular cytokine staining and flow cytometry (<b title="valid: False, node: 457, tag: b, level: 16" node_number="457">Fig. S4</b>). Additionally, convalescent COVID-19 patients infected with the ancestral SARS-CoV-2 strain or Beta were included in this study. Samples were obtained a median of 98 days [IQR: 79-110] after a positive PCR test for first wave participants, and 67 days [IQR: 54-105] for second wave participants (<b title="valid: False, node: 458, tag: b, level: 16" node_number="458">Fig. S2A</b>). The study was approved by the University of Cape Town Human Research Ethics Committee (HREC: 207/2020 and R021/2020) and written informed consent was obtained from all participants.</div></section><section class="valid" valid="valid" title="valid: True, node: 459, tag: section, level: 14" node_number="459"><h3 title="valid: False, node: 460, tag: h3, level: 15" node_number="460">SARS-CoV-2 spike whole genome sequencing</h3><div title="valid: False, node: 461, tag: div, level: 15" node_number="461">Whole genome sequencing of SARS-CoV-2 was performed using nasopharyngeal swabs obtained from 19 of the hospitalized patients recruited during the second wave.</div><div title="valid: False, node: 462, tag: div, level: 15" node_number="462">Sequencing was performed as previously published (<a title="valid: False, node: 463, tag: a, level: 16" node_number="463"><i title="valid: False, node: 464, tag: i, level: 17" node_number="464">41</i></a>). Briefly, cDNA was synthesized from RNA extracted from swabs using the Superscript IV First Strand synthesis system (Life Technologies) and random hexamer primers. Whole genome amplification was performed by multiplex PCR using the ARTIC V3 protocol (https://www.protocols.io/view/ncov-2019-sequencing-protocol-v3-locost-bh42j8ye). PCR products were purified with AMPure XP magnetic beads (Beckman Coulter) and quantified using the Qubit dsDNA High Sensitivity assay on the Qubit 3.0 instrument (Life Technologies). The Illumina&#174; DNA Prep kit was used to prepare indexed paired end libraries of genomic DNA. Sequencing libraries were normalized to 4 nM, pooled, and denatured with 0.2 N sodium hydroxide. Libraries were sequenced on the Illumina MiSeq instrument. The quality control checks on raw sequence data and the genome assembly were performed using Genome Detective 1.132 (<a title="valid: False, node: 465, tag: a, level: 16" node_number="465">https://www.genomedetective.com</a>) and the Coronavirus Typing Tool (<a title="valid: False, node: 466, tag: a, level: 16" node_number="466"><i title="valid: False, node: 467, tag: i, level: 17" node_number="467">64</i></a>). The initial assembly was polished by aligning mapped reads to the references and filtering out low-quality mutations using bcftools 1.7-2 mpileup method. Mutations were confirmed visually with bam files using Geneious software (Biomatters Ltd). Phylogenetic clade classification of the genomes in this study consisted of analyzing them against a global reference dataset using a custom pipeline based on a local version of NextStrain (<a title="valid: False, node: 468, tag: a, level: 16" node_number="468">https://github.com/nextstrain/ncov</a>) (<a title="valid: False, node: 469, tag: a, level: 16" node_number="469"><i title="valid: False, node: 470, tag: i, level: 17" node_number="470">65</i></a>). The workflow performs alignment of genomes, phylogenetic tree inference, tree dating and ancestral state construction and annotation. Phylogenetic trees were visualized using ggplot and ggtree (<a title="valid: False, node: 471, tag: a, level: 16" node_number="471"><i title="valid: False, node: 472, tag: i, level: 17" node_number="472">66</i></a>). GISAID accession numbers are as follows: EPI_ISL_1040644, 1040645, 1040646, 1040650, 1040654, 1040656, 1040659, 1040672, 1040683, 1040692, 1040696, 1040697, 1040698, 1040707, 1040714, 1040716, 1040754, 1040758, 1534362.</div></section><section class="valid" valid="valid" title="valid: True, node: 473, tag: section, level: 14" node_number="473"><h3 title="valid: False, node: 474, tag: h3, level: 15" node_number="474">Ancestral (wild type) and Beta variant SARS-CoV-2 peptides</h3><div title="valid: False, node: 475, tag: div, level: 15" node_number="475">To assess the response to the full length SARS-CoV-2 spike protein, we combined two commercially available peptide pools (PepTivator&#174;, Miltenyi Biotech) including: i) a pool of peptides (15mers with 11 aa overlap) covering the ancestral N-terminal S1 domain of SARS-CoV-2 (GenBank MN908947.3, Protein QHD43416.1) from aa 1 to 692 and ii) a pool of peptides(15mers with 11 aa overlap) covering the immunodominant sequence domains of the ancestral C-terminal S2 domain of SARS-CoV-2 (GenBank MN908947.3, Protein QHD43416.1) including aa 683-707, aa 741-770, aa 785-802, and aa 885-1273. Pools were resuspended in distilled water at 50 &#956;g/mL. Individual peptides (15mers with 11 aa overlap) spanning ancestral or Beta spike mutation sites (L18F, D80A, D215G, del 242-244, R246I, K417N, E484K, N501Y and A701V) were synthesized (GenScript) and individually resuspended in dimethyl sulfoxide (DMSO; Sigma-Aldrich) at 20 &#956;g/mL. Peptide sequences are provided in <b title="valid: False, node: 476, tag: b, level: 16" node_number="476">Table S1</b>, which also indicates where their recognition has been previously described (<a title="valid: False, node: 477, tag: a, level: 16" node_number="477"><i title="valid: False, node: 478, tag: i, level: 17" node_number="478">30</i></a>, <a title="valid: False, node: 479, tag: a, level: 16" node_number="479"><i title="valid: False, node: 480, tag: i, level: 17" node_number="480">31</i></a>, <a title="valid: False, node: 481, tag: a, level: 16" node_number="481"><i title="valid: False, node: 482, tag: i, level: 17" node_number="482">55</i></a>). Ancestral or Beta pools (16 peptides) selectively spanning the mutated regions were created by pooling aliquots of these individual peptides at a final concentration of 160 &#956;g/mL. To assess T cell responses to SARS-CoV-2 nucleocapsid and membrane proteins, commercially available peptide pools (15mers with 11 aa overlap, PepTivator&#174;, Miltenyi) covering the complete sequence of the SARS-CoV-2 membrane glycoprotein (M, GenBank MN908947.3, Protein QHD43419.1) or nucleocapsid (N, GenBank MN908947.3, Protein QHD43423.2) were used.</div></section><section class="valid" valid="valid" title="valid: True, node: 483, tag: section, level: 14" node_number="483"><h3 title="valid: False, node: 484, tag: h3, level: 15" node_number="484">Isolation of peripheral blood mononuclear cells (PBMC)</h3><div title="valid: False, node: 485, tag: div, level: 15" node_number="485">Blood was collected in heparin tubes and processed within 3 hours. PBMC were isolated by density gradient sedimentation using Ficoll-Paque (Amersham Biosciences) as per the manufacturer&#8217;s instructions and cryopreserved in freezing media consisting of heat-inactivated fetal bovine serum (FBS, Thermo Fisher Scientific) containing 10% DMSO and stored in liquid nitrogen.</div></section><section class="valid" valid="valid" title="valid: True, node: 486, tag: section, level: 14" node_number="486"><h3 title="valid: False, node: 487, tag: h3, level: 15" node_number="487">Cell stimulation and flow cytometry staining</h3><div title="valid: False, node: 488, tag: div, level: 15" node_number="488">Cryopreserved PBMC were thawed, washed and rested in RPMI 1640 containing 10% heat-inactivated FBS for 4 hours. PBMC were seeded in a 96-well V-bottom plate at ~2 &#215; 10<sup title="valid: False, node: 489, tag: sup, level: 16" node_number="489">6</sup> PBMC per well and stimulated with SARS-CoV-2 M or N peptide pools (4 &#956;g/mL), SARS-CoV-2 spike peptide pools: full spike pool (4 &#956;g/mL), and ancestral and Beta pools selectively spanning the mutated regions (4 &#956;g/mL). All stimulations were performed in the presence of Brefeldin A (10 &#956;g/mL, Sigma-Aldrich) and co-stimulatory antibodies against CD28 (clone 28.2) and CD49d (clone L25) (1 &#956;g/mL each; BD Biosciences). As a negative control, PBMC were incubated with co-stimulatory antibodies, Brefeldin A and an equimolar amount of DMSO (0.15%).</div><div title="valid: False, node: 490, tag: div, level: 15" node_number="490">After 16 hours of stimulation, cells were washed, stained with LIVE/DEAD Fixable Near-IR Stain (Invitrogen) and subsequently surface stained with the following antibodies: CD4 BV785 (OKT4, Biolegend), CD8 BV510 (RPA-8, Biolegend), PD-1 PE (J105, eBioscience). Cells were then fixed and permeabilized using a Transcription Factor Fixation buffer (eBioscience) and stained with CD3 BV650 (OKT3), IFN-&#947; BV711 (4S.B3), TNF-&#945; PE-cy7 (MAB11) and IL-2 PE-Dazzle (MQ1-17H12) from Biolegend. Finally, cells were washed and fixed in 1% formaldehyde in PBS. Samples were acquired on a BD LSR-II flow cytometer and analyzed using FlowJo (v9.9.6, FlowJo LLC). The gating strategy is presented in <b title="valid: False, node: 491, tag: b, level: 16" node_number="491">Fig. S5.</b> A cytokine response was defined as positive when the frequency of cytokine produced in stimulated wells was at least twice the background of unstimulated cells. All summary data are presented after background subtraction. For the identification of specific spike epitopes, five acute COVID-19 patients and one convalescent donor were tested.</div></section><section class="valid" valid="valid" title="valid: True, node: 492, tag: section, level: 14" node_number="492"><h3 title="valid: False, node: 493, tag: h3, level: 15" node_number="493">SARS-CoV-2 pseudovirus based neutralization assay</h3><div title="valid: False, node: 494, tag: div, level: 15" node_number="494">SARS-CoV-2 pseudotyped lentiviruses were prepared by co-transfecting the HEK 293T cell line with the SARS-CoV-2 614G spike (D614G) or SARS-CoV-2 Beta spike (L18F, D80A, D215G, K417N, E484K, N501Y, A701V, 242-244 del) plasmids with a firefly luciferase encoding lentivirus backbone plasmid. The parental plasmids were provided by Drs Elise Landais and Devin Sok (IAVI). For the neutralization assays, heat-inactivated plasma samples were incubated with SARS-CoV-2 pseudotyped virus for 1 hour at 37&#176;C, 5% CO<sub title="valid: False, node: 495, tag: sub, level: 16" node_number="495">2</sub>. Subsequently, 1x10<sup title="valid: False, node: 496, tag: sup, level: 16" node_number="496">4</sup> HEK293T cells engineered to overexpress ACE-2, provided by Dr Michael Farzan (Scripps Research Institute), were added and the incubated at 37&#176;C, 5% CO<sub title="valid: False, node: 497, tag: sub, level: 16" node_number="497">2</sub> for 72 hours, upon which the luminescence of the luciferase gene was measured. CB6 and CA1 monoclonal antibodies were used as controls.</div></section><section class="valid" valid="valid" title="valid: True, node: 498, tag: section, level: 14" node_number="498"><h3 title="valid: False, node: 499, tag: h3, level: 15" node_number="499">HLA typing</h3><div title="valid: False, node: 500, tag: div, level: 15" node_number="500">Genomic DNA was isolated from PBMC using standard techniques (Qiagen). Amplicons for class I (HLA-A, B and C) and II (DRB1, DQB1 and DPB1) HLA loci were generated using the NGSgo&#174;-MX6-1 multiplex PCR (GenDX), according to the manufacturer&#8217;s instructions. Sequencing libraries were prepared using the NGSgo-LibrX kit (GenDX), dual indexed using the NGSgo-IndX kit (GenDX) and pooled, according to the manufacturer&#8217;s instructions. Pooled libraries were loaded at 12 pM on a MiSeq Micro flow cell (Illumina) and run using a MiSeq reagent kit V2 (Illumina). Paired-end sequencing was performed on the MiSeq NGS platform (Illumina), 151 cycles in each direction. HLA typing calls were made using the NGS-engine HLA typing software package (Version 2.22, GenDX) along with the 3.44.1 version of the IPD-IMGT/HLA database. HLA class II and class I genotypes are presented in <b title="valid: False, node: 501, tag: b, level: 16" node_number="501">Table S3</b> and <b title="valid: False, node: 502, tag: b, level: 16" node_number="502">Table S5</b>. The frequency distributions of HLA-DRB1, HLA-A and HLA-B alleles were comparable between patients recruited during first or second wave of the COVID-19 epidemic (<b title="valid: False, node: 503, tag: b, level: 16" node_number="503">Data file S2</b>).</div></section><section class="valid" valid="valid" title="valid: True, node: 504, tag: section, level: 14" node_number="504"><h3 title="valid: False, node: 505, tag: h3, level: 15" node_number="505">HLA class I and HLA class II binding prediction for T cell epitopes</h3><div title="valid: False, node: 506, tag: div, level: 15" node_number="506">Putative HLA restrictions were inferred using the Immune Epitope Database (IEDB, <a title="valid: False, node: 507, tag: a, level: 16" node_number="507">http://tools.iedb.org/main/</a>). For HLA class I, all peptides included in the WT and Beta pools (<b title="valid: False, node: 508, tag: b, level: 16" node_number="508">Table S1</b>) were submitted to Tepitool (<a title="valid: False, node: 509, tag: a, level: 16" node_number="509">http://tools.iedb.org/tepitool/</a>) using the NetMHCpan method, including all HLA-A and HLA-B alleles identified in the study cohort (<b title="valid: False, node: 510, tag: b, level: 16" node_number="510">Data file S2</b>). The epitopes that had a predicted IC50 &gt; 50 nM were excluded and sequences ordered by percentile rank (<a title="valid: False, node: 511, tag: a, level: 16" node_number="511"><i title="valid: False, node: 512, tag: i, level: 17" node_number="512">67</i></a>). For class II, the same peptides were submitted to the IEDB MHC class II epitope prediction tool (<a title="valid: False, node: 513, tag: a, level: 16" node_number="513">http://tools.iedb.org/mhcii/</a>) including all HLA-DP, DQ and DR alleles identified in the cohort (<b title="valid: False, node: 514, tag: b, level: 16" node_number="514">Data file S1</b>). HLA class II binding predictions were performed using two methodologies: first, NetMHCIIpan 3.2 (<a title="valid: False, node: 515, tag: a, level: 16" node_number="515"><i title="valid: False, node: 516, tag: i, level: 17" node_number="516">68</i></a>, <a title="valid: False, node: 517, tag: a, level: 16" node_number="517"><i title="valid: False, node: 518, tag: i, level: 17" node_number="518">69</i></a>) was used to extract IC50 predicted values, then the IEDB recommended 2.22 methodology (combining the comblib (<a title="valid: False, node: 519, tag: a, level: 16" node_number="519"><i title="valid: False, node: 520, tag: i, level: 17" node_number="520">70</i></a>), SMM (<a title="valid: False, node: 521, tag: a, level: 16" node_number="521"><i title="valid: False, node: 522, tag: i, level: 17" node_number="522">71</i></a>), NN (<a title="valid: False, node: 523, tag: a, level: 16" node_number="523"><i title="valid: False, node: 524, tag: i, level: 17" node_number="524">68</i></a>) and Sturniolo (<a title="valid: False, node: 525, tag: a, level: 16" node_number="525"><i title="valid: False, node: 526, tag: i, level: 17" node_number="526">72</i></a>) algorithms was used and rank percentile values were extracted. Only epitopes with a predicted IC50 &lt; 500 nM and percentile rank &#8804; 20 were selected.</div></section><section class="valid" valid="valid" title="valid: True, node: 527, tag: section, level: 14" node_number="527"><h3 title="valid: False, node: 528, tag: h3, level: 15" node_number="528">Statistical analyses</h3><div title="valid: False, node: 529, tag: div, level: 15" node_number="529">Analyses were performed in Prism (v9; GraphPad). Non-parametric tests were used for all comparisons. The Mann-Whitney and Wilcoxon tests were used for unmatched and paired samples, respectively. <i title="valid: False, node: 530, tag: i, level: 16" node_number="530">P</i> values less than 0.05 were considered to indicate statistical significance. All data used to compile figures can be found in <b title="valid: False, node: 531, tag: b, level: 16" node_number="531">Data file S4</b>.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 532, tag: section, level: 13" node_number="532"><h2 class="valid" valid="valid" title="valid: True, node: 533, tag: h2, level: 14" node_number="533">Acknowledgments</h2><div class="valid" valid="valid" title="valid: True, node: 534, tag: div, level: 14" node_number="534">We thank the study participants and their families, and the clinical staff and personnel at Groote Schuur Hospital for their support and dedication. We thank the informal Variant consortium of South Africa, chaired by Drs Willem Hanekom and Tulio de Oliveira, for suggestions and discussion of data. For the purposes of open access, the authors have applied a CC BY public copyright license to any author-accepted version arising from this submission.</div><div class="valid" valid="valid" title="valid: True, node: 535, tag: div, level: 14" node_number="535"><b title="valid: False, node: 536, tag: b, level: 15" node_number="536">Funding:</b> This research was supported by the South African Medical Research Council, with funds received from the South African Department of Science and Innovation (DSI), and the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), which is supported by core funding from the Wellcome Trust [203135/Z/16/Z]. CR and WAB are supported by the EDCTP2 program of the European Union (EU)&#8217;s Horizon 2020 program (TMA2017SF-1951-TB-SPEC to CR and TMA2016SF-1535-CaTCH-22 to WAB). This work is further supported by the National Institutes of Health (R21AI148027 to CR), Francis Crick Institute, which receives funding from Wellcome FC0010218, UKRI FC0010218 and CRUK FC0010218 and the Rosetrees Trust grant M926 (to CR and RJW). PLM is supported by the South African Research Chairs Initiative of the DSI and the National Research Foundation (Grant No 9834). NABN acknowledges funding from the SA-MRC, MRC UK, NRF, and the Lily and Ernst Hausmann Trust.</div><div class="valid" valid="valid" title="valid: True, node: 537, tag: div, level: 14" node_number="537"><b title="valid: False, node: 538, tag: b, level: 15" node_number="538">Author contributions:</b> WAB, CR, PLM, NABN and RJW conceived and designed the study, acquired funding and supervised the work. LRC, MM, SS, EdB and CS recruited the study participants. CR, RK, RB, HM, MBT and NB performed the T cell experiments. TH, TM-G and PK performed the neutralizing assays. ZV-O and MS performed HLA typing. HT, DD, LT, AI, GM, CW and TdO performed the sequencing and phylogenetic analyses. CR and WAB analyzed the data and wrote the manuscript, with all authors contributing by providing critical feedback and final review.</div><div class="valid" valid="valid" title="valid: True, node: 539, tag: div, level: 14" node_number="539"><b title="valid: False, node: 540, tag: b, level: 15" node_number="540">Competing interests:</b> The authors declare that they have no competing interests.</div><div class="valid" valid="valid" title="valid: True, node: 541, tag: div, level: 14" node_number="541"><b title="valid: False, node: 542, tag: b, level: 15" node_number="542">Data and materials availability:</b> All data are available in the main text or the supplementary materials. All materials used in this manuscript are commercially available.</div><div class="valid" valid="valid" title="valid: True, node: 543, tag: div, level: 14" node_number="543">This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit <a title="valid: False, node: 544, tag: a, level: 15" node_number="544">https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.</div></section> </div></section><section class="valid" valid="valid" title="valid: True, node: 545, tag: section, level: 11" node_number="545"><div class="valid" valid="valid" title="valid: True, node: 546, tag: div, level: 12" node_number="546"><section class="valid" valid="valid" title="valid: True, node: 547, tag: section, level: 13" node_number="547"><h2 class="valid" valid="valid" title="valid: True, node: 548, tag: h2, level: 14" node_number="548">Supplementary Materials</h2><section class="valid" valid="valid" title="valid: True, node: 549, tag: section, level: 14" node_number="549"><h3 title="valid: False, node: 550, tag: h3, level: 15" node_number="550">This PDF file includes:</h3><div title="valid: False, node: 551, tag: div, level: 15" node_number="551"><div title="valid: False, node: 552, tag: div, level: 16" node_number="552"><div title="valid: False, node: 553, tag: div, level: 17" node_number="553">Figs. S1 to S5</div><div title="valid: False, node: 554, tag: div, level: 17" node_number="554">Tables S1 to S5</div><div title="valid: False, node: 555, tag: div, level: 17" node_number="555">List of members of the South African cellular immunity network (SA-CIN)</div></div><div title="valid: False, node: 556, tag: div, level: 16" node_number="556"><a title="valid: False, node: 557, tag: a, level: 17" node_number="557">Download (772.12 KB)</a></div></div></section><section class="valid" valid="valid" title="valid: True, node: 558, tag: section, level: 14" node_number="558"><h3 title="valid: False, node: 559, tag: h3, level: 15" node_number="559">Other Supplementary Material for this manuscript includes the following:</h3><div title="valid: False, node: 560, tag: div, level: 15" node_number="560"><div title="valid: False, node: 561, tag: div, level: 16" node_number="561"><div title="valid: False, node: 562, tag: div, level: 17" node_number="562">Data files S1 to S4</div></div><div title="valid: False, node: 563, tag: div, level: 16" node_number="563"><a title="valid: False, node: 564, tag: a, level: 17" node_number="564">Download (81.32 KB)</a></div></div><div title="valid: False, node: 565, tag: div, level: 15" node_number="565"><div title="valid: False, node: 566, tag: div, level: 16" node_number="566"><div title="valid: False, node: 567, tag: div, level: 17" node_number="567">MDAR Reproducibility Checklist</div></div><div title="valid: False, node: 568, tag: div, level: 16" node_number="568"><a title="valid: False, node: 569, tag: a, level: 17" node_number="569">Download (68.17 KB)</a></div></div></section></section><section class="valid" valid="valid" title="valid: True, node: 570, tag: section, level: 13" node_number="570"><h2 class="valid" valid="valid" title="valid: True, node: 571, tag: h2, level: 14" node_number="571">References and Notes</h2><div class="valid" valid="valid" title="valid: True, node: 572, tag: div, level: 14" node_number="572"><div title="valid: False, node: 573, tag: div, level: 15" node_number="573">1</div><div title="valid: False, node: 574, tag: div, level: 15" node_number="574"><div title="valid: False, node: 575, tag: div, level: 16" node_number="575"><div title="valid: False, node: 576, tag: div, level: 17" node_number="576">J. A. Plante, B. M. Mitchell, K. S. Plante, K. Debbink, S. C. Weaver, V. D. Menachery, The variant gambit: COVID-19's next move. Cell Host Microbe <b title="valid: False, node: 577, tag: b, level: 18" node_number="577">29</b>, 508&#8211;515 (2021).</div><div title="valid: False, node: 578, tag: div, level: 17" node_number="578"><div title="valid: False, node: 579, tag: div, level: 18" node_number="579"><a title="valid: False, node: 580, tag: a, level: 19" node_number="580">Crossref</a></div><div title="valid: False, node: 581, tag: div, level: 18" node_number="581"><a title="valid: False, node: 582, tag: a, level: 19" node_number="582">PubMed</a></div><div title="valid: False, node: 583, tag: div, level: 18" node_number="583"><a title="valid: False, node: 584, tag: a, level: 19" node_number="584">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 585, tag: div, level: 14" node_number="585"><div title="valid: False, node: 586, tag: div, level: 15" node_number="586">2</div><div title="valid: False, node: 587, tag: div, level: 15" node_number="587"><div title="valid: False, node: 588, tag: div, level: 16" node_number="588"><div title="valid: False, node: 589, tag: div, level: 17" node_number="589">Centers for Disease Control and Prevention, 2021. <a title="valid: False, node: 590, tag: a, level: 18" node_number="590">https://covid.cdc.gov/covid-data-tracker/#datatracker-home</a>. <i title="valid: False, node: 591, tag: i, level: 18" node_number="591">Accessed 10 September 2021</i>.</div><div title="valid: False, node: 592, tag: div, level: 17" node_number="592"><div title="valid: False, node: 593, tag: div, level: 18" node_number="593"><a title="valid: False, node: 594, tag: a, level: 19" node_number="594">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 595, tag: div, level: 14" node_number="595"><div title="valid: False, node: 596, tag: div, level: 15" node_number="596">3</div><div title="valid: False, node: 597, tag: div, level: 15" node_number="597"><div title="valid: False, node: 598, tag: div, level: 16" node_number="598"><div title="valid: False, node: 599, tag: div, level: 17" node_number="599">European Centre for Disease Prevention and Control, 2021. <a title="valid: False, node: 600, tag: a, level: 18" node_number="600">https://www.ecdc.europa.eu/en/covid-19/variants-concern</a>. <i title="valid: False, node: 601, tag: i, level: 18" node_number="601">Accessed 10 September 2021</i>.</div><div title="valid: False, node: 602, tag: div, level: 17" node_number="602"><div title="valid: False, node: 603, tag: div, level: 18" node_number="603"><a title="valid: False, node: 604, tag: a, level: 19" node_number="604">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 605, tag: div, level: 14" node_number="605"><div title="valid: False, node: 606, tag: div, level: 15" node_number="606">4</div><div title="valid: False, node: 607, tag: div, level: 15" node_number="607"><div title="valid: False, node: 608, tag: div, level: 16" node_number="608"><div title="valid: False, node: 609, tag: div, level: 17" node_number="609">S. Cherian, V. Potdar, S. Jadhav, P. Yadav, N. Gupta, M. Das, P. Rakshit, S. Singh, P. Abraham, S. Panda, N. Team, SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms <b title="valid: False, node: 610, tag: b, level: 18" node_number="610">9</b>, 1542 (2021).</div><div title="valid: False, node: 611, tag: div, level: 17" node_number="611"><div title="valid: False, node: 612, tag: div, level: 18" node_number="612"><a title="valid: False, node: 613, tag: a, level: 19" node_number="613">Crossref</a></div><div title="valid: False, node: 614, tag: div, level: 18" node_number="614"><a title="valid: False, node: 615, tag: a, level: 19" node_number="615">PubMed</a></div><div title="valid: False, node: 616, tag: div, level: 18" node_number="616"><a title="valid: False, node: 617, tag: a, level: 19" node_number="617">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 618, tag: div, level: 14" node_number="618"><div title="valid: False, node: 619, tag: div, level: 15" node_number="619">5</div><div title="valid: False, node: 620, tag: div, level: 15" node_number="620"><div title="valid: False, node: 621, tag: div, level: 16" node_number="621"><div title="valid: False, node: 622, tag: div, level: 17" node_number="622">H. Tegally, E. Wilkinson, M. Giovanetti, A. Iranzadeh, V. Fonseca, J. Giandhari, D. Doolabh, S. Pillay, E. J. San, N. Msomi, K. Mlisana, A. von Gottberg, S. Walaza, M. Allam, A. Ismail, T. Mohale, A. J. Glass, S. Engelbrecht, G. Van Zyl, W. Preiser, F. Petruccione, A. Sigal, D. Hardie, G. Marais, N. Y. Hsiao, S. Korsman, M.-A. Davies, L. Tyers, I. Mudau, D. York, C. Maslo, D. Goedhals, S. Abrahams, O. Laguda-Akingba, A. Alisoltani-Dehkordi, A. Godzik, C. K. Wibmer, B. T. Sewell, J. Louren&#231;o, L. C. J. Alcantara, S. L. Kosakovsky Pond, S. Weaver, D. Martin, R. J. Lessells, J. N. Bhiman, C. Williamson, T. de Oliveira, Detection of a SARS-CoV-2 variant of concern in South Africa. Nature <b title="valid: False, node: 623, tag: b, level: 18" node_number="623">592</b>, 438&#8211;443 (2021).</div><div title="valid: False, node: 624, tag: div, level: 17" node_number="624"><div title="valid: False, node: 625, tag: div, level: 18" node_number="625"><a title="valid: False, node: 626, tag: a, level: 19" node_number="626">Crossref</a></div><div title="valid: False, node: 627, tag: div, level: 18" node_number="627"><a title="valid: False, node: 628, tag: a, level: 19" node_number="628">PubMed</a></div><div title="valid: False, node: 629, tag: div, level: 18" node_number="629"><a title="valid: False, node: 630, tag: a, level: 19" node_number="630">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 631, tag: div, level: 14" node_number="631"><div title="valid: False, node: 632, tag: div, level: 15" node_number="632">6</div><div title="valid: False, node: 633, tag: div, level: 15" node_number="633"><div title="valid: False, node: 634, tag: div, level: 16" node_number="634"><div title="valid: False, node: 635, tag: div, level: 17" node_number="635">E. Wilkinson, M. Giovanetti, H. Tegally, J. E. San, R. Lessells, D. Cuadros, D. P. Martin, D. A. Rasmussen, A. N. Zekri, A. K. Sangare, A. S. Ouedraogo, A. K. Sesay, A. Priscilla, A. S. Kemi, A. M. Olubusuyi, A. O. O. Oluwapelumi, A. Hammami, A. A. Amuri, A. Sayed, A. E. O. Ouma, A. Elargoubi, N. A. Ajayi, A. F. Victoria, A. Kazeem, A. George, A. J. Trotter, A. A. Yahaya, A. K. Keita, A. Diallo, A. Kone, A. Souissi, A. Chtourou, A. V. Gutierrez, A. J. Page, A. Vinze, A. Iranzadeh, A. Lambisia, A. Ismail, A. Rosemary, A. Sylverken, A. Femi, A. Ibrahimi, B. Marycelin, B. S. Oderinde, B. Bolajoko, B. Dhaala, B. L. Herring, B. M. Njanpop-Lafourcade, B. Kleinhans, B. McInnis, B. Tegomoh, C. Brook, C. B. Pratt, C. Scheepers, C. G. Akoua-Koffi, C. N. Agoti, C. Peyrefitte, C. Daubenberger, C. M. Morang&#8217;a, D. J. Nokes, D. G. Amoako, D. L. Bugembe, D. Park, D. Baker, D. Doolabh, D. Ssemwanga, D. Tshiabuila, D. Bassirou, D. S. Y. Amuzu, D. Goedhals, D. O. Omuoyo, D. Maruapula, E. Foster-Nyarko, E. K. Lusamaki, E. Simulundu, E. M. Ong&#8217;era, E. N. Ngabana, E. Shumba, E. El Fahime, E. Lokilo, E. Mukantwari, E. Philomena, E. Belarbi, E. Simon-Loriere, E. A. Anoh, F. Leendertz, F. Ajili, F. O. Enoch, F. Wasfi, F. Abdelmoula, F. S. Mosha, F. T. Takawira, F. Derrar, F. Bouzid, F. Onikepe, F. Adeola, F. M. Muyembe, F. Tanser, F. A. Dratibi, G. K. Mbunsu, G. Thilliez, G. L. Kay, G. Githinji, G. van Zyl, G. A. Awandare, G. Schubert, G. P. Maphalala, H. C. Ranaivoson, H. Lemriss, H. Anise, H. Abe, H. H. Karray, H. Nansumba, H. A. Elgahzaly, H. Gumbo, I. Smeti, I. B. Ayed, I. Odia, I. B. Ben Boubaker, I. Gaaloul, I. Gazy, I. Mudau, I. Ssewanyana, I. Konstantinus, J. B. Lekana-Douk, J. C. Makangara, J. M. Tamfum, J. M. Heraud, J. G. Shaffer, J. Giandhari, J. Li, J. Yasuda, J. Q. Mends, J. Kiconco, J. M. Morobe, J. O. Gyapong, J. C. Okolie, J. T. Kayiwa, J. A. Edwards, J. Gyamfi, J. Farah, J. Nakaseegu, J. M. Ngoi, J. Namulondo, J. C. Andeko, J. J. Lutwama, J. O&#8217;Grady, K. Siddle, K. T. Adeyemi, K. A. Tumedi, K. M. Said, K. Hae-Young, K. O. Duedu, L. Belyamani, L. Fki-Berrajah, L. Singh, L. O. Martins, L. Tyers, M. Ramuth, M. Mastouri, M. Aouni, M. El Hefnawi, M. I. Matsheka, M. Kebabonye, M. Diop, M. Turki, M. Paye, M. M. Nyaga, M. Mareka, M. M. Damaris, M. W. Mburu, M. Mpina, M. Nwando, M. Owusu, M. R. Wiley, M. T. Youtchou, M. O. Ayekaba, M. Abouelhoda, M. G. Seadawy, M. K. Khalifa, M. Sekhele, M. Ouadghiri, M. M. Diagne, M. Mwenda, M. Allam, M. V. T. Phan, N. Abid, N. Touil, N. Rujeni, N. Kharrat, N. Ismael, N. Dia, N. Mabunda, N. Y. Hsiao, N. B. Silochi, N. Nsenga, N. Gumede, N. Mulder, N. Ndodo, N. H. Razanajatovo, N. Iguosadolo, O. Judith, O. C. Kingsley, O. Sylvanus, O. Peter, O. Femi, O. Idowu, O. Testimony, O. E. Chukwuma, O. E. Ogah, C. K. Onwuamah, O. Cyril, O. Faye, O. Tomori, P. Ondoa, P. Combe, P. Semanda, P. E. Oluniyi, P. Arnaldo, P. K. Quashie, P. Dussart, P. A. Bester, P. K. Mbala, R. Ayivor-Djanie, R. Njouom, R. O. Phillips, R. Gorman, R. A. Kingsley, R. A. A. Carr, S. El Kabbaj, S. Gargouri, S. Masmoudi, S. Sankhe, S. B. Lawal, S. Kassim, S. Trabelsi, S. Metha, S. Kammoun, S. Lemriss, S. H. A. Agwa, S. Calvignac-Spencer, S. F. Schaffner, S. Doumbia, S. M. Mandanda, S. Aryeetey, S. S. Ahmed, S. Elhamoumi, S. Andriamandimby, S. Tope, S. Lekana-Douki, S. Prosolek, S. Ouangraoua, S. A. Mundeke, S. Rudder, S. Panji, S. Pillay, S. Engelbrecht, S. Nabadda, S. Behillil, S. L. Budiaki, S. van der Werf, T. Mashe, T. Aanniz, T. Mohale, T. Le-Viet, T. Schindler, U. J. Anyaneji, U. Chinedu, U. Ramphal, U. Jessica, U. George, V. Fonseca, V. Enouf, V. Gorova, W. H. Roshdy, W. K. Ampofo, W. Preiser, W. T. Choga, Y. Bediako, Y. Naidoo, Y. Butera, Z. R. de Laurent, A. A. Sall, A. Rebai, A. von Gottberg, B. Kouriba, C. Williamson, D. J. Bridges, I. Chikwe, J. N. Bhiman, M. Mine, M. Cotten, S. Moyo, S. Gaseitsiwe, N. Saasa, P. C. Sabeti, P. Kaleebu, Y. K. Tebeje, S. K. Tessema, C. Happi, J. Nkengasong, T. de Oliveira, A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. Science <b title="valid: False, node: 636, tag: b, level: 18" node_number="636">374</b>, 423&#8211;431 (2021).</div><div title="valid: False, node: 637, tag: div, level: 17" node_number="637"><div title="valid: False, node: 638, tag: div, level: 18" node_number="638"><a title="valid: False, node: 639, tag: a, level: 19" node_number="639">Crossref</a></div><div title="valid: False, node: 640, tag: div, level: 18" node_number="640"><a title="valid: False, node: 641, tag: a, level: 19" node_number="641">PubMed</a></div><div title="valid: False, node: 642, tag: div, level: 18" node_number="642"><a title="valid: False, node: 643, tag: a, level: 19" node_number="643">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 644, tag: div, level: 14" node_number="644"><div title="valid: False, node: 645, tag: div, level: 15" node_number="645">7</div><div title="valid: False, node: 646, tag: div, level: 15" node_number="646"><div title="valid: False, node: 647, tag: div, level: 16" node_number="647"><div title="valid: False, node: 648, tag: div, level: 17" node_number="648">S. S. A. Karim, Q. A. Karim, Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic. Lancet <b title="valid: False, node: 649, tag: b, level: 18" node_number="649">398</b>, 2126&#8211;2128 (2021).</div><div title="valid: False, node: 650, tag: div, level: 17" node_number="650"><div title="valid: False, node: 651, tag: div, level: 18" node_number="651"><a title="valid: False, node: 652, tag: a, level: 19" node_number="652">Crossref</a></div><div title="valid: False, node: 653, tag: div, level: 18" node_number="653"><a title="valid: False, node: 654, tag: a, level: 19" node_number="654">PubMed</a></div><div title="valid: False, node: 655, tag: div, level: 18" node_number="655"><a title="valid: False, node: 656, tag: a, level: 19" node_number="656">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 657, tag: div, level: 14" node_number="657"><div title="valid: False, node: 658, tag: div, level: 15" node_number="658">8</div><div title="valid: False, node: 659, tag: div, level: 15" node_number="659"><div title="valid: False, node: 660, tag: div, level: 16" node_number="660"><div title="valid: False, node: 661, tag: div, level: 17" node_number="661">A. J. Spencer, S. Morris, M. Ulaszewska, C. Powers, R. Kaliath, C. D. Bissett, A. Truby, N. Thakur, J. Newman, E. R. Allen, I. Rudiansyah, C. Lui, W. Dejnirattisai, J. Mongkolsapaya, H. Davies, F. R. Donnellan, D. Pulido, T. P. Peacock, W. S. Barclay, H. Bright, K. Ren, G. Screaton, P. McTammy, D. Bailey, S. C. Gilbert, T. Lambe, The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 B.1.351 and other variants of concern in preclinical studies, Biorxiv, 2021.06.08.447308 (2021).</div><div title="valid: False, node: 662, tag: div, level: 17" node_number="662"><div title="valid: False, node: 663, tag: div, level: 18" node_number="663"><a title="valid: False, node: 664, tag: a, level: 19" node_number="664">Crossref</a></div><div title="valid: False, node: 665, tag: div, level: 18" node_number="665"><a title="valid: False, node: 666, tag: a, level: 19" node_number="666">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 667, tag: div, level: 14" node_number="667"><div title="valid: False, node: 668, tag: div, level: 15" node_number="668">9</div><div title="valid: False, node: 669, tag: div, level: 15" node_number="669"><div title="valid: False, node: 670, tag: div, level: 16" node_number="670"><div title="valid: False, node: 671, tag: div, level: 17" node_number="671">K. Wu, A. Choi, M. Koch, L. Ma, A. Hill, N. Nunna, W. Huang, J. Oestreicher, T. Colpitts, H. Bennett, H. Legault, Y. Paila, B. Nestorova, B. Ding, R. Pajon, J. M. Miller, B. Leav, A. Carfi, R. McPhee, D. K. Edwards, Preliminary Analysis of Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine Booster, Medrxiv, 2021.05.05.21256716 (2021).</div><div title="valid: False, node: 672, tag: div, level: 17" node_number="672"><div title="valid: False, node: 673, tag: div, level: 18" node_number="673"><a title="valid: False, node: 674, tag: a, level: 19" node_number="674">Crossref</a></div><div title="valid: False, node: 675, tag: div, level: 18" node_number="675"><a title="valid: False, node: 676, tag: a, level: 19" node_number="676">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 677, tag: div, level: 14" node_number="677"><div title="valid: False, node: 678, tag: div, level: 15" node_number="678">10</div><div title="valid: False, node: 679, tag: div, level: 15" node_number="679"><div title="valid: False, node: 680, tag: div, level: 16" node_number="680"><div title="valid: False, node: 681, tag: div, level: 17" node_number="681">S. Cele, I. Gazy, L. Jackson, S.-H. Hwa, H. Tegally, G. Lustig, J. Giandhari, S. Pillay, E. Wilkinson, Y. Naidoo, F. Karim, Y. Ganga, K. Khan, M. Bernstein, A. B. Balazs, B. I. Gosnell, W. Hanekom, M. S. Moosa, R. J. Lessells, T. de Oliveira, A. Sigal; Network for Genomic Surveillance in South Africa; COMMIT-KZN Team, Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature <b title="valid: False, node: 682, tag: b, level: 18" node_number="682">593</b>, 142&#8211;146 (2021).</div><div title="valid: False, node: 683, tag: div, level: 17" node_number="683"><div title="valid: False, node: 684, tag: div, level: 18" node_number="684"><a title="valid: False, node: 685, tag: a, level: 19" node_number="685">Crossref</a></div><div title="valid: False, node: 686, tag: div, level: 18" node_number="686"><a title="valid: False, node: 687, tag: a, level: 19" node_number="687">PubMed</a></div><div title="valid: False, node: 688, tag: div, level: 18" node_number="688"><a title="valid: False, node: 689, tag: a, level: 19" node_number="689">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 690, tag: div, level: 14" node_number="690"><div title="valid: False, node: 691, tag: div, level: 15" node_number="691">11</div><div title="valid: False, node: 692, tag: div, level: 15" node_number="692"><div title="valid: False, node: 693, tag: div, level: 16" node_number="693"><div title="valid: False, node: 694, tag: div, level: 17" node_number="694">R. E. Chen, X. Zhang, J. B. Case, E. S. Winkler, Y. Liu, L. A. VanBlargan, J. Liu, J. M. Errico, X. Xie, N. Suryadevara, P. Gilchuk, S. J. Zost, S. Tahan, L. Droit, J. S. Turner, W. Kim, A. J. Schmitz, M. Thapa, D. Wang, A. C. M. Boon, R. M. Presti, J. A. O&#8217;Halloran, A. H. J. Kim, P. Deepak, D. Pinto, D. H. Fremont, J. E. Crowe Jr., D. Corti, H. W. Virgin, A. H. Ellebedy, P.-Y. Shi, M. S. Diamond, Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. <b title="valid: False, node: 695, tag: b, level: 18" node_number="695">27</b>, 717&#8211;726 (2021).</div><div title="valid: False, node: 696, tag: div, level: 17" node_number="696"><div title="valid: False, node: 697, tag: div, level: 18" node_number="697"><a title="valid: False, node: 698, tag: a, level: 19" node_number="698">Crossref</a></div><div title="valid: False, node: 699, tag: div, level: 18" node_number="699"><a title="valid: False, node: 700, tag: a, level: 19" node_number="700">PubMed</a></div><div title="valid: False, node: 701, tag: div, level: 18" node_number="701"><a title="valid: False, node: 702, tag: a, level: 19" node_number="702">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 703, tag: div, level: 14" node_number="703"><div title="valid: False, node: 704, tag: div, level: 15" node_number="704">12</div><div title="valid: False, node: 705, tag: div, level: 15" node_number="705"><div title="valid: False, node: 706, tag: div, level: 16" node_number="706"><div title="valid: False, node: 707, tag: div, level: 17" node_number="707">W. F. Garcia-Beltran, E. C. Lam, K. St Denis, A. D. Nitido, Z. H. Garcia, B. M. Hauser, J. Feldman, M. N. Pavlovic, D. J. Gregory, M. C. Poznansky, A. Sigal, A. G. Schmidt, A. J. Iafrate, V. Naranbhai, A. B. Balazs, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell <b title="valid: False, node: 708, tag: b, level: 18" node_number="708">184</b>, 2523 (2021).</div><div title="valid: False, node: 709, tag: div, level: 17" node_number="709"><div title="valid: False, node: 710, tag: div, level: 18" node_number="710"><a title="valid: False, node: 711, tag: a, level: 19" node_number="711">Crossref</a></div><div title="valid: False, node: 712, tag: div, level: 18" node_number="712"><a title="valid: False, node: 713, tag: a, level: 19" node_number="713">PubMed</a></div><div title="valid: False, node: 714, tag: div, level: 18" node_number="714"><a title="valid: False, node: 715, tag: a, level: 19" node_number="715">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 716, tag: div, level: 14" node_number="716"><div title="valid: False, node: 717, tag: div, level: 15" node_number="717">13</div><div title="valid: False, node: 718, tag: div, level: 15" node_number="718"><div title="valid: False, node: 719, tag: div, level: 16" node_number="719"><div title="valid: False, node: 720, tag: div, level: 17" node_number="720">C. K. Wibmer, F. Ayres, T. Hermanus, M. Madzivhandila, P. Kgagudi, B. Oosthuysen, B. E. Lambson, T. de Oliveira, M. Vermeulen, K. van der Berg, T. Rossouw, M. Boswell, V. Ueckermann, S. Meiring, A. von Gottberg, C. Cohen, L. Morris, J. N. Bhiman, P. L. Moore, SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat. Med. <b title="valid: False, node: 721, tag: b, level: 18" node_number="721">27</b>, 622&#8211;625 (2021).</div><div title="valid: False, node: 722, tag: div, level: 17" node_number="722"><div title="valid: False, node: 723, tag: div, level: 18" node_number="723"><a title="valid: False, node: 724, tag: a, level: 19" node_number="724">Crossref</a></div><div title="valid: False, node: 725, tag: div, level: 18" node_number="725"><a title="valid: False, node: 726, tag: a, level: 19" node_number="726">PubMed</a></div><div title="valid: False, node: 727, tag: div, level: 18" node_number="727"><a title="valid: False, node: 728, tag: a, level: 19" node_number="728">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 729, tag: div, level: 14" node_number="729"><div title="valid: False, node: 730, tag: div, level: 15" node_number="730">14</div><div title="valid: False, node: 731, tag: div, level: 15" node_number="731"><div title="valid: False, node: 732, tag: div, level: 16" node_number="732"><div title="valid: False, node: 733, tag: div, level: 17" node_number="733">P. Wang, M. S. Nair, L. Liu, S. Iketani, Y. Luo, Y. Guo, M. Wang, J. Yu, B. Zhang, P. D. Kwong, B. S. Graham, J. R. Mascola, J. Y. Chang, M. T. Yin, M. Sobieszczyk, C. A. Kyratsous, L. Shapiro, Z. Sheng, Y. Huang, D. D. Ho, Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature <b title="valid: False, node: 734, tag: b, level: 18" node_number="734">593</b>, 130&#8211;135 (2021).</div><div title="valid: False, node: 735, tag: div, level: 17" node_number="735"><div title="valid: False, node: 736, tag: div, level: 18" node_number="736"><a title="valid: False, node: 737, tag: a, level: 19" node_number="737">Crossref</a></div><div title="valid: False, node: 738, tag: div, level: 18" node_number="738"><a title="valid: False, node: 739, tag: a, level: 19" node_number="739">PubMed</a></div><div title="valid: False, node: 740, tag: div, level: 18" node_number="740"><a title="valid: False, node: 741, tag: a, level: 19" node_number="741">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 742, tag: div, level: 14" node_number="742"><div title="valid: False, node: 743, tag: div, level: 15" node_number="743">15</div><div title="valid: False, node: 744, tag: div, level: 15" node_number="744"><div title="valid: False, node: 745, tag: div, level: 16" node_number="745"><div title="valid: False, node: 746, tag: div, level: 17" node_number="746">D. Zhou, W. Dejnirattisai, P. Supasa, C. Liu, A. J. Mentzer, H. M. Ginn, Y. Zhao, H. M. E. Duyvesteyn, A. Tuekprakhon, R. Nutalai, B. Wang, G. C. Paesen, C. Lopez-Camacho, J. Slon-Campos, B. Hallis, N. Coombes, K. Bewley, S. Charlton, T. S. Walter, D. Skelly, S. F. Lumley, C. Dold, R. Levin, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. Gilbert, W. James, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell <b title="valid: False, node: 747, tag: b, level: 18" node_number="747">184</b>, 2348&#8211;2361.e6 (2021).</div><div title="valid: False, node: 748, tag: div, level: 17" node_number="748"><div title="valid: False, node: 749, tag: div, level: 18" node_number="749"><a title="valid: False, node: 750, tag: a, level: 19" node_number="750">Crossref</a></div><div title="valid: False, node: 751, tag: div, level: 18" node_number="751"><a title="valid: False, node: 752, tag: a, level: 19" node_number="752">PubMed</a></div><div title="valid: False, node: 753, tag: div, level: 18" node_number="753"><a title="valid: False, node: 754, tag: a, level: 19" node_number="754">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 755, tag: div, level: 14" node_number="755"><div title="valid: False, node: 756, tag: div, level: 15" node_number="756">16</div><div title="valid: False, node: 757, tag: div, level: 15" node_number="757"><div title="valid: False, node: 758, tag: div, level: 16" node_number="758"><div title="valid: False, node: 759, tag: div, level: 17" node_number="759">S. A. Madhi, V. Baillie, C. L. Cutland, M. Voysey, A. L. Koen, L. Fairlie, S. D. Padayachee, K. Dheda, S. L. Barnabas, Q. E. Bhorat, C. Briner, G. Kwatra, K. Ahmed, P. Aley, S. Bhikha, J. N. Bhiman, A. E. Bhorat, J. du Plessis, A. Esmail, M. Groenewald, E. Horne, S.-H. Hwa, A. Jose, T. Lambe, M. Laubscher, M. Malahleha, M. Masenya, M. Masilela, S. McKenzie, K. Molapo, A. Moultrie, S. Oelofse, F. Patel, S. Pillay, S. Rhead, H. Rodel, L. Rossouw, C. Taoushanis, H. Tegally, A. Thombrayil, S. van Eck, C. K. Wibmer, N. M. Durham, E. J. Kelly, T. L. Villafana, S. Gilbert, A. J. Pollard, T. de Oliveira, P. L. Moore, A. Sigal, A. Izu; NGS-SA Group; Wits-VIDA COVID Group, Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N. Engl. J. Med. <b title="valid: False, node: 760, tag: b, level: 18" node_number="760">384</b>, 1885&#8211;1898 (2021).</div><div title="valid: False, node: 761, tag: div, level: 17" node_number="761"><div title="valid: False, node: 762, tag: div, level: 18" node_number="762"><a title="valid: False, node: 763, tag: a, level: 19" node_number="763">Crossref</a></div><div title="valid: False, node: 764, tag: div, level: 18" node_number="764"><a title="valid: False, node: 765, tag: a, level: 19" node_number="765">PubMed</a></div><div title="valid: False, node: 766, tag: div, level: 18" node_number="766"><a title="valid: False, node: 767, tag: a, level: 19" node_number="767">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 768, tag: div, level: 14" node_number="768"><div title="valid: False, node: 769, tag: div, level: 15" node_number="769">17</div><div title="valid: False, node: 770, tag: div, level: 15" node_number="770"><div title="valid: False, node: 771, tag: div, level: 16" node_number="771"><div title="valid: False, node: 772, tag: div, level: 17" node_number="772">J. Sadoff, G. Gray, A. Vandebosch, V. C&#225;rdenas, G. Shukarev, B. Grinsztejn, P. A. Goepfert, C. Truyers, H. Fennema, B. Spiessens, K. Offergeld, G. Scheper, K. L. Taylor, M. L. Robb, J. Treanor, D. H. Barouch, J. Stoddard, M. F. Ryser, M. A. Marovich, K. M. Neuzil, L. Corey, N. Cauwenberghs, T. Tanner, K. Hardt, J. Ruiz-Gui&#241;az&#250;, M. Le Gars, H. Schuitemaker, J. Van Hoof, F. Struyf, M. Douoguih; ENSEMBLE Study Group, Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N. Engl. J. Med. <b title="valid: False, node: 773, tag: b, level: 18" node_number="773">384</b>, 2187&#8211;2201 (2021).</div><div title="valid: False, node: 774, tag: div, level: 17" node_number="774"><div title="valid: False, node: 775, tag: div, level: 18" node_number="775"><a title="valid: False, node: 776, tag: a, level: 19" node_number="776">Crossref</a></div><div title="valid: False, node: 777, tag: div, level: 18" node_number="777"><a title="valid: False, node: 778, tag: a, level: 19" node_number="778">PubMed</a></div><div title="valid: False, node: 779, tag: div, level: 18" node_number="779"><a title="valid: False, node: 780, tag: a, level: 19" node_number="780">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 781, tag: div, level: 14" node_number="781"><div title="valid: False, node: 782, tag: div, level: 15" node_number="782">18</div><div title="valid: False, node: 783, tag: div, level: 15" node_number="783"><div title="valid: False, node: 784, tag: div, level: 16" node_number="784"><div title="valid: False, node: 785, tag: div, level: 17" node_number="785">V. Shinde, S. Bhikha, Z. Hoosain, M. Archary, Q. Bhorat, L. Fairlie, U. Lalloo, M. S. L. Masilela, D. Moodley, S. Hanley, L. Fouche, C. Louw, M. Tameris, N. Singh, A. Goga, K. Dheda, C. Grobbelaar, G. Kruger, N. Carrim-Ganey, V. Baillie, T. de Oliveira, A. Lombard Koen, J. J. Lombaard, R. Mngqibisa, A. E. Bhorat, G. Benad&#233;, N. Lalloo, A. Pitsi, P.-L. Vollgraaff, A. Luabeya, A. Esmail, F. G. Petrick, A. Oommen-Jose, S. Foulkes, K. Ahmed, A. Thombrayil, L. Fries, S. Cloney-Clark, M. Zhu, C. Bennett, G. Albert, E. Faust, J. S. Plested, A. Robertson, S. Neal, I. Cho, G. M. Glenn, F. Dubovsky, S. A. Madhi; 2019nCoV-501 Study Group, Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N. Engl. J. Med. <b title="valid: False, node: 786, tag: b, level: 18" node_number="786">384</b>, 1899&#8211;1909 (2021).</div><div title="valid: False, node: 787, tag: div, level: 17" node_number="787"><div title="valid: False, node: 788, tag: div, level: 18" node_number="788"><a title="valid: False, node: 789, tag: a, level: 19" node_number="789">Crossref</a></div><div title="valid: False, node: 790, tag: div, level: 18" node_number="790"><a title="valid: False, node: 791, tag: a, level: 19" node_number="791">PubMed</a></div><div title="valid: False, node: 792, tag: div, level: 18" node_number="792"><a title="valid: False, node: 793, tag: a, level: 19" node_number="793">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 794, tag: div, level: 14" node_number="794"><div title="valid: False, node: 795, tag: div, level: 15" node_number="795">19</div><div title="valid: False, node: 796, tag: div, level: 15" node_number="796"><div title="valid: False, node: 797, tag: div, level: 16" node_number="797"><div title="valid: False, node: 798, tag: div, level: 17" node_number="798">L. J. Abu-Raddad, H. Chemaitelly, A. A. Butt; National Study Group for COVID-19 Vaccination, Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N. Engl. J. Med. <b title="valid: False, node: 799, tag: b, level: 18" node_number="799">385</b>, 187&#8211;189 (2021).</div><div title="valid: False, node: 800, tag: div, level: 17" node_number="800"><div title="valid: False, node: 801, tag: div, level: 18" node_number="801"><a title="valid: False, node: 802, tag: a, level: 19" node_number="802">Crossref</a></div><div title="valid: False, node: 803, tag: div, level: 18" node_number="803"><a title="valid: False, node: 804, tag: a, level: 19" node_number="804">PubMed</a></div><div title="valid: False, node: 805, tag: div, level: 18" node_number="805"><a title="valid: False, node: 806, tag: a, level: 19" node_number="806">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 807, tag: div, level: 14" node_number="807"><div title="valid: False, node: 808, tag: div, level: 15" node_number="808">20</div><div title="valid: False, node: 809, tag: div, level: 15" node_number="809"><div title="valid: False, node: 810, tag: div, level: 16" node_number="810"><div title="valid: False, node: 811, tag: div, level: 17" node_number="811">B. Agerer, M. Koblischke, V. Gudipati, L. F. Monta&#241;o-Gutierrez, M. Smyth, A. Popa, J.-W. Genger, L. Endler, D. M. Florian, V. M&#252;hlgrabner, M. Graninger, S. W. Aberle, A.-M. Husa, L. E. Shaw, A. Lercher, P. Gattinger, R. Torralba-Gombau, D. Trapin, T. Penz, D. Barreca, I. Fae, S. Wenda, M. Traugott, G. Walder, W. F. Pickl, V. Thiel, F. Allerberger, H. Stockinger, E. Puchhammer-St&#246;ckl, W. Weninger, G. Fischer, W. Hoepler, E. Pawelka, A. Zoufaly, R. Valenta, C. Bock, W. Paster, R. Geyeregger, M. Farlik, F. Halbritter, J. B. Huppa, J. H. Aberle, A. Bergthaler, SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8<sup title="valid: False, node: 812, tag: sup, level: 18" node_number="812">+</sup> T cell responses. Sci. Immunol. <b title="valid: False, node: 813, tag: b, level: 18" node_number="813">6</b>, eabg6461 (2021).</div><div title="valid: False, node: 814, tag: div, level: 17" node_number="814"><div title="valid: False, node: 815, tag: div, level: 18" node_number="815"><a title="valid: False, node: 816, tag: a, level: 19" node_number="816">Crossref</a></div><div title="valid: False, node: 817, tag: div, level: 18" node_number="817"><a title="valid: False, node: 818, tag: a, level: 19" node_number="818">PubMed</a></div><div title="valid: False, node: 819, tag: div, level: 18" node_number="819"><a title="valid: False, node: 820, tag: a, level: 19" node_number="820">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 821, tag: div, level: 14" node_number="821"><div title="valid: False, node: 822, tag: div, level: 15" node_number="822">21</div><div title="valid: False, node: 823, tag: div, level: 15" node_number="823"><div title="valid: False, node: 824, tag: div, level: 16" node_number="824"><div title="valid: False, node: 825, tag: div, level: 17" node_number="825">T. I. de Silva, G. Liu, B. B. Lindsey, D. Dong, D. Shah, A. J. Mentzer, A. Angyal, R. Brown, M. D. Parker, Z. Ying, X. Yao, L. Turtle, S. Dunachie, C.-19 G. U. (COG-U. Consortium, M. K. Maini, G. Ogg, J. C. Knight, Y. Peng, S. L. Rowland-Jones, T. Dong, The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells, Biorxiv, 2021.04.08.438904 (2021).</div><div title="valid: False, node: 826, tag: div, level: 17" node_number="826"><div title="valid: False, node: 827, tag: div, level: 18" node_number="827"><a title="valid: False, node: 828, tag: a, level: 19" node_number="828">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 829, tag: div, level: 14" node_number="829"><div title="valid: False, node: 830, tag: div, level: 15" node_number="830">22</div><div title="valid: False, node: 831, tag: div, level: 15" node_number="831"><div title="valid: False, node: 832, tag: div, level: 16" node_number="832"><div title="valid: False, node: 833, tag: div, level: 17" node_number="833">K. M. E. Gallagher, M. B. Leick, R. C. Larson, T. R. Berger, K. Katsis, J. Y. Yam, G. Brini, K. Grauwet, M. C.-19 C. P. Team, M. V. Maus, SARS -CoV-2 T-cell immunity to variants of concern following vaccination, Biorxiv<i title="valid: False, node: 834, tag: i, level: 18" node_number="834">,</i> 2021.05.03.442455 (2021).</div><div title="valid: False, node: 835, tag: div, level: 17" node_number="835"><div title="valid: False, node: 836, tag: div, level: 18" node_number="836"><a title="valid: False, node: 837, tag: a, level: 19" node_number="837">Crossref</a></div><div title="valid: False, node: 838, tag: div, level: 18" node_number="838"><a title="valid: False, node: 839, tag: a, level: 19" node_number="839">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 840, tag: div, level: 14" node_number="840"><div title="valid: False, node: 841, tag: div, level: 15" node_number="841">23</div><div title="valid: False, node: 842, tag: div, level: 15" node_number="842"><div title="valid: False, node: 843, tag: div, level: 16" node_number="843"><div title="valid: False, node: 844, tag: div, level: 17" node_number="844">C. Motozono, M. Toyoda, J. Zahradnik, A. Saito, H. Nasser, T. S. Tan, I. Ngare, I. Kimura, K. Uriu, Y. Kosugi, Y. Yue, R. Shimizu, J. Ito, S. Torii, A. Yonekawa, N. Shimono, Y. Nagasaki, R. Minami, T. Toya, N. Sekiya, T. Fukuhara, Y. Matsuura, G. Schreiber, T. Ikeda, S. Nakagawa, T. Ueno, K. Sato; Genotype to Phenotype Japan (G2P-Japan) Consortium, SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe <b title="valid: False, node: 845, tag: b, level: 18" node_number="845">29</b>, 1124&#8211;1136.e11 (2021).</div><div title="valid: False, node: 846, tag: div, level: 17" node_number="846"><div title="valid: False, node: 847, tag: div, level: 18" node_number="847"><a title="valid: False, node: 848, tag: a, level: 19" node_number="848">Crossref</a></div><div title="valid: False, node: 849, tag: div, level: 18" node_number="849"><a title="valid: False, node: 850, tag: a, level: 19" node_number="850">PubMed</a></div><div title="valid: False, node: 851, tag: div, level: 18" node_number="851"><a title="valid: False, node: 852, tag: a, level: 19" node_number="852">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 853, tag: div, level: 14" node_number="853"><div title="valid: False, node: 854, tag: div, level: 15" node_number="854">24</div><div title="valid: False, node: 855, tag: div, level: 15" node_number="855"><div title="valid: False, node: 856, tag: div, level: 16" node_number="856"><div title="valid: False, node: 857, tag: div, level: 17" node_number="857">A. Tarke, J. Sidney, N. Methot, E. D. Yu, Y. Zhang, J. M. Dan, B. Goodwin, P. Rubiro, A. Sutherland, E. Wang, A. Frazier, S. I. Ramirez, S. A. Rawlings, D. M. Smith, R. da Silva Antunes, B. Peters, R. H. Scheuermann, D. Weiskopf, S. Crotty, A. Grifoni, A. Sette, Impact of SARS-CoV-2 variants on the total CD4<sup title="valid: False, node: 858, tag: sup, level: 18" node_number="858">+</sup> and CD8<sup title="valid: False, node: 859, tag: sup, level: 18" node_number="859">+</sup> T&#160;cell reactivity in infected or vaccinated individuals. Cell Rep Med <b title="valid: False, node: 860, tag: b, level: 18" node_number="860">2</b>, 100355 (2021).</div><div title="valid: False, node: 861, tag: div, level: 17" node_number="861"><div title="valid: False, node: 862, tag: div, level: 18" node_number="862"><a title="valid: False, node: 863, tag: a, level: 19" node_number="863">Crossref</a></div><div title="valid: False, node: 864, tag: div, level: 18" node_number="864"><a title="valid: False, node: 865, tag: a, level: 19" node_number="865">PubMed</a></div><div title="valid: False, node: 866, tag: div, level: 18" node_number="866"><a title="valid: False, node: 867, tag: a, level: 19" node_number="867">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 868, tag: div, level: 14" node_number="868"><div title="valid: False, node: 869, tag: div, level: 15" node_number="869">25</div><div title="valid: False, node: 870, tag: div, level: 15" node_number="870"><div title="valid: False, node: 871, tag: div, level: 16" node_number="871"><div title="valid: False, node: 872, tag: div, level: 17" node_number="872">A. Grifoni, D. Weiskopf, S. I. Ramirez, J. Mateus, J. M. Dan, C. R. Moderbacher, S. A. Rawlings, A. Sutherland, L. Premkumar, R. S. Jadi, D. Marrama, A. M. de Silva, A. Frazier, A. F. Carlin, J. A. Greenbaum, B. Peters, F. Krammer, D. M. Smith, S. Crotty, A. Sette, Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell <b title="valid: False, node: 873, tag: b, level: 18" node_number="873">181</b>, 1489&#8211;1501.e15 (2020).</div><div title="valid: False, node: 874, tag: div, level: 17" node_number="874"><div title="valid: False, node: 875, tag: div, level: 18" node_number="875"><a title="valid: False, node: 876, tag: a, level: 19" node_number="876">Crossref</a></div><div title="valid: False, node: 877, tag: div, level: 18" node_number="877"><a title="valid: False, node: 878, tag: a, level: 19" node_number="878">PubMed</a></div><div title="valid: False, node: 879, tag: div, level: 18" node_number="879"><a title="valid: False, node: 880, tag: a, level: 19" node_number="880">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 881, tag: div, level: 14" node_number="881"><div title="valid: False, node: 882, tag: div, level: 15" node_number="882">26</div><div title="valid: False, node: 883, tag: div, level: 15" node_number="883"><div title="valid: False, node: 884, tag: div, level: 16" node_number="884"><div title="valid: False, node: 885, tag: div, level: 17" node_number="885">J. M. Dan, J. Mateus, Y. Kato, K. M. Hastie, E. D. Yu, C. E. Faliti, A. Grifoni, S. I. Ramirez, S. Haupt, A. Frazier, C. Nakao, V. Rayaprolu, S. A. Rawlings, B. Peters, F. Krammer, V. Simon, E. O. Saphire, D. M. Smith, D. Weiskopf, A. Sette, S. Crotty, Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science <b title="valid: False, node: 886, tag: b, level: 18" node_number="886">371</b>, eabf4063 (2021).</div><div title="valid: False, node: 887, tag: div, level: 17" node_number="887"><div title="valid: False, node: 888, tag: div, level: 18" node_number="888"><a title="valid: False, node: 889, tag: a, level: 19" node_number="889">Crossref</a></div><div title="valid: False, node: 890, tag: div, level: 18" node_number="890"><a title="valid: False, node: 891, tag: a, level: 19" node_number="891">PubMed</a></div><div title="valid: False, node: 892, tag: div, level: 18" node_number="892"><a title="valid: False, node: 893, tag: a, level: 19" node_number="893">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 894, tag: div, level: 14" node_number="894"><div title="valid: False, node: 895, tag: div, level: 15" node_number="895">27</div><div title="valid: False, node: 896, tag: div, level: 15" node_number="896"><div title="valid: False, node: 897, tag: div, level: 16" node_number="897"><div title="valid: False, node: 898, tag: div, level: 17" node_number="898">C. Riou, E. du Bruyn, C. Stek, R. Daroowala, R. T. Goliath, F. Abrahams, Q. Said-Hartley, B. W. Allwood, N.-Y. Hsiao, K. A. Wilkinson, C. S. L. Arlehamn, A. Sette, S. Wasserman, R. J. Wilkinson; HIATUS consortium, Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. J. Clin. Invest. <b title="valid: False, node: 899, tag: b, level: 18" node_number="899">131</b>, e149125 (2021).</div><div title="valid: False, node: 900, tag: div, level: 17" node_number="900"><div title="valid: False, node: 901, tag: div, level: 18" node_number="901"><a title="valid: False, node: 902, tag: a, level: 19" node_number="902">Crossref</a></div><div title="valid: False, node: 903, tag: div, level: 18" node_number="903"><a title="valid: False, node: 904, tag: a, level: 19" node_number="904">PubMed</a></div><div title="valid: False, node: 905, tag: div, level: 18" node_number="905"><a title="valid: False, node: 906, tag: a, level: 19" node_number="906">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 907, tag: div, level: 14" node_number="907"><div title="valid: False, node: 908, tag: div, level: 15" node_number="908">28</div><div title="valid: False, node: 909, tag: div, level: 15" node_number="909"><div title="valid: False, node: 910, tag: div, level: 16" node_number="910"><div title="valid: False, node: 911, tag: div, level: 17" node_number="911">K. W. Cohen, S. L. Linderman, Z. Moodie, J. Czartoski, L. Lai, G. Mantus, C. Norwood, L. E. Nyhoff, V. V. Edara, K. Floyd, S. C. De Rosa, H. Ahmed, R. Whaley, S. N. Patel, B. Prigmore, M. P. Lemos, C. W. Davis, S. Furth, J. B. O&#8217;Keefe, M. P. Gharpure, S. Gunisetty, K. Stephens, R. Antia, V. I. Zarnitsyna, D. S. Stephens, S. Edupuganti, N. Rouphael, E. J. Anderson, A. K. Mehta, J. Wrammert, M. S. Suthar, R. Ahmed, M. J. McElrath, Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T&#160;cells. Cell Rep Med <b title="valid: False, node: 912, tag: b, level: 18" node_number="912">2</b>, 100354 (2021).</div><div title="valid: False, node: 913, tag: div, level: 17" node_number="913"><div title="valid: False, node: 914, tag: div, level: 18" node_number="914"><a title="valid: False, node: 915, tag: a, level: 19" node_number="915">Crossref</a></div><div title="valid: False, node: 916, tag: div, level: 18" node_number="916"><a title="valid: False, node: 917, tag: a, level: 19" node_number="917">PubMed</a></div><div title="valid: False, node: 918, tag: div, level: 18" node_number="918"><a title="valid: False, node: 919, tag: a, level: 19" node_number="919">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 920, tag: div, level: 14" node_number="920"><div title="valid: False, node: 921, tag: div, level: 15" node_number="921">29</div><div title="valid: False, node: 922, tag: div, level: 15" node_number="922"><div title="valid: False, node: 923, tag: div, level: 16" node_number="923"><div title="valid: False, node: 924, tag: div, level: 17" node_number="924">D. M. Altmann, R. J. Boyton, R. Beale, Immunity to SARS-CoV-2 variants of concern. Science <b title="valid: False, node: 925, tag: b, level: 18" node_number="925">371</b>, 1103&#8211;1104 (2021).</div><div title="valid: False, node: 926, tag: div, level: 17" node_number="926"><div title="valid: False, node: 927, tag: div, level: 18" node_number="927"><a title="valid: False, node: 928, tag: a, level: 19" node_number="928">Crossref</a></div><div title="valid: False, node: 929, tag: div, level: 18" node_number="929"><a title="valid: False, node: 930, tag: a, level: 19" node_number="930">PubMed</a></div><div title="valid: False, node: 931, tag: div, level: 18" node_number="931"><a title="valid: False, node: 932, tag: a, level: 19" node_number="932">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 933, tag: div, level: 14" node_number="933"><div title="valid: False, node: 934, tag: div, level: 15" node_number="934">30</div><div title="valid: False, node: 935, tag: div, level: 15" node_number="935"><div title="valid: False, node: 936, tag: div, level: 16" node_number="936"><div title="valid: False, node: 937, tag: div, level: 17" node_number="937">J. Mateus, A. Grifoni, A. Tarke, J. Sidney, S. I. Ramirez, J. M. Dan, Z. C. Burger, S. A. Rawlings, D. M. Smith, E. Phillips, S. Mallal, M. Lammers, P. Rubiro, L. Quiambao, A. Sutherland, E. D. Yu, R. da Silva Antunes, J. Greenbaum, A. Frazier, A. J. Markmann, L. Premkumar, A. de Silva, B. Peters, S. Crotty, A. Sette, D. Weiskopf, Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science <b title="valid: False, node: 938, tag: b, level: 18" node_number="938">370</b>, 89&#8211;94 (2020).</div><div title="valid: False, node: 939, tag: div, level: 17" node_number="939"><div title="valid: False, node: 940, tag: div, level: 18" node_number="940"><a title="valid: False, node: 941, tag: a, level: 19" node_number="941">Crossref</a></div><div title="valid: False, node: 942, tag: div, level: 18" node_number="942"><a title="valid: False, node: 943, tag: a, level: 19" node_number="943">PubMed</a></div><div title="valid: False, node: 944, tag: div, level: 18" node_number="944"><a title="valid: False, node: 945, tag: a, level: 19" node_number="945">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 946, tag: div, level: 14" node_number="946"><div title="valid: False, node: 947, tag: div, level: 15" node_number="947">31</div><div title="valid: False, node: 948, tag: div, level: 15" node_number="948"><div title="valid: False, node: 949, tag: div, level: 16" node_number="949"><div title="valid: False, node: 950, tag: div, level: 17" node_number="950">A. Tarke, J. Sidney, C. K. Kidd, J. M. Dan, S. I. Ramirez, E. D. Yu, J. Mateus, R. da Silva Antunes, E. Moore, P. Rubiro, N. Methot, E. Phillips, S. Mallal, A. Frazier, S. A. Rawlings, J. A. Greenbaum, B. Peters, D. M. Smith, S. Crotty, D. Weiskopf, A. Grifoni, A. Sette, Comprehensive analysis of T&#160;cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports Medicine <b title="valid: False, node: 951, tag: b, level: 18" node_number="951">2</b>, 100204 (2021).</div><div title="valid: False, node: 952, tag: div, level: 17" node_number="952"><div title="valid: False, node: 953, tag: div, level: 18" node_number="953"><a title="valid: False, node: 954, tag: a, level: 19" node_number="954">Crossref</a></div><div title="valid: False, node: 955, tag: div, level: 18" node_number="955"><a title="valid: False, node: 956, tag: a, level: 19" node_number="956">PubMed</a></div><div title="valid: False, node: 957, tag: div, level: 18" node_number="957"><a title="valid: False, node: 958, tag: a, level: 19" node_number="958">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 959, tag: div, level: 14" node_number="959"><div title="valid: False, node: 960, tag: div, level: 15" node_number="960">32</div><div title="valid: False, node: 961, tag: div, level: 15" node_number="961"><div title="valid: False, node: 962, tag: div, level: 16" node_number="962"><div title="valid: False, node: 963, tag: div, level: 17" node_number="963">A. Nelde, T. Bilich, J. S. Heitmann, Y. Maringer, H. R. Salih, M. Roerden, M. L&#252;bke, J. Bauer, J. Rieth, M. Wacker, A. Peter, S. H&#246;rber, B. Traenkle, P. D. Kaiser, U. Rothbauer, M. Becker, D. Junker, G. Krause, M. Strengert, N. Schneiderhan-Marra, M. F. Templin, T. O. Joos, D. J. Kowalewski, V. Stos-Zweifel, M. Fehr, A. Rabsteyn, V. Mirakaj, J. Karbach, E. J&#228;ger, M. Graf, L.-C. Gruber, D. Rachfalski, B. Preu&#223;, I. Hagelstein, M. M&#228;rklin, T. Bakchoul, C. Gouttefangeas, O. Kohlbacher, R. Klein, S. Stevanovi&#263;, H.-G. Rammensee, J. S. Walz, SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. <b title="valid: False, node: 964, tag: b, level: 18" node_number="964">22</b>, 74&#8211;85 (2021).</div><div title="valid: False, node: 965, tag: div, level: 17" node_number="965"><div title="valid: False, node: 966, tag: div, level: 18" node_number="966"><a title="valid: False, node: 967, tag: a, level: 19" node_number="967">Crossref</a></div><div title="valid: False, node: 968, tag: div, level: 18" node_number="968"><a title="valid: False, node: 969, tag: a, level: 19" node_number="969">PubMed</a></div><div title="valid: False, node: 970, tag: div, level: 18" node_number="970"><a title="valid: False, node: 971, tag: a, level: 19" node_number="971">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 972, tag: div, level: 14" node_number="972"><div title="valid: False, node: 973, tag: div, level: 15" node_number="973">33</div><div title="valid: False, node: 974, tag: div, level: 15" node_number="974"><div title="valid: False, node: 975, tag: div, level: 16" node_number="975"><div title="valid: False, node: 976, tag: div, level: 17" node_number="976">V. Oberhardt, H. Luxenburger, J. Kemming, I. Schulien, K. Ciminski, S. Giese, B. Csernalabics, J. Lang-Meli, I. Janowska, J. Staniek, K. Wild, K. Basho, M. S. Marinescu, J. Fuchs, F. Topfstedt, A. Janda, O. Sogukpinar, H. Hilger, K. Stete, F. Emmerich, B. Bengsch, C. F. Waller, S. Rieg, T. Sagar, T. Boettler, K. Zoldan, G. Kochs, M. Schwemmle, M. Rizzi, R. Thimme, C. Neumann-Haefelin, M. Hofmann, Rapid and stable mobilization of CD8<sup title="valid: False, node: 977, tag: sup, level: 18" node_number="977">+</sup> T cells by SARS-CoV-2 mRNA vaccine. Nature <b title="valid: False, node: 978, tag: b, level: 18" node_number="978">597</b>, 268&#8211;273 (2021).</div><div title="valid: False, node: 979, tag: div, level: 17" node_number="979"><div title="valid: False, node: 980, tag: div, level: 18" node_number="980"><a title="valid: False, node: 981, tag: a, level: 19" node_number="981">Crossref</a></div><div title="valid: False, node: 982, tag: div, level: 18" node_number="982"><a title="valid: False, node: 983, tag: a, level: 19" node_number="983">PubMed</a></div><div title="valid: False, node: 984, tag: div, level: 18" node_number="984"><a title="valid: False, node: 985, tag: a, level: 19" node_number="985">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 986, tag: div, level: 14" node_number="986"><div title="valid: False, node: 987, tag: div, level: 15" node_number="987">34</div><div title="valid: False, node: 988, tag: div, level: 15" node_number="988"><div title="valid: False, node: 989, tag: div, level: 16" node_number="989"><div title="valid: False, node: 990, tag: div, level: 17" node_number="990">L. G. Thorne, M. Bouhaddou, A.-K. Reuschl, L. Zuliani-Alvarez, B. Polacco, A. Pelin, J. Batra, M. V. X. Whelan, M. Ummadi, A. Rojc, J. Turner, K. Obernier, H. Braberg, M. Soucheray, A. Richards, K.-H. Chen, B. Harjai, D. Memon, M. Hosmillo, J. Hiatt, A. Jahun, I. G. Goodfellow, J. M. Fabius, K. Shokat, N. Jura, K. Verba, M. Noursadeghi, P. Beltrao, D. L. Swaney, A. Garcia-Sastre, C. Jolly, G. J. Towers, N. J. Krogan, Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant, Biorxiv, 2021.06.06.446826 (2021).</div><div title="valid: False, node: 991, tag: div, level: 17" node_number="991"><div title="valid: False, node: 992, tag: div, level: 18" node_number="992"><a title="valid: False, node: 993, tag: a, level: 19" node_number="993">Crossref</a></div><div title="valid: False, node: 994, tag: div, level: 18" node_number="994"><a title="valid: False, node: 995, tag: a, level: 19" node_number="995">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 996, tag: div, level: 14" node_number="996"><div title="valid: False, node: 997, tag: div, level: 15" node_number="997">35</div><div title="valid: False, node: 998, tag: div, level: 15" node_number="998"><div title="valid: False, node: 999, tag: div, level: 16" node_number="999"><div title="valid: False, node: 1000, tag: div, level: 17" node_number="1000">K. Guo, B. S. Barrett, K. L. Mickens, K. J. Hasenkrug, M. L. Santiago, Interferon Resistance of Emerging SARS-CoV-2 Variants, Biorxiv, 2021.03.20.436257 (2021).</div><div title="valid: False, node: 1001, tag: div, level: 17" node_number="1001"><div title="valid: False, node: 1002, tag: div, level: 18" node_number="1002"><a title="valid: False, node: 1003, tag: a, level: 19" node_number="1003">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1004, tag: div, level: 14" node_number="1004"><div title="valid: False, node: 1005, tag: div, level: 15" node_number="1005">36</div><div title="valid: False, node: 1006, tag: div, level: 15" node_number="1006"><div title="valid: False, node: 1007, tag: div, level: 16" node_number="1007"><div title="valid: False, node: 1008, tag: div, level: 17" node_number="1008">C. J. Thieme, M. Anft, K. Paniskaki, A. Blazquez-Navarro, A. Doevelaar, F. S. Seibert, B. Hoelzer, M. J. Konik, M. M. Berger, T. Brenner, C. Tempfer, C. Watzl, T. L. Meister, S. Pfaender, E. Steinmann, S. Dolff, U. Dittmer, T. H. Westhoff, O. Witzke, U. Stervbo, T. Roch, N. Babel, Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients. Cell Reports Medicine <b title="valid: False, node: 1009, tag: b, level: 18" node_number="1009">1</b>, 100092 (2020).</div><div title="valid: False, node: 1010, tag: div, level: 17" node_number="1010"><div title="valid: False, node: 1011, tag: div, level: 18" node_number="1011"><a title="valid: False, node: 1012, tag: a, level: 19" node_number="1012">Crossref</a></div><div title="valid: False, node: 1013, tag: div, level: 18" node_number="1013"><a title="valid: False, node: 1014, tag: a, level: 19" node_number="1014">PubMed</a></div><div title="valid: False, node: 1015, tag: div, level: 18" node_number="1015"><a title="valid: False, node: 1016, tag: a, level: 19" node_number="1016">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1017, tag: div, level: 14" node_number="1017"><div title="valid: False, node: 1018, tag: div, level: 15" node_number="1018">37</div><div title="valid: False, node: 1019, tag: div, level: 15" node_number="1019"><div title="valid: False, node: 1020, tag: div, level: 16" node_number="1020"><div title="valid: False, node: 1021, tag: div, level: 17" node_number="1021">A. Abdel Latif, J. L. Mullen, M. Alkuzweny, G. Tsueng, M. Cano, E. Haag, J. Zhou, M. Zeller, E. Hufbauer, N. Matteson, C. Wu, K. G. Anderson, A. I. Su, K. Gangavarapu, L. D. Hughes, and the Center for Viral Systems Biology, S:L18F Mutation Report. Outbreak.info, (available at <a title="valid: False, node: 1022, tag: a, level: 18" node_number="1022">https://outbreak.info/situation-reports?pangomuts=S%3AL18F</a>). Accessed 4 December 2021.</div><div title="valid: False, node: 1023, tag: div, level: 17" node_number="1023"><div title="valid: False, node: 1024, tag: div, level: 18" node_number="1024"><a title="valid: False, node: 1025, tag: a, level: 19" node_number="1025">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1026, tag: div, level: 14" node_number="1026"><div title="valid: False, node: 1027, tag: div, level: 15" node_number="1027">38</div><div title="valid: False, node: 1028, tag: div, level: 15" node_number="1028"><div title="valid: False, node: 1029, tag: div, level: 16" node_number="1029"><div title="valid: False, node: 1030, tag: div, level: 17" node_number="1030">W. T. Harvey, A. M. Carabelli, B. Jackson, R. K. Gupta, E. C. Thomson, E. M. Harrison, C. Ludden, R. Reeve, A. Rambaut, S. J. Peacock, D. L. Robertson; COVID-19 Genomics UK (COG-UK) Consortium, SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. <b title="valid: False, node: 1031, tag: b, level: 18" node_number="1031">19</b>, 409&#8211;424 (2021).</div><div title="valid: False, node: 1032, tag: div, level: 17" node_number="1032"><div title="valid: False, node: 1033, tag: div, level: 18" node_number="1033"><a title="valid: False, node: 1034, tag: a, level: 19" node_number="1034">Crossref</a></div><div title="valid: False, node: 1035, tag: div, level: 18" node_number="1035"><a title="valid: False, node: 1036, tag: a, level: 19" node_number="1036">PubMed</a></div><div title="valid: False, node: 1037, tag: div, level: 18" node_number="1037"><a title="valid: False, node: 1038, tag: a, level: 19" node_number="1038">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1039, tag: div, level: 14" node_number="1039"><div title="valid: False, node: 1040, tag: div, level: 15" node_number="1040">39</div><div title="valid: False, node: 1041, tag: div, level: 15" node_number="1041"><div title="valid: False, node: 1042, tag: div, level: 16" node_number="1042"><div title="valid: False, node: 1043, tag: div, level: 17" node_number="1043">C. Scheepers, J. Everatt, D. G. Amoako, A. Mnguni, A. Ismail, B. Mahlangu, C. K. Wibmer, E. Wilkinson, H. Tegally, J. E. San, J. Giandhari, N. Ntuli, S. Pillay, T. Mohale, Y. Naidoo, Z. T. Khumalo, Z. Makatini, NGS-SA, A. Sigal, C. Williamson, F. Treurnicht, K. Mlisana, M. Venter, N. Hsiao, N. Wolter, N. Msomi, R. Lessells, T. Maponga, W. Preiser, P. L. Moore, A. von Gottberg, T. de Oliveira, J. N. Bhiman, The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection, Medrxiv, 2021.08.20.21262342 (2021).</div><div title="valid: False, node: 1044, tag: div, level: 17" node_number="1044"><div title="valid: False, node: 1045, tag: div, level: 18" node_number="1045"><a title="valid: False, node: 1046, tag: a, level: 19" node_number="1046">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1047, tag: div, level: 14" node_number="1047"><div title="valid: False, node: 1048, tag: div, level: 15" node_number="1048">40</div><div title="valid: False, node: 1049, tag: div, level: 15" node_number="1049"><div title="valid: False, node: 1050, tag: div, level: 16" node_number="1050"><div title="valid: False, node: 1051, tag: div, level: 17" node_number="1051">A. Abdel Latif, J. L. Mullen, M. Alkuzweny, G. Tsueng, M. Cano, E. Haag, J. Zhou, M. Zeller, E. Hufbauer, N. Matteson, C. Wu, K. G. Andersen, A. I. Su, K. Gangavarapu, L. D. Hughes, and Center for Viral Systems Biology. outbreak.info, (available at <a title="valid: False, node: 1052, tag: a, level: 18" node_number="1052">https://outbreak.info/situation-reports</a>), <i title="valid: False, node: 1053, tag: i, level: 18" node_number="1053">Accessed 10 September 2021</i><i title="valid: False, node: 1054, tag: i, level: 18" node_number="1054">.</i></div><div title="valid: False, node: 1055, tag: div, level: 17" node_number="1055"><div title="valid: False, node: 1056, tag: div, level: 18" node_number="1056"><a title="valid: False, node: 1057, tag: a, level: 19" node_number="1057">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1058, tag: div, level: 14" node_number="1058"><div title="valid: False, node: 1059, tag: div, level: 15" node_number="1059">41</div><div title="valid: False, node: 1060, tag: div, level: 15" node_number="1060"><div title="valid: False, node: 1061, tag: div, level: 16" node_number="1061"><div title="valid: False, node: 1062, tag: div, level: 17" node_number="1062">T. Moyo-Gwete, M. Madzivhandila, Z. Makhado, F. Ayres, D. Mhlanga, B. Oosthuysen, B. E. Lambson, P. Kgagudi, H. Tegally, A. Iranzadeh, D. Doolabh, L. Tyers, L. R. Chinhoyi, M. Mennen, S. Skelem, G. Marais, C. K. Wibmer, J. N. Bhiman, V. Ueckermann, T. Rossouw, M. Boswell, T. de Oliveira, C. Williamson, W. A. Burgers, N. Ntusi, L. Morris, P. L. Moore, Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351). N. Engl. J. Med. <b title="valid: False, node: 1063, tag: b, level: 18" node_number="1063">384</b>, 2161&#8211;2163 (2021).</div><div title="valid: False, node: 1064, tag: div, level: 17" node_number="1064"><div title="valid: False, node: 1065, tag: div, level: 18" node_number="1065"><a title="valid: False, node: 1066, tag: a, level: 19" node_number="1066">Crossref</a></div><div title="valid: False, node: 1067, tag: div, level: 18" node_number="1067"><a title="valid: False, node: 1068, tag: a, level: 19" node_number="1068">PubMed</a></div><div title="valid: False, node: 1069, tag: div, level: 18" node_number="1069"><a title="valid: False, node: 1070, tag: a, level: 19" node_number="1070">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1071, tag: div, level: 14" node_number="1071"><div title="valid: False, node: 1072, tag: div, level: 15" node_number="1072">42</div><div title="valid: False, node: 1073, tag: div, level: 15" node_number="1073"><div title="valid: False, node: 1074, tag: div, level: 16" node_number="1074"><div title="valid: False, node: 1075, tag: div, level: 17" node_number="1075">M. Hoffmann, P. Arora, R. Gro&#223;, A. Seidel, B. F. H&#246;rnich, A. S. Hahn, N. Kr&#252;ger, L. Graichen, H. Hofmann-Winkler, A. Kempf, M. S. Winkler, S. Schulz, H.-M. J&#228;ck, B. Jahrsd&#246;rfer, H. Schrezenmeier, M. M&#252;ller, A. Kleger, J. M&#252;nch, S. P&#246;hlmann, SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell <b title="valid: False, node: 1076, tag: b, level: 18" node_number="1076">184</b>, 2384&#8211;2393.e12 (2021).</div><div title="valid: False, node: 1077, tag: div, level: 17" node_number="1077"><div title="valid: False, node: 1078, tag: div, level: 18" node_number="1078"><a title="valid: False, node: 1079, tag: a, level: 19" node_number="1079">Crossref</a></div><div title="valid: False, node: 1080, tag: div, level: 18" node_number="1080"><a title="valid: False, node: 1081, tag: a, level: 19" node_number="1081">PubMed</a></div><div title="valid: False, node: 1082, tag: div, level: 18" node_number="1082"><a title="valid: False, node: 1083, tag: a, level: 19" node_number="1083">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1084, tag: div, level: 14" node_number="1084"><div title="valid: False, node: 1085, tag: div, level: 15" node_number="1085">43</div><div title="valid: False, node: 1086, tag: div, level: 15" node_number="1086"><div title="valid: False, node: 1087, tag: div, level: 16" node_number="1087"><div title="valid: False, node: 1088, tag: div, level: 17" node_number="1088">C. Liu, H. M. Ginn, W. Dejnirattisai, P. Supasa, B. Wang, A. Tuekprakhon, R. Nutalai, D. Zhou, A. J. Mentzer, Y. Zhao, H. M. E. Duyvesteyn, C. L&#243;pez-Camacho, J. Slon-Campos, T. S. Walter, D. Skelly, S. A. Johnson, T. G. Ritter, C. Mason, S. A. Costa Clemens, F. Gomes Naveca, V. Nascimento, F. Nascimento, C. Fernandes da Costa, P. C. Resende, A. Pauvolid-Correa, M. M. Siqueira, C. Dold, N. Temperton, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. C. Gilbert, T. Malik, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, V. Baillie, N. Serafin, Z. Ditse, K. Da Silva, N. G. Paterson, M. A. Williams, D. R. Hall, S. Madhi, M. C. Nunes, P. Goulder, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell <b title="valid: False, node: 1089, tag: b, level: 18" node_number="1089">184</b>, 4220&#8211;4236.e13 (2021).</div><div title="valid: False, node: 1090, tag: div, level: 17" node_number="1090"><div title="valid: False, node: 1091, tag: div, level: 18" node_number="1091"><a title="valid: False, node: 1092, tag: a, level: 19" node_number="1092">Crossref</a></div><div title="valid: False, node: 1093, tag: div, level: 18" node_number="1093"><a title="valid: False, node: 1094, tag: a, level: 19" node_number="1094">PubMed</a></div><div title="valid: False, node: 1095, tag: div, level: 18" node_number="1095"><a title="valid: False, node: 1096, tag: a, level: 19" node_number="1096">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1097, tag: div, level: 14" node_number="1097"><div title="valid: False, node: 1098, tag: div, level: 15" node_number="1098">44</div><div title="valid: False, node: 1099, tag: div, level: 15" node_number="1099"><div title="valid: False, node: 1100, tag: div, level: 16" node_number="1100"><div title="valid: False, node: 1101, tag: div, level: 17" node_number="1101">D. Planas, D. Veyer, A. Baidaliuk, I. Staropoli, F. Guivel-Benhassine, M. M. Rajah, C. Planchais, F. Porrot, N. Robillard, J. Puech, M. Prot, F. Gallais, P. Gantner, A. Velay, J. Le Guen, N. Kassis-Chikhani, D. Edriss, L. Belec, A. Seve, L. Courtellemont, H. P&#233;r&#233;, L. Hocqueloux, S. Fafi-Kremer, T. Prazuck, H. Mouquet, T. Bruel, E. Simon-Lori&#232;re, F. A. Rey, O. Schwartz, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature <b title="valid: False, node: 1102, tag: b, level: 18" node_number="1102">596</b>, 276&#8211;280 (2021).</div><div title="valid: False, node: 1103, tag: div, level: 17" node_number="1103"><div title="valid: False, node: 1104, tag: div, level: 18" node_number="1104"><a title="valid: False, node: 1105, tag: a, level: 19" node_number="1105">Crossref</a></div><div title="valid: False, node: 1106, tag: div, level: 18" node_number="1106"><a title="valid: False, node: 1107, tag: a, level: 19" node_number="1107">PubMed</a></div><div title="valid: False, node: 1108, tag: div, level: 18" node_number="1108"><a title="valid: False, node: 1109, tag: a, level: 19" node_number="1109">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1110, tag: div, level: 14" node_number="1110"><div title="valid: False, node: 1111, tag: div, level: 15" node_number="1111">45</div><div title="valid: False, node: 1112, tag: div, level: 15" node_number="1112"><div title="valid: False, node: 1113, tag: div, level: 16" node_number="1113"><div title="valid: False, node: 1114, tag: div, level: 17" node_number="1114">D. Planas, D. Veyer, A. Baidaliuk, I. Staropoli, F. Guivel-Benhassine, M. M. Rajah, C. Planchais, F. Porrot, N. Robillard, J. Puech, M. Prot, F. Gallais, P. Gantner, A. Velay, J. Le Guen, N. Kassis-Chikhani, D. Edriss, L. Belec, A. Seve, L. Courtellemont, H. P&#233;r&#233;, L. Hocqueloux, S. Fafi-Kremer, T. Prazuck, H. Mouquet, T. Bruel, E. Simon-Lori&#232;re, F. A. Rey, O. Schwartz, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature <b title="valid: False, node: 1115, tag: b, level: 18" node_number="1115">596</b>, 276&#8211;280 (2021).</div><div title="valid: False, node: 1116, tag: div, level: 17" node_number="1116"><div title="valid: False, node: 1117, tag: div, level: 18" node_number="1117"><a title="valid: False, node: 1118, tag: a, level: 19" node_number="1118">Crossref</a></div><div title="valid: False, node: 1119, tag: div, level: 18" node_number="1119"><a title="valid: False, node: 1120, tag: a, level: 19" node_number="1120">PubMed</a></div><div title="valid: False, node: 1121, tag: div, level: 18" node_number="1121"><a title="valid: False, node: 1122, tag: a, level: 19" node_number="1122">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1123, tag: div, level: 14" node_number="1123"><div title="valid: False, node: 1124, tag: div, level: 15" node_number="1124">46</div><div title="valid: False, node: 1125, tag: div, level: 15" node_number="1125"><div title="valid: False, node: 1126, tag: div, level: 16" node_number="1126"><div title="valid: False, node: 1127, tag: div, level: 17" node_number="1127">L. Dupont, L. B. Snell, C. Graham, J. Seow, B. Merrick, T. Lechmere, T. J. A. Maguire, S. R. Hallett, S. Pickering, T. Charalampous, A. Alcolea-Medina, I. Huettner, J. M. Jimenez-Guarde&#241;o, S. Acors, N. Almeida, D. Cox, R. E. Dickenson, R. P. Galao, N. Kouphou, M. J. Lista, A. M. Ortega-Prieto, H. Wilson, H. Winstone, C. Fairhead, J. Z. Su, G. Nebbia, R. Batra, S. Neil, M. Shankar-Hari, J. D. Edgeworth, M. H. Malim, K. J. Doores, Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern. Nat. Microbiol. <b title="valid: False, node: 1128, tag: b, level: 18" node_number="1128">6</b>, 1433&#8211;1442 (2021).</div><div title="valid: False, node: 1129, tag: div, level: 17" node_number="1129"><div title="valid: False, node: 1130, tag: div, level: 18" node_number="1130"><a title="valid: False, node: 1131, tag: a, level: 19" node_number="1131">Crossref</a></div><div title="valid: False, node: 1132, tag: div, level: 18" node_number="1132"><a title="valid: False, node: 1133, tag: a, level: 19" node_number="1133">PubMed</a></div><div title="valid: False, node: 1134, tag: div, level: 18" node_number="1134"><a title="valid: False, node: 1135, tag: a, level: 19" node_number="1135">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1136, tag: div, level: 14" node_number="1136"><div title="valid: False, node: 1137, tag: div, level: 15" node_number="1137">47</div><div title="valid: False, node: 1138, tag: div, level: 15" node_number="1138"><div title="valid: False, node: 1139, tag: div, level: 16" node_number="1139"><div title="valid: False, node: 1140, tag: div, level: 17" node_number="1140">E. C. Wall, M. Wu, R. Harvey, G. Kelly, S. Warchal, C. Sawyer, R. Daniels, P. Hobson, E. Hatipoglu, Y. Ngai, S. Hussain, J. Nicod, R. Goldstone, K. Ambrose, S. Hindmarsh, R. Beale, A. Riddell, S. Gamblin, M. Howell, G. Kassiotis, V. Libri, B. Williams, C. Swanton, S. Gandhi, D. L. Bauer, Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet <b title="valid: False, node: 1141, tag: b, level: 18" node_number="1141">397</b>, 2331&#8211;2333 (2021).</div><div title="valid: False, node: 1142, tag: div, level: 17" node_number="1142"><div title="valid: False, node: 1143, tag: div, level: 18" node_number="1143"><a title="valid: False, node: 1144, tag: a, level: 19" node_number="1144">Crossref</a></div><div title="valid: False, node: 1145, tag: div, level: 18" node_number="1145"><a title="valid: False, node: 1146, tag: a, level: 19" node_number="1146">PubMed</a></div><div title="valid: False, node: 1147, tag: div, level: 18" node_number="1147"><a title="valid: False, node: 1148, tag: a, level: 19" node_number="1148">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1149, tag: div, level: 14" node_number="1149"><div title="valid: False, node: 1150, tag: div, level: 15" node_number="1150">48</div><div title="valid: False, node: 1151, tag: div, level: 15" node_number="1151"><div title="valid: False, node: 1152, tag: div, level: 16" node_number="1152"><div title="valid: False, node: 1153, tag: div, level: 17" node_number="1153">S. Cele, L. Jackson, K. Khan, D. Khoury, T. Moyo-Gwete, H. Tegally, C. Scheepers, D. Amoako, F. Karim, M. Bernstein, G. Lustig, D. Archary, M. Smith, Y. Ganga, Z. Jule, K. Reedoy, J. Emmanuel San, S.-H. Hwa, J. Giandhari, J. M. Blackburn, B. I. Gosnell, S. A. Karim, W. Hanekom, NGS-SA, COMMIT-KZN Team, A. von Gottberg, J. Bhiman, R. J. Lessells, M.-Y. S. Moosa, M. Davenport, T. de Oliveira, P. L. Moore, A. Sigal. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. MedRXiv (2021).</div><div title="valid: False, node: 1154, tag: div, level: 17" node_number="1154"><div title="valid: False, node: 1155, tag: div, level: 18" node_number="1155"><a title="valid: False, node: 1156, tag: a, level: 19" node_number="1156">Crossref</a></div><div title="valid: False, node: 1157, tag: div, level: 18" node_number="1157"><a title="valid: False, node: 1158, tag: a, level: 19" node_number="1158">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1159, tag: div, level: 14" node_number="1159"><div title="valid: False, node: 1160, tag: div, level: 15" node_number="1160">49</div><div title="valid: False, node: 1161, tag: div, level: 15" node_number="1161"><div title="valid: False, node: 1162, tag: div, level: 16" node_number="1162"><div title="valid: False, node: 1163, tag: div, level: 17" node_number="1163">D. S. Khoury, D. Cromer, A. Reynaldi, T. E. Schlub, A. K. Wheatley, J. A. Juno, K. Subbarao, S. J. Kent, J. A. Triccas, M. P. Davenport, Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. <b title="valid: False, node: 1164, tag: b, level: 18" node_number="1164">27</b>, 1205&#8211;1211 (2021).</div><div title="valid: False, node: 1165, tag: div, level: 17" node_number="1165"><div title="valid: False, node: 1166, tag: div, level: 18" node_number="1166"><a title="valid: False, node: 1167, tag: a, level: 19" node_number="1167">Crossref</a></div><div title="valid: False, node: 1168, tag: div, level: 18" node_number="1168"><a title="valid: False, node: 1169, tag: a, level: 19" node_number="1169">PubMed</a></div><div title="valid: False, node: 1170, tag: div, level: 18" node_number="1170"><a title="valid: False, node: 1171, tag: a, level: 19" node_number="1171">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1172, tag: div, level: 14" node_number="1172"><div title="valid: False, node: 1173, tag: div, level: 15" node_number="1173">50</div><div title="valid: False, node: 1174, tag: div, level: 15" node_number="1174"><div title="valid: False, node: 1175, tag: div, level: 16" node_number="1175"><div title="valid: False, node: 1176, tag: div, level: 17" node_number="1176">K. A. Earle, D. M. Ambrosino, A. Fiore-Gartland, D. Goldblatt, P. B. Gilbert, G. R. Siber, P. Dull, S. A. Plotkin, Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine <b title="valid: False, node: 1177, tag: b, level: 18" node_number="1177">39</b>, 4423&#8211;4428 (2021).</div><div title="valid: False, node: 1178, tag: div, level: 17" node_number="1178"><div title="valid: False, node: 1179, tag: div, level: 18" node_number="1179"><a title="valid: False, node: 1180, tag: a, level: 19" node_number="1180">Crossref</a></div><div title="valid: False, node: 1181, tag: div, level: 18" node_number="1181"><a title="valid: False, node: 1182, tag: a, level: 19" node_number="1182">PubMed</a></div><div title="valid: False, node: 1183, tag: div, level: 18" node_number="1183"><a title="valid: False, node: 1184, tag: a, level: 19" node_number="1184">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1185, tag: div, level: 14" node_number="1185"><div title="valid: False, node: 1186, tag: div, level: 15" node_number="1186">51</div><div title="valid: False, node: 1187, tag: div, level: 15" node_number="1187"><div title="valid: False, node: 1188, tag: div, level: 16" node_number="1188"><div title="valid: False, node: 1189, tag: div, level: 17" node_number="1189">K. McMahan, J. Yu, N. B. Mercado, C. Loos, L. H. Tostanoski, A. Chandrashekar, J. Liu, L. Peter, C. Atyeo, A. Zhu, E. A. Bondzie, G. Dagotto, M. S. Gebre, C. Jacob-Dolan, Z. Li, F. Nampanya, S. Patel, L. Pessaint, A. Van Ry, K. Blade, J. Yalley-Ogunro, M. Cabus, R. Brown, A. Cook, E. Teow, H. Andersen, M. G. Lewis, D. A. Lauffenburger, G. Alter, D. H. Barouch, Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature <b title="valid: False, node: 1190, tag: b, level: 18" node_number="1190">590</b>, 630&#8211;634 (2021).</div><div title="valid: False, node: 1191, tag: div, level: 17" node_number="1191"><div title="valid: False, node: 1192, tag: div, level: 18" node_number="1192"><a title="valid: False, node: 1193, tag: a, level: 19" node_number="1193">Crossref</a></div><div title="valid: False, node: 1194, tag: div, level: 18" node_number="1194"><a title="valid: False, node: 1195, tag: a, level: 19" node_number="1195">PubMed</a></div><div title="valid: False, node: 1196, tag: div, level: 18" node_number="1196"><a title="valid: False, node: 1197, tag: a, level: 19" node_number="1197">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1198, tag: div, level: 14" node_number="1198"><div title="valid: False, node: 1199, tag: div, level: 15" node_number="1199">52</div><div title="valid: False, node: 1200, tag: div, level: 15" node_number="1200"><div title="valid: False, node: 1201, tag: div, level: 16" node_number="1201"><div title="valid: False, node: 1202, tag: div, level: 17" node_number="1202">C. Rydyznski Moderbacher, S. I. Ramirez, J. M. Dan, A. Grifoni, K. M. Hastie, D. Weiskopf, S. Belanger, R. K. Abbott, C. Kim, J. Choi, Y. Kato, E. G. Crotty, C. Kim, S. A. Rawlings, J. Mateus, L. P. V. Tse, A. Frazier, R. Baric, B. Peters, J. Greenbaum, E. Ollmann Saphire, D. M. Smith, A. Sette, S. Crotty, Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell <b title="valid: False, node: 1203, tag: b, level: 18" node_number="1203">183</b>, 996&#8211;1012.e19 (2020).</div><div title="valid: False, node: 1204, tag: div, level: 17" node_number="1204"><div title="valid: False, node: 1205, tag: div, level: 18" node_number="1205"><a title="valid: False, node: 1206, tag: a, level: 19" node_number="1206">Crossref</a></div><div title="valid: False, node: 1207, tag: div, level: 18" node_number="1207"><a title="valid: False, node: 1208, tag: a, level: 19" node_number="1208">PubMed</a></div><div title="valid: False, node: 1209, tag: div, level: 18" node_number="1209"><a title="valid: False, node: 1210, tag: a, level: 19" node_number="1210">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1211, tag: div, level: 14" node_number="1211"><div title="valid: False, node: 1212, tag: div, level: 15" node_number="1212">53</div><div title="valid: False, node: 1213, tag: div, level: 15" node_number="1213"><div title="valid: False, node: 1214, tag: div, level: 16" node_number="1214"><div title="valid: False, node: 1215, tag: div, level: 17" node_number="1215">S. K. Saini, D. S. Hersby, T. Tamhane, H. R. Povlsen, S. P. Amaya Hernandez, M. Nielsen, A. O. Gang, S. R. Hadrup, SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8<sup title="valid: False, node: 1216, tag: sup, level: 18" node_number="1216">+</sup> T cell activation in COVID-19 patients. Sci. Immunol. <b title="valid: False, node: 1217, tag: b, level: 18" node_number="1217">6</b>, eabf7550 (2021).</div><div title="valid: False, node: 1218, tag: div, level: 17" node_number="1218"><div title="valid: False, node: 1219, tag: div, level: 18" node_number="1219"><a title="valid: False, node: 1220, tag: a, level: 19" node_number="1220">Crossref</a></div><div title="valid: False, node: 1221, tag: div, level: 18" node_number="1221"><a title="valid: False, node: 1222, tag: a, level: 19" node_number="1222">PubMed</a></div><div title="valid: False, node: 1223, tag: div, level: 18" node_number="1223"><a title="valid: False, node: 1224, tag: a, level: 19" node_number="1224">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1225, tag: div, level: 14" node_number="1225"><div title="valid: False, node: 1226, tag: div, level: 15" node_number="1226">54</div><div title="valid: False, node: 1227, tag: div, level: 15" node_number="1227"><div title="valid: False, node: 1228, tag: div, level: 16" node_number="1228"><div title="valid: False, node: 1229, tag: div, level: 17" node_number="1229">R. Parker, T. Partridge, C. Wormald, R. Kawahara, V. Stalls, M. Aggelakopoulou, J. Parker, R. Powell Doherty, Y. Ariosa Morejon, E. Lee, K. Saunders, B. F. Haynes, P. Acharya, M. Thaysen-Andersen, P. Borrow, N. Ternette, Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Cell Rep. <b title="valid: False, node: 1230, tag: b, level: 18" node_number="1230">35</b>, 109179 (2021).</div><div title="valid: False, node: 1231, tag: div, level: 17" node_number="1231"><div title="valid: False, node: 1232, tag: div, level: 18" node_number="1232"><a title="valid: False, node: 1233, tag: a, level: 19" node_number="1233">Crossref</a></div><div title="valid: False, node: 1234, tag: div, level: 18" node_number="1234"><a title="valid: False, node: 1235, tag: a, level: 19" node_number="1235">PubMed</a></div><div title="valid: False, node: 1236, tag: div, level: 18" node_number="1236"><a title="valid: False, node: 1237, tag: a, level: 19" node_number="1237">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1238, tag: div, level: 14" node_number="1238"><div title="valid: False, node: 1239, tag: div, level: 15" node_number="1239">55</div><div title="valid: False, node: 1240, tag: div, level: 15" node_number="1240"><div title="valid: False, node: 1241, tag: div, level: 16" node_number="1241"><div title="valid: False, node: 1242, tag: div, level: 17" node_number="1242">Y. Peng, A. J. Mentzer, G. Liu, X. Yao, Z. Yin, D. Dong, W. Dejnirattisai, T. Rostron, P. Supasa, C. Liu, C. L&#243;pez-Camacho, J. Slon-Campos, Y. Zhao, D. I. Stuart, G. C. Paesen, J. M. Grimes, A. A. Antson, O. W. Bayfield, D. E. D. P. Hawkins, D.-S. Ker, B. Wang, L. Turtle, K. Subramaniam, P. Thomson, P. Zhang, C. Dold, J. Ratcliff, P. Simmonds, T. de Silva, P. Sopp, D. Wellington, U. Rajapaksa, Y.-L. Chen, M. Salio, G. Napolitani, W. Paes, P. Borrow, B. M. Kessler, J. W. Fry, N. F. Schwabe, M. G. Semple, J. K. Baillie, S. C. Moore, P. J. M. Openshaw, M. A. Ansari, S. Dunachie, E. Barnes, J. Frater, G. Kerr, P. Goulder, T. Lockett, R. Levin, Y. Zhang, R. Jing, L.-P. Ho, R. J. Cornall, C. P. Conlon, P. Klenerman, G. R. Screaton, J. Mongkolsapaya, A. McMichael, J. C. Knight, G. Ogg, T. Dong; Oxford Immunology Network Covid-19 Response T cell Consortium; ISARIC4C Investigators, Broad and strong memory CD4<sup title="valid: False, node: 1243, tag: sup, level: 18" node_number="1243">+</sup> and CD8<sup title="valid: False, node: 1244, tag: sup, level: 18" node_number="1244">+</sup> T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. <b title="valid: False, node: 1245, tag: b, level: 18" node_number="1245">21</b>, 1336&#8211;1345 (2020).</div><div title="valid: False, node: 1246, tag: div, level: 17" node_number="1246"><div title="valid: False, node: 1247, tag: div, level: 18" node_number="1247"><a title="valid: False, node: 1248, tag: a, level: 19" node_number="1248">Crossref</a></div><div title="valid: False, node: 1249, tag: div, level: 18" node_number="1249"><a title="valid: False, node: 1250, tag: a, level: 19" node_number="1250">PubMed</a></div><div title="valid: False, node: 1251, tag: div, level: 18" node_number="1251"><a title="valid: False, node: 1252, tag: a, level: 19" node_number="1252">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1253, tag: div, level: 14" node_number="1253"><div title="valid: False, node: 1254, tag: div, level: 15" node_number="1254">56</div><div title="valid: False, node: 1255, tag: div, level: 15" node_number="1255"><div title="valid: False, node: 1256, tag: div, level: 16" node_number="1256"><div title="valid: False, node: 1257, tag: div, level: 17" node_number="1257">J. A. Juno, D. van Bockel, S. J. Kent, A. D. Kelleher, J. J. Zaunders, C. M. L. Munier, Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? Front. Immunol. <b title="valid: False, node: 1258, tag: b, level: 18" node_number="1258">8</b>, 19 (2017).</div><div title="valid: False, node: 1259, tag: div, level: 17" node_number="1259"><div title="valid: False, node: 1260, tag: div, level: 18" node_number="1260"><a title="valid: False, node: 1261, tag: a, level: 19" node_number="1261">Crossref</a></div><div title="valid: False, node: 1262, tag: div, level: 18" node_number="1262"><a title="valid: False, node: 1263, tag: a, level: 19" node_number="1263">PubMed</a></div><div title="valid: False, node: 1264, tag: div, level: 18" node_number="1264"><a title="valid: False, node: 1265, tag: a, level: 19" node_number="1265">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1266, tag: div, level: 14" node_number="1266"><div title="valid: False, node: 1267, tag: div, level: 15" node_number="1267">57</div><div title="valid: False, node: 1268, tag: div, level: 15" node_number="1268"><div title="valid: False, node: 1269, tag: div, level: 16" node_number="1269"><div title="valid: False, node: 1270, tag: div, level: 17" node_number="1270">B. J. Meckiff, C. Ram&#237;rez-Su&#225;stegui, V. Fajardo, S. J. Chee, A. Kusnadi, H. Simon, S. Eschweiler, A. Grifoni, E. Pelosi, D. Weiskopf, A. Sette, F. Ay, G. Seumois, C. H. Ottensmeier, P. Vijayanand, Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4<sup title="valid: False, node: 1271, tag: sup, level: 18" node_number="1271">+</sup> T Cells in COVID-19. Cell <b title="valid: False, node: 1272, tag: b, level: 18" node_number="1272">183</b>, 1340&#8211;1353.e16 (2020).</div><div title="valid: False, node: 1273, tag: div, level: 17" node_number="1273"><div title="valid: False, node: 1274, tag: div, level: 18" node_number="1274"><a title="valid: False, node: 1275, tag: a, level: 19" node_number="1275">Crossref</a></div><div title="valid: False, node: 1276, tag: div, level: 18" node_number="1276"><a title="valid: False, node: 1277, tag: a, level: 19" node_number="1277">PubMed</a></div><div title="valid: False, node: 1278, tag: div, level: 18" node_number="1278"><a title="valid: False, node: 1279, tag: a, level: 19" node_number="1279">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1280, tag: div, level: 14" node_number="1280"><div title="valid: False, node: 1281, tag: div, level: 15" node_number="1281">58</div><div title="valid: False, node: 1282, tag: div, level: 15" node_number="1282"><div title="valid: False, node: 1283, tag: div, level: 16" node_number="1283"><div title="valid: False, node: 1284, tag: div, level: 17" node_number="1284">N. Kaneko, J. Boucau, H.-H. Kuo, C. Perugino, V. S. Mahajan, J. R. Farmer, H. Liu, T. J. Diefenbach, A. Piechocka-Trocha, K. Lefteri, M. T. Waring, K. R. Premo, B. D. Walker, J. Z. Li, G. Gaiha, X. G. Yu, M. Lichterfeld, R. F. Padera, S. Pillai, Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19, Medrxiv, 2021.03.23.21253885 (2021).</div><div title="valid: False, node: 1285, tag: div, level: 17" node_number="1285"><div title="valid: False, node: 1286, tag: div, level: 18" node_number="1286"><a title="valid: False, node: 1287, tag: a, level: 19" node_number="1287">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1288, tag: div, level: 14" node_number="1288"><div title="valid: False, node: 1289, tag: div, level: 15" node_number="1289">59</div><div title="valid: False, node: 1290, tag: div, level: 15" node_number="1290"><div title="valid: False, node: 1291, tag: div, level: 16" node_number="1291"><div title="valid: False, node: 1292, tag: div, level: 17" node_number="1292">A. Fiore-Gartland, B. A. Manso, D. P. Friedrich, E. E. Gabriel, G. Finak, Z. Moodie, T. Hertz, S. C. De Rosa, N. Frahm, P. B. Gilbert, M. J. McElrath, Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials. PLOS ONE <b title="valid: False, node: 1293, tag: b, level: 18" node_number="1293">11</b>, e0147812 (2016).</div><div title="valid: False, node: 1294, tag: div, level: 17" node_number="1294"><div title="valid: False, node: 1295, tag: div, level: 18" node_number="1295"><a title="valid: False, node: 1296, tag: a, level: 19" node_number="1296">Crossref</a></div><div title="valid: False, node: 1297, tag: div, level: 18" node_number="1297"><a title="valid: False, node: 1298, tag: a, level: 19" node_number="1298">PubMed</a></div><div title="valid: False, node: 1299, tag: div, level: 18" node_number="1299"><a title="valid: False, node: 1300, tag: a, level: 19" node_number="1300">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1301, tag: div, level: 14" node_number="1301"><div title="valid: False, node: 1302, tag: div, level: 15" node_number="1302">60</div><div title="valid: False, node: 1303, tag: div, level: 15" node_number="1303"><div title="valid: False, node: 1304, tag: div, level: 16" node_number="1304"><div title="valid: False, node: 1305, tag: div, level: 17" node_number="1305">R. Keeton, S. I. Richardson, T. Moyo-Gwete, T. Hermanus, M. B. Tincho, N. Benede, N. P. Manamela, R, Baguma, Z. Makhado, A. Ngomti, T. Motlou, M. Mennen, L. Chinhoyi, S. Skelem, H. Maboreke, D. Doolabh, A. Iranzadeh, A. D. Otter, T. Brooks, M. Noursadeghi, J. Moon, J. Blackburn, N-Y. Hsiao, C. Williamson, C. Riou, A. Goga, N. Garrett, L-G. Bekker, G. Gray, N. A. B. Ntusi, P. L. Moore, W. A. Burgers, Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner, Medrxiv, 2021.07.24.21261037 (2021).</div><div title="valid: False, node: 1306, tag: div, level: 17" node_number="1306"><div title="valid: False, node: 1307, tag: div, level: 18" node_number="1307"><a title="valid: False, node: 1308, tag: a, level: 19" node_number="1308">Crossref</a></div><div title="valid: False, node: 1309, tag: div, level: 18" node_number="1309"><a title="valid: False, node: 1310, tag: a, level: 19" node_number="1310">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1311, tag: div, level: 14" node_number="1311"><div title="valid: False, node: 1312, tag: div, level: 15" node_number="1312">61</div><div title="valid: False, node: 1313, tag: div, level: 15" node_number="1313"><div title="valid: False, node: 1314, tag: div, level: 16" node_number="1314"><div title="valid: False, node: 1315, tag: div, level: 17" node_number="1315">A. Tarke, J. Sidney, N. Methot, E. D. Yu, Y. Zhang, J. M. Dan, B. Goodwin, P. Rubiro, A. Sutherland, E. Wang, A. Frazier, S. I. Ramirez, S. A. Rawlings, D. M. Smith, R. da Silva Antunes, B. Peters, R. H. Scheuermann, D. Weiskopf, S. Crotty, A. Grifoni, A. Sette, Impact of SARS-CoV-2 variants on the total CD4<sup title="valid: False, node: 1316, tag: sup, level: 18" node_number="1316">+</sup> and CD8<sup title="valid: False, node: 1317, tag: sup, level: 18" node_number="1317">+</sup> T&#160;cell reactivity in infected or vaccinated individuals. Cell Reports Medicine <b title="valid: False, node: 1318, tag: b, level: 18" node_number="1318">2</b>, 100355 (2021).</div><div title="valid: False, node: 1319, tag: div, level: 17" node_number="1319"><div title="valid: False, node: 1320, tag: div, level: 18" node_number="1320"><a title="valid: False, node: 1321, tag: a, level: 19" node_number="1321">Crossref</a></div><div title="valid: False, node: 1322, tag: div, level: 18" node_number="1322"><a title="valid: False, node: 1323, tag: a, level: 19" node_number="1323">PubMed</a></div><div title="valid: False, node: 1324, tag: div, level: 18" node_number="1324"><a title="valid: False, node: 1325, tag: a, level: 19" node_number="1325">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1326, tag: div, level: 14" node_number="1326"><div title="valid: False, node: 1327, tag: div, level: 15" node_number="1327">62</div><div title="valid: False, node: 1328, tag: div, level: 15" node_number="1328"><div title="valid: False, node: 1329, tag: div, level: 16" node_number="1329"><div title="valid: False, node: 1330, tag: div, level: 17" node_number="1330">D. Geers, M. C. Shamier, S. Bogers, G. den Hartog, L. Gommers, N. N. Nieuwkoop, K. S. Schmitz, L. C. Rijsbergen, J. A. T. van Osch, E. Dijkhuizen, G. Smits, A. Comvalius, D. van Mourik, T. G. Caniels, M. J. van Gils, R. W. Sanders, B. B. Oude Munnink, R. Molenkamp, H. J. de Jager, B. L. Haagmans, R. L. de Swart, M. P. G. Koopmans, R. S. van Binnendijk, R. D. de Vries, C. H. GeurtsvanKessel, SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci. Immunol. <b title="valid: False, node: 1331, tag: b, level: 18" node_number="1331">6</b>, eabj1750 (2021).</div><div title="valid: False, node: 1332, tag: div, level: 17" node_number="1332"><div title="valid: False, node: 1333, tag: div, level: 18" node_number="1333"><a title="valid: False, node: 1334, tag: a, level: 19" node_number="1334">Crossref</a></div><div title="valid: False, node: 1335, tag: div, level: 18" node_number="1335"><a title="valid: False, node: 1336, tag: a, level: 19" node_number="1336">PubMed</a></div><div title="valid: False, node: 1337, tag: div, level: 18" node_number="1337"><a title="valid: False, node: 1338, tag: a, level: 19" node_number="1338">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1339, tag: div, level: 14" node_number="1339"><div title="valid: False, node: 1340, tag: div, level: 15" node_number="1340">63</div><div title="valid: False, node: 1341, tag: div, level: 15" node_number="1341"><div title="valid: False, node: 1342, tag: div, level: 16" node_number="1342"><div title="valid: False, node: 1343, tag: div, level: 17" node_number="1343">C. J. Reynolds, C. Pade, J. M. Gibbons, D. K. Butler, A. D. Otter, K. Menacho, M. Fontana, A. Smit, J. E. Sackville-West, T. Cutino-Moguel, M. K. Maini, B. Chain, M. Noursadeghi, T. Brooks, A. Semper, C. Manisty, T. A. Treibel, J. C. Moon, A. M. Valdes, &#193;. McKnight, D. M. Altmann, R. Boyton; UK COVIDsortium Immune Correlates Network; UK COVIDsortium Investigators, Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science <b title="valid: False, node: 1344, tag: b, level: 18" node_number="1344">&#8226;&#8226;&#8226;</b>, eabh1282 (2021).</div><div title="valid: False, node: 1345, tag: div, level: 17" node_number="1345"><div title="valid: False, node: 1346, tag: div, level: 18" node_number="1346"><a title="valid: False, node: 1347, tag: a, level: 19" node_number="1347">PubMed</a></div><div title="valid: False, node: 1348, tag: div, level: 18" node_number="1348"><a title="valid: False, node: 1349, tag: a, level: 19" node_number="1349">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1350, tag: div, level: 14" node_number="1350"><div title="valid: False, node: 1351, tag: div, level: 15" node_number="1351">64</div><div title="valid: False, node: 1352, tag: div, level: 15" node_number="1352"><div title="valid: False, node: 1353, tag: div, level: 16" node_number="1353"><div title="valid: False, node: 1354, tag: div, level: 17" node_number="1354">S. Cleemput, W. Dumon, V. Fonseca, W. Abdool Karim, M. Giovanetti, L. C. Alcantara, K. Deforche, T. de Oliveira, Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes. Bioinformatics <b title="valid: False, node: 1355, tag: b, level: 18" node_number="1355">36</b>, 3552&#8211;3555 (2020).</div><div title="valid: False, node: 1356, tag: div, level: 17" node_number="1356"><div title="valid: False, node: 1357, tag: div, level: 18" node_number="1357"><a title="valid: False, node: 1358, tag: a, level: 19" node_number="1358">Crossref</a></div><div title="valid: False, node: 1359, tag: div, level: 18" node_number="1359"><a title="valid: False, node: 1360, tag: a, level: 19" node_number="1360">PubMed</a></div><div title="valid: False, node: 1361, tag: div, level: 18" node_number="1361"><a title="valid: False, node: 1362, tag: a, level: 19" node_number="1362">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1363, tag: div, level: 14" node_number="1363"><div title="valid: False, node: 1364, tag: div, level: 15" node_number="1364">65</div><div title="valid: False, node: 1365, tag: div, level: 15" node_number="1365"><div title="valid: False, node: 1366, tag: div, level: 16" node_number="1366"><div title="valid: False, node: 1367, tag: div, level: 17" node_number="1367">J. Hadfield, C. Megill, S. M. Bell, J. Huddleston, B. Potter, C. Callender, P. Sagulenko, T. Bedford, R. A. Neher, Nextstrain: Real-time tracking of pathogen evolution. Bioinformatics <b title="valid: False, node: 1368, tag: b, level: 18" node_number="1368">34</b>, 4121&#8211;4123 (2018).</div><div title="valid: False, node: 1369, tag: div, level: 17" node_number="1369"><div title="valid: False, node: 1370, tag: div, level: 18" node_number="1370"><a title="valid: False, node: 1371, tag: a, level: 19" node_number="1371">Crossref</a></div><div title="valid: False, node: 1372, tag: div, level: 18" node_number="1372"><a title="valid: False, node: 1373, tag: a, level: 19" node_number="1373">PubMed</a></div><div title="valid: False, node: 1374, tag: div, level: 18" node_number="1374"><a title="valid: False, node: 1375, tag: a, level: 19" node_number="1375">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1376, tag: div, level: 14" node_number="1376"><div title="valid: False, node: 1377, tag: div, level: 15" node_number="1377">66</div><div title="valid: False, node: 1378, tag: div, level: 15" node_number="1378"><div title="valid: False, node: 1379, tag: div, level: 16" node_number="1379"><div title="valid: False, node: 1380, tag: div, level: 17" node_number="1380">G. Yu, D. K. Smith, H. Zhu, Y. Guan, T. T. Lam, ggtree: An r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. <b title="valid: False, node: 1381, tag: b, level: 18" node_number="1381">8</b>, 28&#8211;36 (2017).</div><div title="valid: False, node: 1382, tag: div, level: 17" node_number="1382"><div title="valid: False, node: 1383, tag: div, level: 18" node_number="1383"><a title="valid: False, node: 1384, tag: a, level: 19" node_number="1384">Crossref</a></div><div title="valid: False, node: 1385, tag: div, level: 18" node_number="1385"><a title="valid: False, node: 1386, tag: a, level: 19" node_number="1386">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1387, tag: div, level: 14" node_number="1387"><div title="valid: False, node: 1388, tag: div, level: 15" node_number="1388">67</div><div title="valid: False, node: 1389, tag: div, level: 15" node_number="1389"><div title="valid: False, node: 1390, tag: div, level: 16" node_number="1390"><div title="valid: False, node: 1391, tag: div, level: 17" node_number="1391">S. Paul, J. Sidney, A. Sette, B. Peters, TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates, <i title="valid: False, node: 1392, tag: i, level: 18" node_number="1392">Curr Protoc Immunol</i> <b title="valid: False, node: 1393, tag: b, level: 18" node_number="1393">114</b>, 18.19.1-18.19.24 (2016). </div><div title="valid: False, node: 1394, tag: div, level: 17" node_number="1394"><div title="valid: False, node: 1395, tag: div, level: 18" node_number="1395"><a title="valid: False, node: 1396, tag: a, level: 19" node_number="1396">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1397, tag: div, level: 14" node_number="1397"><div title="valid: False, node: 1398, tag: div, level: 15" node_number="1398">68</div><div title="valid: False, node: 1399, tag: div, level: 15" node_number="1399"><div title="valid: False, node: 1400, tag: div, level: 16" node_number="1400"><div title="valid: False, node: 1401, tag: div, level: 17" node_number="1401">K. K. Jensen, M. Andreatta, P. Marcatili, S. Buus, J. A. Greenbaum, Z. Yan, A. Sette, B. Peters, M. Nielsen, Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology <b title="valid: False, node: 1402, tag: b, level: 18" node_number="1402">154</b>, 394&#8211;406 (2018).</div><div title="valid: False, node: 1403, tag: div, level: 17" node_number="1403"><div title="valid: False, node: 1404, tag: div, level: 18" node_number="1404"><a title="valid: False, node: 1405, tag: a, level: 19" node_number="1405">Crossref</a></div><div title="valid: False, node: 1406, tag: div, level: 18" node_number="1406"><a title="valid: False, node: 1407, tag: a, level: 19" node_number="1407">PubMed</a></div><div title="valid: False, node: 1408, tag: div, level: 18" node_number="1408"><a title="valid: False, node: 1409, tag: a, level: 19" node_number="1409">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1410, tag: div, level: 14" node_number="1410"><div title="valid: False, node: 1411, tag: div, level: 15" node_number="1411">69</div><div title="valid: False, node: 1412, tag: div, level: 15" node_number="1412"><div title="valid: False, node: 1413, tag: div, level: 16" node_number="1413"><div title="valid: False, node: 1414, tag: div, level: 17" node_number="1414">M. Andreatta, E. Karosiene, M. Rasmussen, A. Stryhn, S. Buus, M. Nielsen, Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics <b title="valid: False, node: 1415, tag: b, level: 18" node_number="1415">67</b>, 641&#8211;650 (2015).</div><div title="valid: False, node: 1416, tag: div, level: 17" node_number="1416"><div title="valid: False, node: 1417, tag: div, level: 18" node_number="1417"><a title="valid: False, node: 1418, tag: a, level: 19" node_number="1418">Crossref</a></div><div title="valid: False, node: 1419, tag: div, level: 18" node_number="1419"><a title="valid: False, node: 1420, tag: a, level: 19" node_number="1420">PubMed</a></div><div title="valid: False, node: 1421, tag: div, level: 18" node_number="1421"><a title="valid: False, node: 1422, tag: a, level: 19" node_number="1422">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1423, tag: div, level: 14" node_number="1423"><div title="valid: False, node: 1424, tag: div, level: 15" node_number="1424">70</div><div title="valid: False, node: 1425, tag: div, level: 15" node_number="1425"><div title="valid: False, node: 1426, tag: div, level: 16" node_number="1426"><div title="valid: False, node: 1427, tag: div, level: 17" node_number="1427">J. Sidney, E. Assarsson, C. Moore, S. Ngo, C. Pinilla, A. Sette, B. Peters, Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. <b title="valid: False, node: 1428, tag: b, level: 18" node_number="1428">4</b>, 2 (2008).</div><div title="valid: False, node: 1429, tag: div, level: 17" node_number="1429"><div title="valid: False, node: 1430, tag: div, level: 18" node_number="1430"><a title="valid: False, node: 1431, tag: a, level: 19" node_number="1431">Crossref</a></div><div title="valid: False, node: 1432, tag: div, level: 18" node_number="1432"><a title="valid: False, node: 1433, tag: a, level: 19" node_number="1433">PubMed</a></div><div title="valid: False, node: 1434, tag: div, level: 18" node_number="1434"><a title="valid: False, node: 1435, tag: a, level: 19" node_number="1435">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1436, tag: div, level: 14" node_number="1436"><div title="valid: False, node: 1437, tag: div, level: 15" node_number="1437">71</div><div title="valid: False, node: 1438, tag: div, level: 15" node_number="1438"><div title="valid: False, node: 1439, tag: div, level: 16" node_number="1439"><div title="valid: False, node: 1440, tag: div, level: 17" node_number="1440">M. Nielsen, C. Lundegaard, O. Lund, Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics <b title="valid: False, node: 1441, tag: b, level: 18" node_number="1441">8</b>, 238 (2007).</div><div title="valid: False, node: 1442, tag: div, level: 17" node_number="1442"><div title="valid: False, node: 1443, tag: div, level: 18" node_number="1443"><a title="valid: False, node: 1444, tag: a, level: 19" node_number="1444">Crossref</a></div><div title="valid: False, node: 1445, tag: div, level: 18" node_number="1445"><a title="valid: False, node: 1446, tag: a, level: 19" node_number="1446">PubMed</a></div><div title="valid: False, node: 1447, tag: div, level: 18" node_number="1447"><a title="valid: False, node: 1448, tag: a, level: 19" node_number="1448">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1449, tag: div, level: 14" node_number="1449"><div title="valid: False, node: 1450, tag: div, level: 15" node_number="1450">72</div><div title="valid: False, node: 1451, tag: div, level: 15" node_number="1451"><div title="valid: False, node: 1452, tag: div, level: 16" node_number="1452"><div title="valid: False, node: 1453, tag: div, level: 17" node_number="1453">T. Sturniolo, E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia, J. Hammer, Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. <b title="valid: False, node: 1454, tag: b, level: 18" node_number="1454">17</b>, 555&#8211;561 (1999).</div><div title="valid: False, node: 1455, tag: div, level: 17" node_number="1455"><div title="valid: False, node: 1456, tag: div, level: 18" node_number="1456"><a title="valid: False, node: 1457, tag: a, level: 19" node_number="1457">Crossref</a></div><div title="valid: False, node: 1458, tag: div, level: 18" node_number="1458"><a title="valid: False, node: 1459, tag: a, level: 19" node_number="1459">PubMed</a></div><div title="valid: False, node: 1460, tag: div, level: 18" node_number="1460"><a title="valid: False, node: 1461, tag: a, level: 19" node_number="1461">Google Scholar</a></div></div></div></div></div></section></div></section><div class="valid" valid="valid" title="valid: True, node: 1462, tag: div, level: 11" node_number="1462"><div class="valid" valid="valid" title="valid: True, node: 1463, tag: div, level: 12" node_number="1463"><header class="valid" valid="valid" title="valid: True, node: 1464, tag: header, level: 13" node_number="1464"><h2 class="valid" valid="valid" title="valid: True, node: 1465, tag: h2, level: 14" node_number="1465">Information Authors</h2></header><section class="valid" valid="valid" title="valid: True, node: 1466, tag: section, level: 13" node_number="1466"><h3 class="valid" valid="valid" title="valid: True, node: 1467, tag: h3, level: 14" node_number="1467">Information</h3><section class="valid" valid="valid" title="valid: True, node: 1468, tag: section, level: 14" node_number="1468"><h4 title="valid: False, node: 1469, tag: h4, level: 15" node_number="1469">Published In</h4><div title="valid: False, node: 1470, tag: div, level: 15" node_number="1470"> <div title="valid: False, node: 1471, tag: div, level: 16" node_number="1471"><div title="valid: False, node: 1472, tag: div, level: 17" node_number="1472">Science Translational Medicine</div><div title="valid: False, node: 1473, tag: div, level: 17" node_number="1473">First Release</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1474, tag: section, level: 14" node_number="1474"><h4 title="valid: False, node: 1475, tag: h4, level: 15" node_number="1475">Copyright</h4><div title="valid: False, node: 1476, tag: div, level: 15" node_number="1476">Copyright &#169; 2021, American Association for the Advancement of Science.</div><div title="valid: False, node: 1477, tag: div, level: 15" node_number="1477">https://creativecommons.org/licenses/by/4.0/ </div><div title="valid: False, node: 1478, tag: div, level: 15" node_number="1478">This is an open-access article distributed under the terms of the <a title="valid: False, node: 1479, tag: a, level: 16" node_number="1479">Creative Commons Attribution license</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></section><section class="valid" valid="valid" title="valid: True, node: 1480, tag: section, level: 14" node_number="1480"><h4 title="valid: False, node: 1481, tag: h4, level: 15" node_number="1481">Submission history</h4><div title="valid: False, node: 1482, tag: div, level: 15" node_number="1482"><b title="valid: False, node: 1483, tag: b, level: 16" node_number="1483">Received</b>: 31 May 2021</div><div title="valid: False, node: 1484, tag: div, level: 15" node_number="1484"><b title="valid: False, node: 1485, tag: b, level: 16" node_number="1485">Accepted</b>: 15 December 2021</div></section><section class="valid" valid="valid" title="valid: True, node: 1486, tag: section, level: 14" node_number="1486"><h4 title="valid: False, node: 1487, tag: h4, level: 15" node_number="1487">Permissions</h4><div title="valid: False, node: 1488, tag: div, level: 15" node_number="1488">Request permissions for this article.</div><div title="valid: False, node: 1489, tag: div, level: 15" node_number="1489"><a title="valid: False, node: 1490, tag: a, level: 16" node_number="1490">Request Permissions</a></div></section><section class="valid" valid="valid" title="valid: True, node: 1491, tag: section, level: 14" node_number="1491"><h4 title="valid: False, node: 1492, tag: h4, level: 15" node_number="1492">Acknowledgments</h4><div title="valid: False, node: 1493, tag: div, level: 15" node_number="1493">We thank the study participants and their families, and the clinical staff and personnel at Groote Schuur Hospital for their support and dedication. We thank the informal Variant consortium of South Africa, chaired by Drs Willem Hanekom and Tulio de Oliveira, for suggestions and discussion of data. For the purposes of open access, the authors have applied a CC BY public copyright license to any author-accepted version arising from this submission.</div><div title="valid: False, node: 1494, tag: div, level: 15" node_number="1494"><b title="valid: False, node: 1495, tag: b, level: 16" node_number="1495">Funding:</b> This research was supported by the South African Medical Research Council, with funds received from the South African Department of Science and Innovation (DSI), and the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), which is supported by core funding from the Wellcome Trust [203135/Z/16/Z]. CR and WAB are supported by the EDCTP2 program of the European Union (EU)&#8217;s Horizon 2020 program (TMA2017SF-1951-TB-SPEC to CR and TMA2016SF-1535-CaTCH-22 to WAB). This work is further supported by the National Institutes of Health (R21AI148027 to CR), Francis Crick Institute, which receives funding from Wellcome FC0010218, UKRI FC0010218 and CRUK FC0010218 and the Rosetrees Trust grant M926 (to CR and RJW). PLM is supported by the South African Research Chairs Initiative of the DSI and the National Research Foundation (Grant No 9834). NABN acknowledges funding from the SA-MRC, MRC UK, NRF, and the Lily and Ernst Hausmann Trust.</div><div title="valid: False, node: 1496, tag: div, level: 15" node_number="1496"><b title="valid: False, node: 1497, tag: b, level: 16" node_number="1497">Author contributions:</b> WAB, CR, PLM, NABN and RJW conceived and designed the study, acquired funding and supervised the work. LRC, MM, SS, EdB and CS recruited the study participants. CR, RK, RB, HM, MBT and NB performed the T cell experiments. TH, TM-G and PK performed the neutralizing assays. ZV-O and MS performed HLA typing. HT, DD, LT, AI, GM, CW and TdO performed the sequencing and phylogenetic analyses. CR and WAB analyzed the data and wrote the manuscript, with all authors contributing by providing critical feedback and final review.</div><div title="valid: False, node: 1498, tag: div, level: 15" node_number="1498"><b title="valid: False, node: 1499, tag: b, level: 16" node_number="1499">Competing interests:</b> The authors declare that they have no competing interests.</div><div title="valid: False, node: 1500, tag: div, level: 15" node_number="1500"><b title="valid: False, node: 1501, tag: b, level: 16" node_number="1501">Data and materials availability:</b> All data are available in the main text or the supplementary materials. All materials used in this manuscript are commercially available.</div><div title="valid: False, node: 1502, tag: div, level: 15" node_number="1502">This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit <a title="valid: False, node: 1503, tag: a, level: 16" node_number="1503">https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 1504, tag: section, level: 13" node_number="1504"><h3 class="valid" valid="valid" title="valid: True, node: 1505, tag: h3, level: 14" node_number="1505">Authors</h3><section class="valid" valid="valid" title="valid: True, node: 1506, tag: section, level: 14" node_number="1506"><h4 title="valid: False, node: 1507, tag: h4, level: 15" node_number="1507">Affiliations</h4><div title="valid: False, node: 1508, tag: div, level: 15" node_number="1508"><div title="valid: False, node: 1509, tag: div, level: 16" node_number="1509">Catherine Riou<sup title="valid: False, node: 1510, tag: sup, level: 17" node_number="1510">*</sup> <a title="valid: False, node: 1511, tag: a, level: 17" node_number="1511">https://orcid.org/0000-0001-9679-0745</a> <a title="valid: False, node: 1512, tag: a, level: 17" node_number="1512">[email&#160;protected]</a></div><div title="valid: False, node: 1513, tag: div, level: 16" node_number="1513"><div title="valid: False, node: 1514, tag: div, level: 17" node_number="1514"><div title="valid: False, node: 1515, tag: div, level: 18" node_number="1515">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1516, tag: div, level: 18" node_number="1516">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1517, tag: div, level: 18" node_number="1517">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1518, tag: div, level: 17" node_number="1518">View all articles by this author</div></div></div><div title="valid: False, node: 1519, tag: div, level: 15" node_number="1519"><div title="valid: False, node: 1520, tag: div, level: 16" node_number="1520">Roanne Keeton https://orcid.org/0000-0003-4808-9756</div><div title="valid: False, node: 1521, tag: div, level: 16" node_number="1521"><div title="valid: False, node: 1522, tag: div, level: 17" node_number="1522"><div title="valid: False, node: 1523, tag: div, level: 18" node_number="1523">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1524, tag: div, level: 18" node_number="1524">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1525, tag: div, level: 17" node_number="1525">View all articles by this author</div></div></div><div title="valid: False, node: 1526, tag: div, level: 15" node_number="1526"><div title="valid: False, node: 1527, tag: div, level: 16" node_number="1527">Thandeka Moyo-Gwete https://orcid.org/0000-0002-4269-9281</div><div title="valid: False, node: 1528, tag: div, level: 16" node_number="1528"><div title="valid: False, node: 1529, tag: div, level: 17" node_number="1529"><div title="valid: False, node: 1530, tag: div, level: 18" node_number="1530">National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div title="valid: False, node: 1531, tag: div, level: 18" node_number="1531">MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div title="valid: False, node: 1532, tag: div, level: 17" node_number="1532">View all articles by this author</div></div></div><div title="valid: False, node: 1533, tag: div, level: 15" node_number="1533"><div title="valid: False, node: 1534, tag: div, level: 16" node_number="1534">Tandile Hermanus https://orcid.org/0000-0003-4734-1980</div><div title="valid: False, node: 1535, tag: div, level: 16" node_number="1535"><div title="valid: False, node: 1536, tag: div, level: 17" node_number="1536"><div title="valid: False, node: 1537, tag: div, level: 18" node_number="1537">National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div title="valid: False, node: 1538, tag: div, level: 18" node_number="1538">MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div title="valid: False, node: 1539, tag: div, level: 17" node_number="1539">View all articles by this author</div></div></div><div title="valid: False, node: 1540, tag: div, level: 15" node_number="1540"><div title="valid: False, node: 1541, tag: div, level: 16" node_number="1541">Prudence Kgagudi</div><div title="valid: False, node: 1542, tag: div, level: 16" node_number="1542"><div title="valid: False, node: 1543, tag: div, level: 17" node_number="1543"><div title="valid: False, node: 1544, tag: div, level: 18" node_number="1544">National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div title="valid: False, node: 1545, tag: div, level: 18" node_number="1545">MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div title="valid: False, node: 1546, tag: div, level: 17" node_number="1546">View all articles by this author</div></div></div><div title="valid: False, node: 1547, tag: div, level: 15" node_number="1547"><div title="valid: False, node: 1548, tag: div, level: 16" node_number="1548">Richard Baguma https://orcid.org/0000-0002-5106-021X</div><div title="valid: False, node: 1549, tag: div, level: 16" node_number="1549"><div title="valid: False, node: 1550, tag: div, level: 17" node_number="1550"><div title="valid: False, node: 1551, tag: div, level: 18" node_number="1551">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1552, tag: div, level: 18" node_number="1552">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1553, tag: div, level: 17" node_number="1553">View all articles by this author</div></div></div><div title="valid: False, node: 1554, tag: div, level: 15" node_number="1554"><div title="valid: False, node: 1555, tag: div, level: 16" node_number="1555">Ziyaad Valley-Omar https://orcid.org/0000-0003-4804-3774</div><div title="valid: False, node: 1556, tag: div, level: 16" node_number="1556"><div title="valid: False, node: 1557, tag: div, level: 17" node_number="1557"><div title="valid: False, node: 1558, tag: div, level: 18" node_number="1558">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1559, tag: div, level: 17" node_number="1559">View all articles by this author</div></div></div><div title="valid: False, node: 1560, tag: div, level: 15" node_number="1560"><div title="valid: False, node: 1561, tag: div, level: 16" node_number="1561">Mikhail Smith</div><div title="valid: False, node: 1562, tag: div, level: 16" node_number="1562"><div title="valid: False, node: 1563, tag: div, level: 17" node_number="1563"><div title="valid: False, node: 1564, tag: div, level: 18" node_number="1564">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1565, tag: div, level: 17" node_number="1565">View all articles by this author</div></div></div><div title="valid: False, node: 1566, tag: div, level: 15" node_number="1566"><div title="valid: False, node: 1567, tag: div, level: 16" node_number="1567">Houriiyah Tegally https://orcid.org/0000-0002-7102-8540</div><div title="valid: False, node: 1568, tag: div, level: 16" node_number="1568"><div title="valid: False, node: 1569, tag: div, level: 17" node_number="1569"><div title="valid: False, node: 1570, tag: div, level: 18" node_number="1570">KwaZulu-Natal Research Innovation and Sequencing Platform; Durban, South Africa.</div></div><div title="valid: False, node: 1571, tag: div, level: 17" node_number="1571">View all articles by this author</div></div></div><div title="valid: False, node: 1572, tag: div, level: 15" node_number="1572"><div title="valid: False, node: 1573, tag: div, level: 16" node_number="1573">Deelan Doolabh</div><div title="valid: False, node: 1574, tag: div, level: 16" node_number="1574"><div title="valid: False, node: 1575, tag: div, level: 17" node_number="1575"><div title="valid: False, node: 1576, tag: div, level: 18" node_number="1576">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1577, tag: div, level: 17" node_number="1577">View all articles by this author</div></div></div><div title="valid: False, node: 1578, tag: div, level: 15" node_number="1578"><div title="valid: False, node: 1579, tag: div, level: 16" node_number="1579">Arash Iranzadeh</div><div title="valid: False, node: 1580, tag: div, level: 16" node_number="1580"><div title="valid: False, node: 1581, tag: div, level: 17" node_number="1581"><div title="valid: False, node: 1582, tag: div, level: 18" node_number="1582">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1583, tag: div, level: 17" node_number="1583">View all articles by this author</div></div></div><div title="valid: False, node: 1584, tag: div, level: 15" node_number="1584"><div title="valid: False, node: 1585, tag: div, level: 16" node_number="1585">Lynn Tyers https://orcid.org/0000-0002-0535-9165</div><div title="valid: False, node: 1586, tag: div, level: 16" node_number="1586"><div title="valid: False, node: 1587, tag: div, level: 17" node_number="1587"><div title="valid: False, node: 1588, tag: div, level: 18" node_number="1588">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1589, tag: div, level: 17" node_number="1589">View all articles by this author</div></div></div><div title="valid: False, node: 1590, tag: div, level: 15" node_number="1590"><div title="valid: False, node: 1591, tag: div, level: 16" node_number="1591">Hygon Mutavhatsindi https://orcid.org/0000-0001-6605-6275</div><div title="valid: False, node: 1592, tag: div, level: 16" node_number="1592"><div title="valid: False, node: 1593, tag: div, level: 17" node_number="1593"><div title="valid: False, node: 1594, tag: div, level: 18" node_number="1594">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1595, tag: div, level: 18" node_number="1595">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1596, tag: div, level: 17" node_number="1596">View all articles by this author</div></div></div><div title="valid: False, node: 1597, tag: div, level: 15" node_number="1597"><div title="valid: False, node: 1598, tag: div, level: 16" node_number="1598">Marius B. Tincho https://orcid.org/0000-0002-1293-5933</div><div title="valid: False, node: 1599, tag: div, level: 16" node_number="1599"><div title="valid: False, node: 1600, tag: div, level: 17" node_number="1600"><div title="valid: False, node: 1601, tag: div, level: 18" node_number="1601">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1602, tag: div, level: 18" node_number="1602">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1603, tag: div, level: 17" node_number="1603">View all articles by this author</div></div></div><div title="valid: False, node: 1604, tag: div, level: 15" node_number="1604"><div title="valid: False, node: 1605, tag: div, level: 16" node_number="1605">Ntombi Benede https://orcid.org/0000-0002-3319-8215</div><div title="valid: False, node: 1606, tag: div, level: 16" node_number="1606"><div title="valid: False, node: 1607, tag: div, level: 17" node_number="1607"><div title="valid: False, node: 1608, tag: div, level: 18" node_number="1608">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1609, tag: div, level: 18" node_number="1609">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1610, tag: div, level: 17" node_number="1610">View all articles by this author</div></div></div><div title="valid: False, node: 1611, tag: div, level: 15" node_number="1611"><div title="valid: False, node: 1612, tag: div, level: 16" node_number="1612">Gert Marais https://orcid.org/0000-0003-1477-6101</div><div title="valid: False, node: 1613, tag: div, level: 16" node_number="1613"><div title="valid: False, node: 1614, tag: div, level: 17" node_number="1614"><div title="valid: False, node: 1615, tag: div, level: 18" node_number="1615">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1616, tag: div, level: 18" node_number="1616">Groote Schuur Hospital Medical Virology Laboratory of the National Health Laboratory Service; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1617, tag: div, level: 17" node_number="1617">View all articles by this author</div></div></div><div title="valid: False, node: 1618, tag: div, level: 15" node_number="1618"><div title="valid: False, node: 1619, tag: div, level: 16" node_number="1619">Lionel R. Chinhoyi https://orcid.org/0000-0002-5266-4613</div><div title="valid: False, node: 1620, tag: div, level: 16" node_number="1620"><div title="valid: False, node: 1621, tag: div, level: 17" node_number="1621"><div title="valid: False, node: 1622, tag: div, level: 18" node_number="1622">Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div title="valid: False, node: 1623, tag: div, level: 18" node_number="1623">Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1624, tag: div, level: 17" node_number="1624">View all articles by this author</div></div></div><div title="valid: False, node: 1625, tag: div, level: 15" node_number="1625"><div title="valid: False, node: 1626, tag: div, level: 16" node_number="1626">Mathilda Mennen</div><div title="valid: False, node: 1627, tag: div, level: 16" node_number="1627"><div title="valid: False, node: 1628, tag: div, level: 17" node_number="1628"><div title="valid: False, node: 1629, tag: div, level: 18" node_number="1629">Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div title="valid: False, node: 1630, tag: div, level: 18" node_number="1630">Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1631, tag: div, level: 17" node_number="1631">View all articles by this author</div></div></div><div title="valid: False, node: 1632, tag: div, level: 15" node_number="1632"><div title="valid: False, node: 1633, tag: div, level: 16" node_number="1633">Sango Skelem</div><div title="valid: False, node: 1634, tag: div, level: 16" node_number="1634"><div title="valid: False, node: 1635, tag: div, level: 17" node_number="1635"><div title="valid: False, node: 1636, tag: div, level: 18" node_number="1636">Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div title="valid: False, node: 1637, tag: div, level: 18" node_number="1637">Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1638, tag: div, level: 17" node_number="1638">View all articles by this author</div></div></div><div title="valid: False, node: 1639, tag: div, level: 15" node_number="1639"><div title="valid: False, node: 1640, tag: div, level: 16" node_number="1640">Elsa du Bruyn https://orcid.org/0000-0002-5088-2158</div><div title="valid: False, node: 1641, tag: div, level: 16" node_number="1641"><div title="valid: False, node: 1642, tag: div, level: 17" node_number="1642"><div title="valid: False, node: 1643, tag: div, level: 18" node_number="1643">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1644, tag: div, level: 18" node_number="1644">Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1645, tag: div, level: 17" node_number="1645">View all articles by this author</div></div></div><div title="valid: False, node: 1646, tag: div, level: 15" node_number="1646"><div title="valid: False, node: 1647, tag: div, level: 16" node_number="1647">Cari Stek</div><div title="valid: False, node: 1648, tag: div, level: 16" node_number="1648"><div title="valid: False, node: 1649, tag: div, level: 17" node_number="1649"><div title="valid: False, node: 1650, tag: div, level: 18" node_number="1650">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1651, tag: div, level: 18" node_number="1651">Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div title="valid: False, node: 1652, tag: div, level: 18" node_number="1652">Department of Infectious Diseases, Imperial College London; W12 0NN, UK.</div></div><div title="valid: False, node: 1653, tag: div, level: 17" node_number="1653">View all articles by this author</div></div></div><div title="valid: False, node: 1654, tag: div, level: 15" node_number="1654"><div title="valid: False, node: 1655, tag: div, level: 16" node_number="1655">SA-CIN<a title="valid: False, node: 1656, tag: a, level: 17" node_number="1656"><sup title="valid: False, node: 1657, tag: sup, level: 18" node_number="1657">&#8224;</sup></a></div></div><div title="valid: False, node: 1658, tag: div, level: 15" node_number="1658"><div title="valid: False, node: 1659, tag: div, level: 16" node_number="1659">Tulio de Oliveira https://orcid.org/0000-0002-3027-5254</div><div title="valid: False, node: 1660, tag: div, level: 16" node_number="1660"><div title="valid: False, node: 1661, tag: div, level: 17" node_number="1661"><div title="valid: False, node: 1662, tag: div, level: 18" node_number="1662">KwaZulu-Natal Research Innovation and Sequencing Platform; Durban, South Africa.</div></div><div title="valid: False, node: 1663, tag: div, level: 17" node_number="1663">View all articles by this author</div></div></div><div title="valid: False, node: 1664, tag: div, level: 15" node_number="1664"><div title="valid: False, node: 1665, tag: div, level: 16" node_number="1665">Carolyn Williamson https://orcid.org/0000-0003-0125-1226</div><div title="valid: False, node: 1666, tag: div, level: 16" node_number="1666"><div title="valid: False, node: 1667, tag: div, level: 17" node_number="1667"><div title="valid: False, node: 1668, tag: div, level: 18" node_number="1668">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1669, tag: div, level: 18" node_number="1669">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1670, tag: div, level: 18" node_number="1670">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1671, tag: div, level: 17" node_number="1671">View all articles by this author</div></div></div><div title="valid: False, node: 1672, tag: div, level: 15" node_number="1672"><div title="valid: False, node: 1673, tag: div, level: 16" node_number="1673">Penny L. Moore https://orcid.org/0000-0001-8719-4028</div><div title="valid: False, node: 1674, tag: div, level: 16" node_number="1674"><div title="valid: False, node: 1675, tag: div, level: 17" node_number="1675"><div title="valid: False, node: 1676, tag: div, level: 18" node_number="1676">National Institute for Communicable Diseases of the National Health Laboratory Services; Johannesburg, South Africa.</div><div title="valid: False, node: 1677, tag: div, level: 18" node_number="1677">MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.</div></div><div title="valid: False, node: 1678, tag: div, level: 17" node_number="1678">View all articles by this author</div></div></div><div title="valid: False, node: 1679, tag: div, level: 15" node_number="1679"><div title="valid: False, node: 1680, tag: div, level: 16" node_number="1680">Robert J. Wilkinson</div><div title="valid: False, node: 1681, tag: div, level: 16" node_number="1681"><div title="valid: False, node: 1682, tag: div, level: 17" node_number="1682"><div title="valid: False, node: 1683, tag: div, level: 18" node_number="1683">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1684, tag: div, level: 18" node_number="1684">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1685, tag: div, level: 18" node_number="1685">Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div title="valid: False, node: 1686, tag: div, level: 18" node_number="1686">Department of Infectious Diseases, Imperial College London; W12 0NN, UK.</div><div title="valid: False, node: 1687, tag: div, level: 18" node_number="1687">The Francis Crick Institute; London, NW1 1AT, UK.</div></div><div title="valid: False, node: 1688, tag: div, level: 17" node_number="1688">View all articles by this author</div></div></div><div title="valid: False, node: 1689, tag: div, level: 15" node_number="1689"><div title="valid: False, node: 1690, tag: div, level: 16" node_number="1690">Ntobeko A. B. Ntusi https://orcid.org/0000-0003-2347-7883</div><div title="valid: False, node: 1691, tag: div, level: 16" node_number="1691"><div title="valid: False, node: 1692, tag: div, level: 17" node_number="1692"><div title="valid: False, node: 1693, tag: div, level: 18" node_number="1693">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1694, tag: div, level: 18" node_number="1694">Department of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory 7925, South Africa.</div><div title="valid: False, node: 1695, tag: div, level: 18" node_number="1695">Hatter Institute for Cardiovascular Research in Africa, Faculty of Health Sciences, University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1696, tag: div, level: 17" node_number="1696">View all articles by this author</div></div></div><div title="valid: False, node: 1697, tag: div, level: 15" node_number="1697"><div title="valid: False, node: 1698, tag: div, level: 16" node_number="1698">Wendy A. Burgers<sup title="valid: False, node: 1699, tag: sup, level: 17" node_number="1699">*</sup> https://orcid.org/0000-0003-3396-9398 [email&#160;protected]</div><div title="valid: False, node: 1700, tag: div, level: 16" node_number="1700"><div title="valid: False, node: 1701, tag: div, level: 17" node_number="1701"><div title="valid: False, node: 1702, tag: div, level: 18" node_number="1702">Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1703, tag: div, level: 18" node_number="1703">Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Observatory 7925, South Africa.</div><div title="valid: False, node: 1704, tag: div, level: 18" node_number="1704">Division of Medical Virology, Department of Pathology; University of Cape Town; Observatory 7925, South Africa.</div></div><div title="valid: False, node: 1705, tag: div, level: 17" node_number="1705">View all articles by this author</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1706, tag: section, level: 14" node_number="1706"><h4 title="valid: False, node: 1707, tag: h4, level: 15" node_number="1707">Funding Information</h4><div title="valid: False, node: 1708, tag: div, level: 15" node_number="1708">National Institutes of Health: R21AI148027</div><div title="valid: False, node: 1709, tag: div, level: 15" node_number="1709">ASCRS Research Foundation: </div><div title="valid: False, node: 1710, tag: div, level: 15" node_number="1710"><a title="valid: False, node: 1711, tag: a, level: 16" node_number="1711">University of Kentucky</a>: </div><div title="valid: False, node: 1712, tag: div, level: 15" node_number="1712"><a title="valid: False, node: 1713, tag: a, level: 16" node_number="1713">Wellcome</a>: 203135/Z/16/Z</div><div title="valid: False, node: 1714, tag: div, level: 15" node_number="1714"><a title="valid: False, node: 1715, tag: a, level: 16" node_number="1715">Wellcome</a>: 222754</div><div title="valid: False, node: 1716, tag: div, level: 15" node_number="1716"><a title="valid: False, node: 1717, tag: a, level: 16" node_number="1717">Francis Crick Institute</a>: Wellcome FC0010218, UKRI FC0010218 and CRUK FC0010218</div><div title="valid: False, node: 1718, tag: div, level: 15" node_number="1718"><a title="valid: False, node: 1719, tag: a, level: 16" node_number="1719">National Research Foundation</a>: 129614</div><div title="valid: False, node: 1720, tag: div, level: 15" node_number="1720"><a title="valid: False, node: 1721, tag: a, level: 16" node_number="1721">Norsk Revmatikerforbund</a>: 203135/Z/16/Z</div><div title="valid: False, node: 1722, tag: div, level: 15" node_number="1722"><a title="valid: False, node: 1723, tag: a, level: 16" node_number="1723">Norsk Revmatikerforbund</a>: EDCTP2</div><div title="valid: False, node: 1724, tag: div, level: 15" node_number="1724"><a title="valid: False, node: 1725, tag: a, level: 16" node_number="1725">Norsk Revmatikerforbund</a>: TMA2017SF-1951-TB-SPEC</div><div title="valid: False, node: 1726, tag: div, level: 15" node_number="1726"><a title="valid: False, node: 1727, tag: a, level: 16" node_number="1727">Norsk Revmatikerforbund</a>: TMA2016SF-1535-C</div><div title="valid: False, node: 1728, tag: div, level: 15" node_number="1728"><a title="valid: False, node: 1729, tag: a, level: 16" node_number="1729">Norsk Revmatikerforbund</a>: R21AI148027</div><div title="valid: False, node: 1730, tag: div, level: 15" node_number="1730"><a title="valid: False, node: 1731, tag: a, level: 16" node_number="1731">Norsk Revmatikerforbund</a>: FC0010218</div><div title="valid: False, node: 1732, tag: div, level: 15" node_number="1732"><a title="valid: False, node: 1733, tag: a, level: 16" node_number="1733">Norsk Revmatikerforbund</a>: UKRI FC0010218</div><div title="valid: False, node: 1734, tag: div, level: 15" node_number="1734"><a title="valid: False, node: 1735, tag: a, level: 16" node_number="1735">Norsk Revmatikerforbund</a>: CRUK FC0010218</div><div title="valid: False, node: 1736, tag: div, level: 15" node_number="1736"><a title="valid: False, node: 1737, tag: a, level: 16" node_number="1737">Computational Renewables</a>: </div><div title="valid: False, node: 1738, tag: div, level: 15" node_number="1738"><a title="valid: False, node: 1739, tag: a, level: 16" node_number="1739">Defence Science Institute</a>: </div><div title="valid: False, node: 1740, tag: div, level: 15" node_number="1740"><a title="valid: False, node: 1741, tag: a, level: 16" node_number="1741">South African Medical Research Council</a>: </div><div title="valid: False, node: 1742, tag: div, level: 15" node_number="1742"><a title="valid: False, node: 1743, tag: a, level: 16" node_number="1743">European and Developing Countries Clinical Trials Partnership</a>: TMA2016SF-1535-CaTCH-22</div><div title="valid: False, node: 1744, tag: div, level: 15" node_number="1744"><a title="valid: False, node: 1745, tag: a, level: 16" node_number="1745">European and Developing Countries Clinical Trials Partnership</a>: TMA2017SF-1951-TB-SPEC</div><div title="valid: False, node: 1746, tag: div, level: 15" node_number="1746"><a title="valid: False, node: 1747, tag: a, level: 16" node_number="1747">Rosetrees Trust</a>: M926</div><div title="valid: False, node: 1748, tag: div, level: 15" node_number="1748"><a title="valid: False, node: 1749, tag: a, level: 16" node_number="1749">Medical Research Centre</a>: </div><div title="valid: False, node: 1750, tag: div, level: 15" node_number="1750"><a title="valid: False, node: 1751, tag: a, level: 16" node_number="1751">Norsk Revmatikerforbund</a>: </div><div title="valid: False, node: 1752, tag: div, level: 15" node_number="1752">South African Research Chairs Initiative of the Department of Science and Innovation and the National Research Foundation: 9834</div></section><section class="valid" valid="valid" title="valid: True, node: 1753, tag: section, level: 14" node_number="1753"><h4 title="valid: False, node: 1754, tag: h4, level: 15" node_number="1754">Notes</h4><div title="valid: False, node: 1755, tag: div, level: 15" node_number="1755">*Corresponding authors. Catherine Riou; email: <a title="valid: False, node: 1756, tag: a, level: 16" node_number="1756">[email&#160;protected]</a>; Wendy Burgers; email: <a title="valid: False, node: 1757, tag: a, level: 16" node_number="1757">[email&#160;protected]</a></div><div title="valid: False, node: 1758, tag: div, level: 15" node_number="1758"><div title="valid: False, node: 1759, tag: div, level: 16" node_number="1759"><sup title="valid: False, node: 1760, tag: sup, level: 17" node_number="1760">&#8224;</sup></div><div title="valid: False, node: 1761, tag: div, level: 16" node_number="1761">South African Cellular Immunology Network (SA-CIN) collaborators and affiliations are listed in the supplementary materials.</div></div></section></section></div><div class="valid" valid="valid" title="valid: True, node: 1762, tag: div, level: 12" node_number="1762"><header class="valid" valid="valid" title="valid: True, node: 1763, tag: header, level: 13" node_number="1763"><h2 class="valid" valid="valid" title="valid: True, node: 1764, tag: h2, level: 14" node_number="1764">Metrics Citations</h2></header><section class="valid" valid="valid" title="valid: True, node: 1765, tag: section, level: 13" node_number="1765"><h3 class="valid" valid="valid" title="valid: True, node: 1766, tag: h3, level: 14" node_number="1766">Metrics</h3><section class="valid" valid="valid" title="valid: True, node: 1767, tag: section, level: 14" node_number="1767"> <h5 title="valid: False, node: 1768, tag: h5, level: 15" node_number="1768"> Article Usage </h5> </section><section class="valid" valid="valid" title="valid: True, node: 1769, tag: section, level: 14" node_number="1769"> <h5 title="valid: False, node: 1770, tag: h5, level: 15" node_number="1770"> Altmetrics </h5> </section></section><section class="valid" valid="valid" title="valid: True, node: 1771, tag: section, level: 13" node_number="1771"><h3 class="valid" valid="valid" title="valid: True, node: 1772, tag: h3, level: 14" node_number="1772">Citations</h3><section class="valid" valid="valid" title="valid: True, node: 1773, tag: section, level: 14" node_number="1773"> <div title="valid: False, node: 1774, tag: div, level: 15" node_number="1774"> <h5 title="valid: False, node: 1775, tag: h5, level: 16" node_number="1775">Export citation</h5> <p title="valid: False, node: 1776, tag: p, level: 16" node_number="1776">Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div class="valid" valid="valid" title="valid: True, node: 1777, tag: div, level: 12" node_number="1777"><header class="valid" valid="valid" title="valid: True, node: 1778, tag: header, level: 13" node_number="1778"><h2 class="valid" valid="valid" title="valid: True, node: 1779, tag: h2, level: 14" node_number="1779">View Options</h2></header><div class="valid" valid="valid" title="valid: True, node: 1780, tag: div, level: 13" node_number="1780"><h3 class="valid" valid="valid" title="valid: True, node: 1781, tag: h3, level: 14" node_number="1781">View options</h3><section class="valid" valid="valid" title="valid: True, node: 1782, tag: section, level: 14" node_number="1782"><h4 title="valid: False, node: 1783, tag: h4, level: 15" node_number="1783">PDF format</h4><p title="valid: False, node: 1784, tag: p, level: 15" node_number="1784">Download this article as a PDF file</p><a title="valid: False, node: 1785, tag: a, level: 15" node_number="1785">Download PDF</a></section></div><div class="valid" valid="valid" title="valid: True, node: 1786, tag: div, level: 13" node_number="1786"><h3 class="valid" valid="valid" title="valid: True, node: 1787, tag: h3, level: 14" node_number="1787">Get Access</h3><section class="valid" valid="valid" title="valid: True, node: 1788, tag: section, level: 14" node_number="1788"> <div title="valid: False, node: 1789, tag: div, level: 15" node_number="1789"><h5 title="valid: False, node: 1790, tag: h5, level: 16" node_number="1790">Log in to view the full text</h5> <p title="valid: False, node: 1791, tag: p, level: 16" node_number="1791"><a title="valid: False, node: 1792, tag: a, level: 17" node_number="1792">AAAS Log in</a></p> <p title="valid: False, node: 1793, tag: p, level: 16" node_number="1793">AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul title="valid: False, node: 1794, tag: ul, level: 16" node_number="1794"> <li title="valid: False, node: 1795, tag: li, level: 17" node_number="1795">Become a AAAS Member</li> <li title="valid: False, node: 1796, tag: li, level: 17" node_number="1796"><a title="valid: False, node: 1797, tag: a, level: 18" node_number="1797">Activate your Account</a></li> <li title="valid: False, node: 1798, tag: li, level: 17" node_number="1798"><a title="valid: False, node: 1799, tag: a, level: 18" node_number="1799">Purchase Access to Other Journals in the Science Family</a></li> <li title="valid: False, node: 1800, tag: li, level: 17" node_number="1800"><a title="valid: False, node: 1801, tag: a, level: 18" node_number="1801">Account Help</a></li> </ul> <div title="valid: False, node: 1802, tag: div, level: 16" node_number="1802"> <div title="valid: False, node: 1803, tag: div, level: 17" node_number="1803">Log in via OpenAthens. <div title="valid: False, node: 1804, tag: div, level: 18" node_number="1804"><a title="valid: False, node: 1805, tag: a, level: 19" node_number="1805">via OpenAthens</a></div> </div> <div title="valid: False, node: 1806, tag: div, level: 17" node_number="1806">Log in via Shibboleth. <div title="valid: False, node: 1807, tag: div, level: 18" node_number="1807"><a title="valid: False, node: 1808, tag: a, level: 19" node_number="1808">via Shibboleth</a></div> </div> </div> </div> <div title="valid: False, node: 1809, tag: div, level: 15" node_number="1809"><h4 title="valid: False, node: 1810, tag: h4, level: 16" node_number="1810">More options</h4><p title="valid: False, node: 1811, tag: p, level: 16" node_number="1811"><a title="valid: False, node: 1812, tag: a, level: 17" node_number="1812">Purchase digital access to this article</a></p><p title="valid: False, node: 1813, tag: p, level: 16" node_number="1813">Download and print this article for your personal scholarly, research, and educational use.</p></div> </section></div></div><div class="valid" valid="valid" title="valid: True, node: 1814, tag: div, level: 12" node_number="1814"><header class="valid" valid="valid" title="valid: True, node: 1815, tag: header, level: 13" node_number="1815"><h2 class="valid" valid="valid" title="valid: True, node: 1816, tag: h2, level: 14" node_number="1816">Media</h2></header><section class="valid" valid="valid" title="valid: True, node: 1817, tag: section, level: 13" node_number="1817"><h3 class="valid" valid="valid" title="valid: True, node: 1818, tag: h3, level: 14" node_number="1818">Figures</h3></section><section class="valid" valid="valid" title="valid: True, node: 1819, tag: section, level: 13" node_number="1819"><h3 class="valid" valid="valid" title="valid: True, node: 1820, tag: h3, level: 14" node_number="1820">Multimedia</h3></section></div><div class="valid" valid="valid" title="valid: True, node: 1821, tag: div, level: 12" node_number="1821"><header class="valid" valid="valid" title="valid: True, node: 1822, tag: header, level: 13" node_number="1822"><h2 class="valid" valid="valid" title="valid: True, node: 1823, tag: h2, level: 14" node_number="1823">Tables</h2></header></div><div class="valid" valid="valid" title="valid: True, node: 1824, tag: div, level: 12" node_number="1824"><header class="valid" valid="valid" title="valid: True, node: 1825, tag: header, level: 13" node_number="1825"><h2 class="valid" valid="valid" title="valid: True, node: 1826, tag: h2, level: 14" node_number="1826">Share</h2></header><h3 class="valid" valid="valid" title="valid: True, node: 1827, tag: h3, level: 13" node_number="1827">Share</h3><div class="valid" valid="valid" title="valid: True, node: 1828, tag: div, level: 13" node_number="1828"><section class="valid" valid="valid" title="valid: True, node: 1829, tag: section, level: 14" node_number="1829"><h4 title="valid: False, node: 1830, tag: h4, level: 15" node_number="1830">Share article link</h4><div title="valid: False, node: 1831, tag: div, level: 15" node_number="1831"><a title="valid: False, node: 1832, tag: a, level: 16" node_number="1832">Copy Link</a><div title="valid: False, node: 1833, tag: div, level: 16" node_number="1833"><p title="valid: False, node: 1834, tag: p, level: 17" node_number="1834">Copied!</p><p title="valid: False, node: 1835, tag: p, level: 17" node_number="1835">Copying failed.</p></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1836, tag: section, level: 14" node_number="1836"><h4 title="valid: False, node: 1837, tag: h4, level: 15" node_number="1837">Share on social media</h4><div title="valid: False, node: 1838, tag: div, level: 15" node_number="1838"><a title="valid: False, node: 1839, tag: a, level: 16" node_number="1839">facebook</a><a title="valid: False, node: 1840, tag: a, level: 16" node_number="1840">twitter</a><a title="valid: False, node: 1841, tag: a, level: 16" node_number="1841">linkedin</a><a title="valid: False, node: 1842, tag: a, level: 16" node_number="1842">email</a></div></section></div></div></div></article><section class="valid" valid="valid" title="valid: True, node: 1843, tag: section, level: 10" node_number="1843"><div class="valid" valid="valid" title="valid: True, node: 1844, tag: div, level: 11" node_number="1844"><div class="valid" valid="valid" title="valid: True, node: 1845, tag: div, level: 12" node_number="1845"><div class="valid" valid="valid" title="valid: True, node: 1846, tag: div, level: 13" node_number="1846"><div class="valid" valid="valid" title="valid: True, node: 1847, tag: div, level: 14" node_number="1847"><h3 title="valid: False, node: 1848, tag: h3, level: 15" node_number="1848">Submit a Response to This Article</h3></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 1849, tag: div, level: 11" node_number="1849"> <div class="valid" valid="valid" title="valid: True, node: 1850, tag: div, level: 12" node_number="1850"> <h2 class="valid" valid="valid" title="valid: True, node: 1851, tag: h2, level: 13" node_number="1851">(0)eLetters</h2> </div> <p class="valid" valid="valid" title="valid: True, node: 1852, tag: p, level: 12" node_number="1852">eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p class="valid" valid="valid" title="valid: True, node: 1853, tag: p, level: 12" node_number="1853">No eLetters have been published for this article yet.</p> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 1854, tag: div, level: 10" node_number="1854"><a class="valid" valid="valid" title="valid: True, node: 1855, tag: a, level: 11" node_number="1855">View Full Text</a><a class="valid" valid="valid" title="valid: True, node: 1856, tag: a, level: 11" node_number="1856">Download PDF</a></div> </div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1857, tag: div, level: 6" node_number="1857"><div class="valid" valid="valid" title="valid: True, node: 1858, tag: div, level: 7" node_number="1858"><div class="valid" valid="valid" title="valid: True, node: 1859, tag: div, level: 8" node_number="1859"><div class="valid" valid="valid" title="valid: True, node: 1860, tag: div, level: 9" node_number="1860"><section class="valid" valid="valid" title="valid: True, node: 1861, tag: section, level: 10" node_number="1861"><div class="valid" valid="valid" title="valid: True, node: 1862, tag: div, level: 11" node_number="1862"><h4 class="valid" valid="valid" title="valid: True, node: 1863, tag: h4, level: 12" node_number="1863"> Current Issue </h4><div class="valid" valid="valid" title="valid: True, node: 1864, tag: div, level: 12" node_number="1864"><div class="valid" valid="valid" title="valid: True, node: 1865, tag: div, level: 13" node_number="1865"> <div class="valid" valid="valid" title="valid: True, node: 1866, tag: div, level: 14" node_number="1866"><div title="valid: False, node: 1867, tag: div, level: 15" node_number="1867"><article title="valid: False, node: 1868, tag: article, level: 16" node_number="1868"><div title="valid: False, node: 1869, tag: div, level: 17" node_number="1869"><div title="valid: False, node: 1870, tag: div, level: 18" node_number="1870"><h3 title="valid: False, node: 1871, tag: h3, level: 19" node_number="1871"><a title="valid: False, node: 1872, tag: a, level: 20" node_number="1872">Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics</a></h3><ul title="valid: False, node: 1873, tag: ul, level: 19" node_number="1873"><li title="valid: False, node: 1874, tag: li, level: 20" node_number="1874">By<ul title="valid: False, node: 1875, tag: ul, level: 21" node_number="1875"> <li title="valid: False, node: 1876, tag: li, level: 22" node_number="1876">Jay-Hyun Jo</li> <li title="valid: False, node: 1877, tag: li, level: 22" node_number="1877">Catriona P. Harkins</li> <li title="valid: False, node: 1878, tag: li, level: 22" node_number="1878">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 1879, tag: article, level: 16" node_number="1879"><div title="valid: False, node: 1880, tag: div, level: 17" node_number="1880"><div title="valid: False, node: 1881, tag: div, level: 18" node_number="1881"><h3 title="valid: False, node: 1882, tag: h3, level: 19" node_number="1882">A human orthogonal IL-2 and IL-2R&#946; system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia</h3><ul title="valid: False, node: 1883, tag: ul, level: 19" node_number="1883"><li title="valid: False, node: 1884, tag: li, level: 20" node_number="1884">By<ul title="valid: False, node: 1885, tag: ul, level: 21" node_number="1885"> <li title="valid: False, node: 1886, tag: li, level: 22" node_number="1886">Qian Zhang</li> <li title="valid: False, node: 1887, tag: li, level: 22" node_number="1887">Morgan E. Hresko</li> <li title="valid: False, node: 1888, tag: li, level: 22" node_number="1888">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 1889, tag: article, level: 16" node_number="1889"><div title="valid: False, node: 1890, tag: div, level: 17" node_number="1890"><div title="valid: False, node: 1891, tag: div, level: 18" node_number="1891"><h3 title="valid: False, node: 1892, tag: h3, level: 19" node_number="1892">An orthogonal IL-2 and IL-2R&#946; system drives persistence and activation of CAR T cells and clearance of bulky lymphoma</h3><ul title="valid: False, node: 1893, tag: ul, level: 19" node_number="1893"><li title="valid: False, node: 1894, tag: li, level: 20" node_number="1894">By<ul title="valid: False, node: 1895, tag: ul, level: 21" node_number="1895"> <li title="valid: False, node: 1896, tag: li, level: 22" node_number="1896">Paul-Joseph Aspuria</li> <li title="valid: False, node: 1897, tag: li, level: 22" node_number="1897">Sandro Vivona</li> <li title="valid: False, node: 1898, tag: li, level: 22" node_number="1898">et al.</li> </ul> </li></ul></div></div></article></div><div title="valid: False, node: 1899, tag: div, level: 15" node_number="1899">Table of Contents</div></div> </div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 1900, tag: section, level: 10" node_number="1900"> <h4 class="valid" valid="valid" title="valid: True, node: 1901, tag: h4, level: 11" node_number="1901">LATEST NEWS</h4> <div class="valid" valid="valid" title="valid: True, node: 1902, tag: div, level: 11" node_number="1902"> <div class="valid" valid="valid" title="valid: True, node: 1903, tag: div, level: 12" node_number="1903"><div class="valid" valid="valid" title="valid: True, node: 1904, tag: div, level: 13" node_number="1904"> <article class="valid" valid="valid" title="valid: True, node: 1905, tag: article, level: 14" node_number="1905"> <div title="valid: False, node: 1906, tag: div, level: 15" node_number="1906"> <div title="valid: False, node: 1907, tag: div, level: 16" node_number="1907"> News<time title="valid: False, node: 1908, tag: time, level: 17" node_number="1908">30 Dec 2021</time> </div> <div title="valid: False, node: 1909, tag: div, level: 16" node_number="1909"> Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1910, tag: article, level: 14" node_number="1910"> <div title="valid: False, node: 1911, tag: div, level: 15" node_number="1911"> <div title="valid: False, node: 1912, tag: div, level: 16" node_number="1912"> ScienceInsider<time title="valid: False, node: 1913, tag: time, level: 17" node_number="1913">29 Dec 2021</time> </div> <div title="valid: False, node: 1914, tag: div, level: 16" node_number="1914"> <a title="valid: False, node: 1915, tag: a, level: 17" node_number="1915"> Once a &#8216;crazy idea,&#8217; patent-pooling nonprofit will help bring COVID-19 pills to world&#8217;s poor </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1916, tag: article, level: 14" node_number="1916"> <div title="valid: False, node: 1917, tag: div, level: 15" node_number="1917"> <div title="valid: False, node: 1918, tag: div, level: 16" node_number="1918"> ScienceInsider<time title="valid: False, node: 1919, tag: time, level: 17" node_number="1919">28 Dec 2021</time> </div> <div title="valid: False, node: 1920, tag: div, level: 16" node_number="1920"> The natural world loses two of its biggest advocates </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1921, tag: article, level: 14" node_number="1921"> <div title="valid: False, node: 1922, tag: div, level: 15" node_number="1922"> <div title="valid: False, node: 1923, tag: div, level: 16" node_number="1923"> ScienceInsider<time title="valid: False, node: 1924, tag: time, level: 17" node_number="1924">28 Dec 2021</time> </div> <div title="valid: False, node: 1925, tag: div, level: 16" node_number="1925"> <a title="valid: False, node: 1926, tag: a, level: 17" node_number="1926"> What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1927, tag: article, level: 14" node_number="1927"> <div title="valid: False, node: 1928, tag: div, level: 15" node_number="1928"> <div title="valid: False, node: 1929, tag: div, level: 16" node_number="1929"> ScienceInsider<time title="valid: False, node: 1930, tag: time, level: 17" node_number="1930">25 Dec 2021</time> </div> <div title="valid: False, node: 1931, tag: div, level: 16" node_number="1931"> NASA&#8217;s Webb telescope takes flight&#8212;a Christmas gift to astronomers everywhere </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 1932, tag: article, level: 14" node_number="1932"> <div title="valid: False, node: 1933, tag: div, level: 15" node_number="1933"> <div title="valid: False, node: 1934, tag: div, level: 16" node_number="1934"> News<time title="valid: False, node: 1935, tag: time, level: 17" node_number="1935">23 Dec 2021</time> </div> <div title="valid: False, node: 1936, tag: div, level: 16" node_number="1936"> <a title="valid: False, node: 1937, tag: a, level: 17" node_number="1937"> More than a virus: Science&#8217;s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>